Shared
Attribute: Data Use Codes¶
| Valid Value | Description | Ontology |
|---|---|---|
| Pending Annotation | Data Use Codes have not yet been provided or documented for this resource. | Not available |
| DUO:0000042 | This data use permission indicates that use is allowed for general research use for any research purpose. | DUO:0000042 |
| DUO:0000027 | This data use modifier indicates that use is limited to use within an approved project. | DUO:0000027 |
| DUO:0000016 | This data use modifier indicates that use is limited to genetic studies only (i.e., studies that include genotype research alone or both genotype and phenotype research, but not phenotype research exclusively) | DUO:0000016 |
| DUO:0000029 | This data use modifier indicates that the requestor must return derived/enriched data to the database/resource. | DUO:0000029 |
| DUO:0000043 | This data use modifier indicates that use is allowed for clinical use and care. | DUO:0000043 |
| DUO:0000015 | This data use modifier indicates that use does not allow methods development research (e.g., development of software or algorithms). | DUO:0000015 |
| DUO:0000004 | This data use permission indicates there is no restriction on use. | DUO:0000004 |
| DUO:0000045 | This data use modifier indicates that use of the data is limited to not-for-profit organizations. | DUO:0000045 |
| DUO:0000017 | Data use modifiers indicate additional conditions for use. | DUO:0000017 |
| DUO:0000011 | This data use permission indicates that use of the data is limited to the study of population origins or ancestry. | DUO:0000011 |
| DUO:0000046 | This data use modifier indicates that use of the data is limited to not-for-profit use. | DUO:0000046 |
| DUO:0000018 | This data use modifier indicates that use of the data is limited to not-for-profit organizations and not-for-profit use, non-commercial use. | DUO:0000018 |
| DUO:0000044 | This data use modifier indicates use for purposes of population, origin, or ancestry research is prohibited. | DUO:0000044 |
| DUO:0000021 | This data use modifier indicates that the requestor must provide documentation of local IRB/ERB approval. | DUO:0000021 |
| DUO:0000006 | This data use permission indicates that use is allowed for health/medical/biomedical purposes; does not include the study of population origins or ancestry. | DUO:0000006 |
| DUO:0000019 | This data use modifier indicates that requestor agrees to make results of studies using the data available to the larger scientific community. | DUO:0000019 |
| DUO:0000026 | This data use modifier indicates that use is limited to use by approved users. If providing this term, please describe the restrictions in column userSpecificRestriction. | DUO:0000026 |
| DUO:0000020 | This data use modifier indicates that the requestor must agree to collaboration with the primary study investigator(s). If providing this term, please note the contact email in column collaborationRequired. | DUO:0000020 |
| DUO:0000012 | This data use modifier indicates that use is limited to studies of a certain research type. If providing this term, please note the research type(s) in column researchSpecificRestrictions. | DUO:0000012 |
| DUO:0000025 | This data use modifier indicates that use is approved for a specific number of months. If providing this term, please provide the number of months in column timeLimitOnUse. | DUO:0000025 |
| DUO:0000024 | This data use modifier indicates that requestor agrees not to publish results of studies until a specific date. If providing this term, please provide the date in column publicationMoratorium. | DUO:0000024 |
| DUO:0000028 | This data use modifier indicates that use is limited to use within an approved institution. If providing this term, please provide the institution ROR ID(s) in column institutionSpecificRestriction. | DUO:0000028 |
| DUO:0000022 | This data use modifier indicates that use is limited to within a specific geographic region. If providing this term, please provide the applicable country code(s) in column geographicalRestriction. | DUO:0000022 |
| DUO:0000007 | This data use permission indicates that use is allowed provided it is related to the specified disease. If providing this term, please provide the disease MONDO ID(s) in column diseaseSpecificResearch. | DUO:0000007 |
| DUOPlus1 | Source geography is relevant to governance decisions. If providing this term, please provide the applicable country code(s) in column sourceGeography | Not available |
| DUOPlus2 | Study population is relevant to governance decisions. If providing this term, please provide the applicable population type(s) in column populationType. | Not available |
| DUOPlus3 | Data deidentification is relevant to governance decisions. If providing this term, please provide the applicable deidentification type(s) in column deidentificationType. | Not available |
| DUOPlus4 | A data permission designation is associated with the Study. If providing this term, please provide the applicable permission type(s) in column dataPermission. | Not available |
| DUOPlus5 | A data tier designation is associated with the Study. If providing this term, please provide the applicable data tier designation(s) in column dataTier. | Not available |
| DUOPlus6 | A license is associated with the Study. If providing this term, please provide the applicable license in column license. | Not available |
| DUOPlus7 | Attribution conditions are associated with this Study. If providing this term, please provide the attribution statement in column attribution. | Not available |
Attribute: dataUseModifiers¶
| Valid Value | Description | Ontology |
|---|---|---|
| Pending Annotation | Data Use Codes have not yet been provided or documented for this resource. | Not available |
| DUO:0000042 | This data use permission indicates that use is allowed for general research use for any research purpose. | DUO:0000042 |
| DUO:0000027 | This data use modifier indicates that use is limited to use within an approved project. | DUO:0000027 |
| DUO:0000016 | This data use modifier indicates that use is limited to genetic studies only (i.e., studies that include genotype research alone or both genotype and phenotype research, but not phenotype research exclusively) | DUO:0000016 |
| DUO:0000029 | This data use modifier indicates that the requestor must return derived/enriched data to the database/resource. | DUO:0000029 |
| DUO:0000043 | This data use modifier indicates that use is allowed for clinical use and care. | DUO:0000043 |
| DUO:0000015 | This data use modifier indicates that use does not allow methods development research (e.g., development of software or algorithms). | DUO:0000015 |
| DUO:0000004 | This data use permission indicates there is no restriction on use. | DUO:0000004 |
| DUO:0000045 | This data use modifier indicates that use of the data is limited to not-for-profit organizations. | DUO:0000045 |
| DUO:0000017 | Data use modifiers indicate additional conditions for use. | DUO:0000017 |
| DUO:0000011 | This data use permission indicates that use of the data is limited to the study of population origins or ancestry. | DUO:0000011 |
| DUO:0000046 | This data use modifier indicates that use of the data is limited to not-for-profit use. | DUO:0000046 |
| DUO:0000018 | This data use modifier indicates that use of the data is limited to not-for-profit organizations and not-for-profit use, non-commercial use. | DUO:0000018 |
| DUO:0000044 | This data use modifier indicates use for purposes of population, origin, or ancestry research is prohibited. | DUO:0000044 |
| DUO:0000021 | This data use modifier indicates that the requestor must provide documentation of local IRB/ERB approval. | DUO:0000021 |
| DUO:0000006 | This data use permission indicates that use is allowed for health/medical/biomedical purposes; does not include the study of population origins or ancestry. | DUO:0000006 |
| DUO:0000019 | This data use modifier indicates that requestor agrees to make results of studies using the data available to the larger scientific community. | DUO:0000019 |
| DUO:0000026 | This data use modifier indicates that use is limited to use by approved users. If providing this term, please describe the restrictions in column userSpecificRestriction. | DUO:0000026 |
| DUO:0000020 | This data use modifier indicates that the requestor must agree to collaboration with the primary study investigator(s). If providing this term, please note the contact email in column collaborationRequired. | DUO:0000020 |
| DUO:0000012 | This data use modifier indicates that use is limited to studies of a certain research type. If providing this term, please note the research type(s) in column researchSpecificRestrictions. | DUO:0000012 |
| DUO:0000025 | This data use modifier indicates that use is approved for a specific number of months. If providing this term, please provide the number of months in column timeLimitOnUse. | DUO:0000025 |
| DUO:0000024 | This data use modifier indicates that requestor agrees not to publish results of studies until a specific date. If providing this term, please provide the date in column publicationMoratorium. | DUO:0000024 |
| DUO:0000028 | This data use modifier indicates that use is limited to use within an approved institution. If providing this term, please provide the institution ROR ID(s) in column institutionSpecificRestriction. | DUO:0000028 |
| DUO:0000022 | This data use modifier indicates that use is limited to within a specific geographic region. If providing this term, please provide the applicable country code(s) in column geographicalRestriction. | DUO:0000022 |
| DUO:0000007 | This data use permission indicates that use is allowed provided it is related to the specified disease. If providing this term, please provide the disease MONDO ID(s) in column diseaseSpecificResearch. | DUO:0000007 |
| DUOPlus1 | Source geography is relevant to governance decisions. If providing this term, please provide the applicable country code(s) in column sourceGeography | Not available |
| DUOPlus2 | Study population is relevant to governance decisions. If providing this term, please provide the applicable population type(s) in column populationType. | Not available |
| DUOPlus3 | Data deidentification is relevant to governance decisions. If providing this term, please provide the applicable deidentification type(s) in column deidentificationType. | Not available |
| DUOPlus4 | A data permission designation is associated with the Study. If providing this term, please provide the applicable permission type(s) in column dataPermission. | Not available |
| DUOPlus5 | A data tier designation is associated with the Study. If providing this term, please provide the applicable data tier designation(s) in column dataTier. | Not available |
| DUOPlus6 | A license is associated with the Study. If providing this term, please provide the applicable license in column license. | Not available |
| DUOPlus7 | Attribution conditions are associated with this Study. If providing this term, please provide the attribution statement in column attribution. | Not available |
Attribute: File Assay Category¶
| Valid Value | Description | Ontology |
|---|---|---|
| DNA Sequencing | The determination of the sequence of purines and pyrimidines in deoxyribonucleic acid (DNA). | NCIT:C153598 |
| Immunofluorescence | A microscopy staining method that utilizes immunofluorescent markers for use with histological applications of preserved cells. | NCIT:C142337 |
| LC-MS/MS | An analytical technique wherein liquid chromatography is coupled to tandem mass spectrometry in order to separate, identify, and quantify substances in a sample. | NCIT:C122168 |
| Methylation Analysis | An analysis of DNA or protein to detect the presence and/or location of methyl groups. | NCIT:C190764 |
| Multigene Expression Assay | An assay that can simultaneously analyze the expression of multiple genes or genetic loci of interest. | NCIT:C210244 |
| Pathology | The medical science, and specialty practice, concerned with all aspects of disease, with special reference to the essential nature, causes, and development of abnormal conditions. | NCIT:C18189 |
| Quantitative Immunofluorescence | Immunofluorescence techniques that allow for objective, continuous-scale measurement of a target molecule. | NCIT:C221816 |
| Radiology | The branch of medical science dealing with the medical use of X-rays or other penetrating radiation. | NCIT:C17059 |
| RNA Sequencing | A procedure that can determine the RNA sequences for all or part of the poly-A tail-containing messenger RNA transcripts in an individual. | NCIT:C124261 |
Attribute: geographicalRestriction¶
| Valid Value | Description | Ontology |
|---|---|---|
| AD | Andorra | Not available |
| AE | United Arab Emirates (the) | Not available |
| AF | Afghanistan | Not available |
| AG | Antigua and Barbuda | Not available |
| AI | Anguilla | Not available |
| AL | Albania | Not available |
| AM | Armenia | Not available |
| AO | Angola | Not available |
| AQ | Antarctica | Not available |
| AR | Argentina | Not available |
| AS | American Samoa | Not available |
| AT | Austria | Not available |
| AU | Australia | Not available |
| AW | Aruba | Not available |
| AX | Åland Islands | Not available |
| AZ | Azerbaijan | Not available |
| BA | Bosnia and Herzegovina | Not available |
| BB | Barbados | Not available |
| BD | Bangladesh | Not available |
| BE | Belgium | Not available |
| BF | Burkina Faso | Not available |
| BG | Bulgaria | Not available |
| BH | Bahrain | Not available |
| BI | Burundi | Not available |
| BJ | Benin | Not available |
| BL | Saint Barthélemy | Not available |
| BM | Bermuda | Not available |
| BN | Brunei Darussalam | Not available |
| BO | Bolivia (Plurinational State of) | Not available |
| BQ | Bonaire, Sint Eustatius and Saba | Not available |
| BR | Brazil | Not available |
| BS | Bahamas (the) | Not available |
| BT | Bhutan | Not available |
| BV | Bouvet Island | Not available |
| BW | Botswana | Not available |
| BY | Belarus | Not available |
| BZ | Belize | Not available |
| CA | Canada | Not available |
| CC | Cocos (Keeling) Islands (the) | Not available |
| CD | Congo (the Democratic Republic of the) | Not available |
| CF | Central African Republic (the) | Not available |
| CG | Congo (the) | Not available |
| CH | Switzerland | Not available |
| CI | Côte d'Ivoire | Not available |
| CK | Cook Islands (the) | Not available |
| CL | Chile | Not available |
| CM | Cameroon | Not available |
| CN | China | Not available |
| CO | Colombia | Not available |
| CR | Costa Rica | Not available |
| CU | Cuba | Not available |
| CV | Cabo Verde | Not available |
| CW | Curaçao | Not available |
| CX | Christmas Island | Not available |
| CY | Cyprus | Not available |
| CZ | Czechia | Not available |
| DE | Germany | Not available |
| DJ | Djibouti | Not available |
| DK | Denmark | Not available |
| DM | Dominica | Not available |
| DO | Dominican Republic (the) | Not available |
| DZ | Algeria | Not available |
| EC | Ecuador | Not available |
| EE | Estonia | Not available |
| EG | Egypt | Not available |
| EH | Western Sahara* | Not available |
| ER | Eritrea | Not available |
| ES | Spain | Not available |
| ET | Ethiopia | Not available |
| FI | Finland | Not available |
| FJ | Fiji | Not available |
| FK | Falkland Islands (the) [Malvinas] | Not available |
| FM | Micronesia (Federated States of) | Not available |
| FO | Faroe Islands (the) | Not available |
| FR | France | Not available |
| GA | Gabon | Not available |
| GB | United Kingdom of Great Britain and Northern Ireland (the) | Not available |
| GD | Grenada | Not available |
| GE | Georgia | Not available |
| GF | French Guiana | Not available |
| GG | Guernsey | Not available |
| GH | Ghana | Not available |
| GI | Gibraltar | Not available |
| GL | Greenland | Not available |
| GM | Gambia (the) | Not available |
| GN | Guinea | Not available |
| GP | Guadeloupe | Not available |
| GQ | Equatorial Guinea | Not available |
| GR | Greece | Not available |
| GS | South Georgia and the South Sandwich Islands | Not available |
| GT | Guatemala | Not available |
| GU | Guam | Not available |
| GW | Guinea-Bissau | Not available |
| GY | Guyana | Not available |
| HK | Hong Kong | Not available |
| HM | Heard Island and McDonald Islands | Not available |
| HN | Honduras | Not available |
| HR | Croatia | Not available |
| HT | Haiti | Not available |
| HU | Hungary | Not available |
| ID | Indonesia | Not available |
| IE | Ireland | Not available |
| IL | Israel | Not available |
| IM | Isle of Man | Not available |
| IN | India | Not available |
| IO | British Indian Ocean Territory (the) | Not available |
| IQ | Iraq | Not available |
| IR | Iran (Islamic Republic of) | Not available |
| IS | Iceland | Not available |
| IT | Italy | Not available |
| JE | Jersey | Not available |
| JM | Jamaica | Not available |
| JO | Jordan | Not available |
| JP | Japan | Not available |
| KE | Kenya | Not available |
| KG | Kyrgyzstan | Not available |
| KH | Cambodia | Not available |
| KI | Kiribati | Not available |
| KM | Comoros (the) | Not available |
| KN | Saint Kitts and Nevis | Not available |
| KP | Korea (the Democratic People's Republic of) | Not available |
| KR | Korea (the Republic of) | Not available |
| KW | Kuwait | Not available |
| KY | Cayman Islands (the) | Not available |
| KZ | Kazakhstan | Not available |
| LA | Lao People's Democratic Republic (the) | Not available |
| LB | Lebanon | Not available |
| LC | Saint Lucia | Not available |
| LI | Liechtenstein | Not available |
| LK | Sri Lanka | Not available |
| LR | Liberia | Not available |
| LS | Lesotho | Not available |
| LT | Lithuania | Not available |
| LU | Luxembourg | Not available |
| LV | Latvia | Not available |
| LY | Libya | Not available |
| MA | Morocco | Not available |
| MC | Monaco | Not available |
| MD | Moldova (the Republic of) | Not available |
| ME | Montenegro | Not available |
| MF | Saint Martin (French part) | Not available |
| MG | Madagascar | Not available |
| MH | Marshall Islands (the) | Not available |
| MK | North Macedonia | Not available |
| ML | Mali | Not available |
| MM | Myanmar | Not available |
| MN | Mongolia | Not available |
| MO | Macao | Not available |
| MP | Northern Mariana Islands (the) | Not available |
| MQ | Martinique | Not available |
| MR | Mauritania | Not available |
| MS | Montserrat | Not available |
| MT | Malta | Not available |
| MU | Mauritius | Not available |
| MV | Maldives | Not available |
| MW | Malawi | Not available |
| MX | Mexico | Not available |
| MY | Malaysia | Not available |
| MZ | Mozambique | Not available |
| NA | Namibia | Not available |
| NC | New Caledonia | Not available |
| NE | Niger (the) | Not available |
| NF | Norfolk Island | Not available |
| NG | Nigeria | Not available |
| NI | Nicaragua | Not available |
| NL | Netherlands (Kingdom of the) | Not available |
| NO | Norway | Not available |
| NP | Nepal | Not available |
| NR | Nauru | Not available |
| NU | Niue | Not available |
| NZ | New Zealand | Not available |
| OM | Oman | Not available |
| PA | Panama | Not available |
| PE | Peru | Not available |
| PF | French Polynesia | Not available |
| PG | Papua New Guinea | Not available |
| PH | Philippines (the) | Not available |
| PK | Pakistan | Not available |
| PL | Poland | Not available |
| PM | Saint Pierre and Miquelon | Not available |
| PN | Pitcairn | Not available |
| PR | Puerto Rico | Not available |
| PS | Palestine, State of | Not available |
| PT | Portugal | Not available |
| PW | Palau | Not available |
| PY | Paraguay | Not available |
| QA | Qatar | Not available |
| RE | Réunion | Not available |
| RO | Romania | Not available |
| RS | Serbia | Not available |
| RU | Russian Federation (the) | Not available |
| RW | Rwanda | Not available |
| SA | Saudi Arabia | Not available |
| SB | Solomon Islands | Not available |
| SC | Seychelles | Not available |
| SD | Sudan (the) | Not available |
| SE | Sweden | Not available |
| SG | Singapore | Not available |
| SH | Saint Helena, Ascension and Tristan da Cunha | Not available |
| SI | Slovenia | Not available |
| SJ | Svalbard and Jan Mayen | Not available |
| SK | Slovakia | Not available |
| SL | Sierra Leone | Not available |
| SM | San Marino | Not available |
| SN | Senegal | Not available |
| SO | Somalia | Not available |
| SR | Suriname | Not available |
| SS | South Sudan | Not available |
| ST | Sao Tome and Principe | Not available |
| SV | El Salvador | Not available |
| SX | Sint Maarten (Dutch part) | Not available |
| SY | Syrian Arab Republic (the) | Not available |
| SZ | Eswatini | Not available |
| TC | Turks and Caicos Islands (the) | Not available |
| TD | Chad | Not available |
| TF | French Southern Territories (the) | Not available |
| TG | Togo | Not available |
| TH | Thailand | Not available |
| TJ | Tajikistan | Not available |
| TK | Tokelau | Not available |
| TL | Timor-Leste | Not available |
| TM | Turkmenistan | Not available |
| TN | Tunisia | Not available |
| TO | Tonga | Not available |
| TR | Türkiye | Not available |
| TT | Trinidad and Tobago | Not available |
| TV | Tuvalu | Not available |
| TW | Taiwan (Province of China) | Not available |
| TZ | Tanzania, the United Republic of | Not available |
| UA | Ukraine | Not available |
| UG | Uganda | Not available |
| UM | United States Minor Outlying Islands (the) | Not available |
| US | United States of America (the) | Not available |
| UY | Uruguay | Not available |
| UZ | Uzbekistan | Not available |
| VA | Holy See (the) | Not available |
| VC | Saint Vincent and the Grenadines | Not available |
| VE | Venezuela (Bolivarian Republic of) | Not available |
| VG | Virgin Islands (British) | Not available |
| VI | Virgin Islands (U.S.) | Not available |
| VN | Viet Nam | Not available |
| VU | Vanuatu | Not available |
| WF | Wallis and Futuna | Not available |
| WS | Samoa | Not available |
| YE | Yemen | Not available |
| YT | Mayotte | Not available |
| ZA | South Africa | Not available |
| ZM | Zambia | Not available |
| ZW | Zimbabwe | Not available |
Attribute: sourceGeography¶
| Valid Value | Description | Ontology |
|---|---|---|
| AD | Andorra | Not available |
| AE | United Arab Emirates (the) | Not available |
| AF | Afghanistan | Not available |
| AG | Antigua and Barbuda | Not available |
| AI | Anguilla | Not available |
| AL | Albania | Not available |
| AM | Armenia | Not available |
| AO | Angola | Not available |
| AQ | Antarctica | Not available |
| AR | Argentina | Not available |
| AS | American Samoa | Not available |
| AT | Austria | Not available |
| AU | Australia | Not available |
| AW | Aruba | Not available |
| AX | Åland Islands | Not available |
| AZ | Azerbaijan | Not available |
| BA | Bosnia and Herzegovina | Not available |
| BB | Barbados | Not available |
| BD | Bangladesh | Not available |
| BE | Belgium | Not available |
| BF | Burkina Faso | Not available |
| BG | Bulgaria | Not available |
| BH | Bahrain | Not available |
| BI | Burundi | Not available |
| BJ | Benin | Not available |
| BL | Saint Barthélemy | Not available |
| BM | Bermuda | Not available |
| BN | Brunei Darussalam | Not available |
| BO | Bolivia (Plurinational State of) | Not available |
| BQ | Bonaire, Sint Eustatius and Saba | Not available |
| BR | Brazil | Not available |
| BS | Bahamas (the) | Not available |
| BT | Bhutan | Not available |
| BV | Bouvet Island | Not available |
| BW | Botswana | Not available |
| BY | Belarus | Not available |
| BZ | Belize | Not available |
| CA | Canada | Not available |
| CC | Cocos (Keeling) Islands (the) | Not available |
| CD | Congo (the Democratic Republic of the) | Not available |
| CF | Central African Republic (the) | Not available |
| CG | Congo (the) | Not available |
| CH | Switzerland | Not available |
| CI | Côte d'Ivoire | Not available |
| CK | Cook Islands (the) | Not available |
| CL | Chile | Not available |
| CM | Cameroon | Not available |
| CN | China | Not available |
| CO | Colombia | Not available |
| CR | Costa Rica | Not available |
| CU | Cuba | Not available |
| CV | Cabo Verde | Not available |
| CW | Curaçao | Not available |
| CX | Christmas Island | Not available |
| CY | Cyprus | Not available |
| CZ | Czechia | Not available |
| DE | Germany | Not available |
| DJ | Djibouti | Not available |
| DK | Denmark | Not available |
| DM | Dominica | Not available |
| DO | Dominican Republic (the) | Not available |
| DZ | Algeria | Not available |
| EC | Ecuador | Not available |
| EE | Estonia | Not available |
| EG | Egypt | Not available |
| EH | Western Sahara* | Not available |
| ER | Eritrea | Not available |
| ES | Spain | Not available |
| ET | Ethiopia | Not available |
| FI | Finland | Not available |
| FJ | Fiji | Not available |
| FK | Falkland Islands (the) [Malvinas] | Not available |
| FM | Micronesia (Federated States of) | Not available |
| FO | Faroe Islands (the) | Not available |
| FR | France | Not available |
| GA | Gabon | Not available |
| GB | United Kingdom of Great Britain and Northern Ireland (the) | Not available |
| GD | Grenada | Not available |
| GE | Georgia | Not available |
| GF | French Guiana | Not available |
| GG | Guernsey | Not available |
| GH | Ghana | Not available |
| GI | Gibraltar | Not available |
| GL | Greenland | Not available |
| GM | Gambia (the) | Not available |
| GN | Guinea | Not available |
| GP | Guadeloupe | Not available |
| GQ | Equatorial Guinea | Not available |
| GR | Greece | Not available |
| GS | South Georgia and the South Sandwich Islands | Not available |
| GT | Guatemala | Not available |
| GU | Guam | Not available |
| GW | Guinea-Bissau | Not available |
| GY | Guyana | Not available |
| HK | Hong Kong | Not available |
| HM | Heard Island and McDonald Islands | Not available |
| HN | Honduras | Not available |
| HR | Croatia | Not available |
| HT | Haiti | Not available |
| HU | Hungary | Not available |
| ID | Indonesia | Not available |
| IE | Ireland | Not available |
| IL | Israel | Not available |
| IM | Isle of Man | Not available |
| IN | India | Not available |
| IO | British Indian Ocean Territory (the) | Not available |
| IQ | Iraq | Not available |
| IR | Iran (Islamic Republic of) | Not available |
| IS | Iceland | Not available |
| IT | Italy | Not available |
| JE | Jersey | Not available |
| JM | Jamaica | Not available |
| JO | Jordan | Not available |
| JP | Japan | Not available |
| KE | Kenya | Not available |
| KG | Kyrgyzstan | Not available |
| KH | Cambodia | Not available |
| KI | Kiribati | Not available |
| KM | Comoros (the) | Not available |
| KN | Saint Kitts and Nevis | Not available |
| KP | Korea (the Democratic People's Republic of) | Not available |
| KR | Korea (the Republic of) | Not available |
| KW | Kuwait | Not available |
| KY | Cayman Islands (the) | Not available |
| KZ | Kazakhstan | Not available |
| LA | Lao People's Democratic Republic (the) | Not available |
| LB | Lebanon | Not available |
| LC | Saint Lucia | Not available |
| LI | Liechtenstein | Not available |
| LK | Sri Lanka | Not available |
| LR | Liberia | Not available |
| LS | Lesotho | Not available |
| LT | Lithuania | Not available |
| LU | Luxembourg | Not available |
| LV | Latvia | Not available |
| LY | Libya | Not available |
| MA | Morocco | Not available |
| MC | Monaco | Not available |
| MD | Moldova (the Republic of) | Not available |
| ME | Montenegro | Not available |
| MF | Saint Martin (French part) | Not available |
| MG | Madagascar | Not available |
| MH | Marshall Islands (the) | Not available |
| MK | North Macedonia | Not available |
| ML | Mali | Not available |
| MM | Myanmar | Not available |
| MN | Mongolia | Not available |
| MO | Macao | Not available |
| MP | Northern Mariana Islands (the) | Not available |
| MQ | Martinique | Not available |
| MR | Mauritania | Not available |
| MS | Montserrat | Not available |
| MT | Malta | Not available |
| MU | Mauritius | Not available |
| MV | Maldives | Not available |
| MW | Malawi | Not available |
| MX | Mexico | Not available |
| MY | Malaysia | Not available |
| MZ | Mozambique | Not available |
| NA | Namibia | Not available |
| NC | New Caledonia | Not available |
| NE | Niger (the) | Not available |
| NF | Norfolk Island | Not available |
| NG | Nigeria | Not available |
| NI | Nicaragua | Not available |
| NL | Netherlands (Kingdom of the) | Not available |
| NO | Norway | Not available |
| NP | Nepal | Not available |
| NR | Nauru | Not available |
| NU | Niue | Not available |
| NZ | New Zealand | Not available |
| OM | Oman | Not available |
| PA | Panama | Not available |
| PE | Peru | Not available |
| PF | French Polynesia | Not available |
| PG | Papua New Guinea | Not available |
| PH | Philippines (the) | Not available |
| PK | Pakistan | Not available |
| PL | Poland | Not available |
| PM | Saint Pierre and Miquelon | Not available |
| PN | Pitcairn | Not available |
| PR | Puerto Rico | Not available |
| PS | Palestine, State of | Not available |
| PT | Portugal | Not available |
| PW | Palau | Not available |
| PY | Paraguay | Not available |
| QA | Qatar | Not available |
| RE | Réunion | Not available |
| RO | Romania | Not available |
| RS | Serbia | Not available |
| RU | Russian Federation (the) | Not available |
| RW | Rwanda | Not available |
| SA | Saudi Arabia | Not available |
| SB | Solomon Islands | Not available |
| SC | Seychelles | Not available |
| SD | Sudan (the) | Not available |
| SE | Sweden | Not available |
| SG | Singapore | Not available |
| SH | Saint Helena, Ascension and Tristan da Cunha | Not available |
| SI | Slovenia | Not available |
| SJ | Svalbard and Jan Mayen | Not available |
| SK | Slovakia | Not available |
| SL | Sierra Leone | Not available |
| SM | San Marino | Not available |
| SN | Senegal | Not available |
| SO | Somalia | Not available |
| SR | Suriname | Not available |
| SS | South Sudan | Not available |
| ST | Sao Tome and Principe | Not available |
| SV | El Salvador | Not available |
| SX | Sint Maarten (Dutch part) | Not available |
| SY | Syrian Arab Republic (the) | Not available |
| SZ | Eswatini | Not available |
| TC | Turks and Caicos Islands (the) | Not available |
| TD | Chad | Not available |
| TF | French Southern Territories (the) | Not available |
| TG | Togo | Not available |
| TH | Thailand | Not available |
| TJ | Tajikistan | Not available |
| TK | Tokelau | Not available |
| TL | Timor-Leste | Not available |
| TM | Turkmenistan | Not available |
| TN | Tunisia | Not available |
| TO | Tonga | Not available |
| TR | Türkiye | Not available |
| TT | Trinidad and Tobago | Not available |
| TV | Tuvalu | Not available |
| TW | Taiwan (Province of China) | Not available |
| TZ | Tanzania, the United Republic of | Not available |
| UA | Ukraine | Not available |
| UG | Uganda | Not available |
| UM | United States Minor Outlying Islands (the) | Not available |
| US | United States of America (the) | Not available |
| UY | Uruguay | Not available |
| UZ | Uzbekistan | Not available |
| VA | Holy See (the) | Not available |
| VC | Saint Vincent and the Grenadines | Not available |
| VE | Venezuela (Bolivarian Republic of) | Not available |
| VG | Virgin Islands (British) | Not available |
| VI | Virgin Islands (U.S.) | Not available |
| VN | Viet Nam | Not available |
| VU | Vanuatu | Not available |
| WF | Wallis and Futuna | Not available |
| WS | Samoa | Not available |
| YE | Yemen | Not available |
| YT | Mayotte | Not available |
| ZA | South Africa | Not available |
| ZM | Zambia | Not available |
| ZW | Zimbabwe | Not available |
Attribute: deidentificationType¶
| Valid Value | Description | Ontology |
|---|---|---|
| Manual | Of or related to the hands; reference to a method, process, task, or activity being done by hand (as opposed as being performed with the assistance of automation or other supportive means). | NCIT:C63513 |
| Semiautomatic | Of or related to a method or process performed using a combination of manual and automatic means. | NCIT:C172484 |
| Automatic | Operating with minimal human intervention; independent of external control. | NCIT:C70669 |
| Not Applicable | Determination of a value is not relevant in the current context. | NCIT:C48660 |
Attribute: dataPermission¶
| Valid Value | Description | Ontology |
|---|---|---|
| Agreement | Access or use of the data is governed by a signed data use agreement between the requester and the data provider. | Not available |
| Attestation | Access or use of the data requires the requester to attest to certain conditions of use (e.g., intended purpose, compliance with policies). | Not available |
| Award | Access or use of the data is granted as part of a formal award or allocation process (e.g., a data access committee approval). | Not available |
| Other | A data permission mechanism not covered by any of the other listed values. | Not available |
Attribute: dataTier¶
| Valid Value | Description | Ontology |
|---|---|---|
| Anonymous | Data can be viewed and downloaded anonymously by anyone on the internet. | Not available |
| Open | Users must have a Synapse account to download data. | Not available |
| Controlled | Users must have a Synapse account and satisfy access conditions to download data. | Not available |
| Private | Users must be provided access to data in Synapse by a project administrator. | Not available |
Attribute: Sex¶
| Valid Value | Description | Ontology |
|---|---|---|
| Female | An individual who belongs to the sex that normally produces ova. | NCIT:C16576 |
| Male | An individual who belongs to the sex that normally produces sperm. | NCIT:C20197 |
| Unknown | Not known, observed, recorded, or reported as unknown by the data contributor. | NCIT:C17998 |
Attribute: Tumor Grade¶
| Valid Value | Description | Ontology |
|---|---|---|
| GB Borderline | A morphologic qualifier indicating that a neoplasm is of borderline malignancy. | NCIT:C113729 |
| GX Grade Cannot Be Assessed | A morphologic qualifier indicating that the grade of a neoplasm cannot be assessed. | NCIT:C113730 |
| Not Applicable | Determination of a value is not relevant in the current context. | NCIT:C48660 |
| Not Reported | Not provided or available. | NCIT:C43234 |
| Unknown | Not known, observed, recorded, or reported as unknown by the data contributor. | NCIT:C17998 |
| G3 High Grade | A morphologic qualifier indicating that a cancerous lesion is poorly differentiated (Grade 3). | NCIT:C28079 |
| G2 Intermediate Grade | A morphologic qualifier indicating that a cancerous lesion is moderately differentiated (Grade 2). | NCIT:C28078 |
| G1 Low Grade | A morphologic qualifier indicating that a cancerous lesion is well differentiated (Grade 1). | NCIT:C28077 |
| G4 Anaplastic | A morphologic qualifier indicating that a cancerous lesion is undifferentiated (Grade 4). | NCIT:C28082 |
Attribute: Last Known Disease Status¶
| Valid Value | Description | Ontology |
|---|---|---|
| Biochemical evidence of disease without structural correlate | An indication that biochemical markers of a disease are present but morphological markers are absent. | NCIT:C165197 |
| Tumor Free | There is no evidence of a tumor in the individual. | NCIT:C156848 |
| Unknown | Not known, observed, recorded, or reported as unknown by the data contributor. | NCIT:C17998 |
| With Tumor | There is evidence of a tumor in an individual. | NCIT:C156849 |
| Not Reported | Not provided or available. | NCIT:C43234 |
| Not Applicable | Determination of a value is not relevant in the current context. | NCIT:C48660 |
| Not Allowed To Collect | An indication that specifies that a collection event was not permitted. | NCIT:C141478 |
| Distant Metastasis | The presence of cancer cells that have spread from the primary tumor site and been detected at a distal anatomic site. | NCIT:C18206 |
| Localized Disease | A disease that is confined to a specific organ or tissue and has not spread to other anatomic sites. | NCIT:C36162 |
| Regional Disease | A disease or condition that extends beyond the site of origin and spreads into adjacent tissues and regional lymph nodes. | NCIT:C41844 |
| New Tumor Event | The presence of a primary, recurrent or metastatic neoplasm which has not been previously noted. | NCIT:C200667 |
Attribute: Treatment Type¶
| Valid Value | Description | Ontology |
|---|---|---|
| 3-Dimensional Conformal Radiation Therapy | A process by which a dose of radiation is automatically shaped to closely conform to the entire volume of the tumor, so that surrounding normal tissue is spared and treatment toxicity is decreased. | NCIT:C16035 |
| Allogeneic Hematopoietic Stem Cell Transplantation | A clinical treatment in which hematopoietic stem cells (HSCs) are transferred from one genetically dissimilar individual to another. | NCIT:C46089 |
| Autologous Stem Cell Transplantation | Stem cell transfer or transplantation in which the patient is their own donor. | NCIT:C201465 |
| Brachytherapy | A type of radiation therapy in which radioactive material is placed inside the body, into a tumor or body cavity. | NCIT:C15195 |
| Cellular Therapy | Utilization of specific cells, modified or not, for treatment of diseases. Donor lymphocyte infusion is a type of cellular therapy. | NCIT:C70601 |
| Chemotherapy | The use of synthetic or naturally-occurring chemicals for the treatment of diseases. | NCIT:C15632 |
| Concurrent Chemoradiation | Treatment in which radiation therapy is administered at the same time as chemotherapy. | NCIT:C141342 |
| Conditioning Therapy | Administration of high doses of chemotherapy or radiation therapy, as well as immunosuppressive therapy, to a transplant recipient prior to a bone marrow or hematopoietic stem cell transplant. | NCIT:C64468 |
| Ablation Therapy | Removal, separation, detachment, extirpation, or eradication of a body part, pathway, or function by surgery, chemical destruction, morbid process, or noxious substance. | NCIT:C20985 |
| Control | A negative control in which the subject or specimen received no active treatment, used as a comparator. | NCIT:C184729 |
| Conventional Radiotherapy | A course of radiotherapy where minimal imaging support (i.e. X-ray films) is used to determine the positioning of radiotherapy. | NCIT:C165189 |
| Electron Beam Radiation Therapy | Radiation therapy using an electron beam. | NCIT:C15650 |
| External Beam Radiation Therapy | Radiation therapy in which high-energy beams are delivered to the tumor from outside of the body. | NCIT:C15751 |
| High-Dose Rate Brachytherapy | Internal radiation treatment that targets a cancerous tissue with accurate, high doses of radiation through the use of inserted temporary implants. | NCIT:C15651 |
| Hormone Therapy | Various treatment modalities that produce the desired therapeutic effect by means of a change of hormone/hormones level. | NCIT:C15445 |
| Immunosuppressive Therapy/GVHD Prophylaxis for Transplant | Graft versus host disease prophylaxis or therapy administered in the context of a transplant. | NCIT:C15448 |
| Immunotherapy | Therapy designed to induce changes in a patient's immune status in order to treat disease. | NCIT:C15262 |
| Intensity-Modulated Radiation Therapy | An advanced form of 3-Dimensional Conformal Radiation Therapy (3D CRT) that involves the use of varying intensities of small radiation beams to produce dosage distributions that are more precise than those possible with 3D CRT. | NCIT:C16135 |
| Low-Dose Rate Brachytherapy | Internal radiation treatment that targets a cancerous tissue with low doses of radiation through the use of inserted temporary or permanent implants. | NCIT:C85254 |
| Not Reported | Not provided or available. | NCIT:C43234 |
| Oncolytic Virus Therapy | A targeted therapy that uses viral infection to cause the lysis of tumor cells. | NCIT:C62713 |
| Organ Transplantation | The transfer of an organ, organ part, or tissue from one body to another, for the purpose of replacing the recipient's damaged or failing organ with a working one from the donor. Donors can be living, or cadaveric (dead). | NCIT:C15289 |
| Palliative Care | The patient- and family-centered active holistic care of patients with advanced, progressive disease, encompassing pain and symptom control, communication about treatment and prognosis, and psychosocial and spiritual support, with the goal of achieving the best quality of life for patients and their families. | NCIT:C15292 |
| Pharmacotherapy | Treatment of disease through the use of drugs. | NCIT:C15986 |
| Photon Beam Radiation Therapy | Radiation therapy using a photon beam. | NCIT:C104914 |
| Post-Transplant Salvage Therapy | Treatment administered after a transplant when standard therapy has failed or a relapse has occurred. | NCIT:C15359 |
| Proton Beam Radiation Therapy | A type of external beam radiation therapy using a beam of protons. It has the advantage of precisely localizing the radiation dose on the targeted tissue and avoiding damage to the healthy surrounding tissue. | NCIT:C66897 |
| Radiation Therapy | Treatment of a disease by means of exposure of the target or the whole body to radiation. Radiation therapy is often used as part of curative therapy and occasionally as a component of palliative treatment for cancer. | NCIT:C15313 |
| Radiofrequency Ablation | A therapeutic procedure to kill tissue using radiowaves to generate heat. The procedure is performed by the insertion of an electrode into a target tissue; electrical energy delivered to the electrode heats and destroys the tissue. | NCIT:C15666 |
| Radiopharmaceutical | An agent that contains a radioactive isotope and is used for diagnostic or therapeutic purposes. | NCIT:C1446 |
| Stem Cell Transplant | A therapeutic procedure that involves the transplantation of hematopoietic stem cells, either with the patient as their own donor or from a donor to the patient, used for the treatment of malignant and non-malignant diseases. | NCIT:C15431 |
| Stereotactic Body Radiation Therapy | Stereotactic radiation therapy in which one or several maximum dose radiation treatments are delivered targeting cancers of the body, excluding the brain or spine. | NCIT:C118286 |
| Stereotactic Radiosurgery | A non-surgical procedure that was developed to deliver one or several maximum dose targeted radiation treatments for cancers in the brain or spine. | NCIT:C15358 |
| Surgical Procedure | A diagnostic or treatment procedure performed by manual and/or instrumental means, often involving an incision and the removal or replacement of a diseased organ or tissue. | NCIT:C15329 |
| Targeted Molecular Therapy | Cancer therapies designed to act upon specific molecules in metabolic pathways or processes involved in carcinogenesis, tumor growth, or tumor spread. | NCIT:C76243 |
| Targeted Therapy | A type of cancer treatment that uses testing and medication to more precisely identify and treat cancer, targeting genes or proteins necessary to the proliferation of cancer cells. | NCIT:C93352 |
| Unknown | Not known, observed, recorded; or reported as unknown by the data contributor. | NCIT:C17998 |
| Vaccine Therapy | Immunotherapy using a preparation that stimulates the immune system to destroy pathogenic microorganisms or tumor cells. | NCIT:C15347 |
Attribute: Treatment Response¶
| Valid Value | Description | Ontology |
|---|---|---|
| Complete Response | The disappearance of all signs of cancer in response to treatment. | NCIT:C4870 |
| No Evidence of Disease | Diagnostic tests fail to detect presence of disease. | NCIT:C40413 |
| No Response | No apparent pathologic and/or clinical changes resulting from treatment. | NCIT:C162704 |
| Not Applicable | Determination of a value is not relevant in the current context. | NCIT:C48660 |
| Not Evaluable | Indicates that an assessment was not performed. | NCIT:C139527 |
| Not Reported | Not provided or available. | NCIT:C43234 |
| Partial Response | A finding indicating that there is a decrease in the size and the extent of tissue involvement by a malignant tumor in a patient. | NCIT:C18058 |
| Persistent Disease | The persistence of tumor cells in the body following cancer treatment. | NCIT:C4809 |
| Progressive Disease | A clinical, pathologic, and/or molecular finding indicating that the course of a disease is worsening. | NCIT:C35571 |
| Stable Disease | A disease that is neither decreasing nor increasing in extent or severity. | NCIT:C18213 |
| Unknown | Not known, observed, recorded, or reported as unknown by the data contributor. | NCIT:C17998 |
| Less than Partial Response | Less than Partial Clinical Response | NCIT:C151961 |
| Too Early | Too Early to be Assessed | NCIT:C222061 |
| Not Assessed | NOT ASSESSED | NCIT:C139527 |
Attribute: Disease Type¶
| Valid Value | Description | Ontology |
|---|---|---|
| Acinar Cell Neoplasms | A neoplasm with acinar cell differentiation, arising from the secretory cells of exocrine glands such as the pancreas, salivary glands, or lungs. | NCIT:C4197 |
| Adenomas and Adenocarcinomas | A neoplasm arising from or exhibiting the features of glandular epithelium; encompasses a broad morphological category including adenomas, adenocarcinomas, and related glandular tumors. | NCIT:C7132 |
| Adnexal and Skin Appendage Neoplasms | A neoplasm arising from skin appendage structures, including hair follicles, sebaceous glands, and eccrine or apocrine sweat glands. | NCIT:C212119 |
| Basal Cell Neoplasms | A neoplastic proliferation of basal cells in the epidermis or other anatomic sites (most frequently the salivary glands); the epidermal proliferation results in basal cell carcinomas, while the salivary gland proliferation can be benign (basal cell adenoma) or malignant (basal cell adenocarcinoma). | NCIT:C3784 |
| Blood Vessel Tumors | An ICD-O-3 morphology category comprising benign and malignant neoplasms that arise from blood vessels, such as hemangioma, hemangioendothelioma, and angiosarcoma. | NCIT:C7388 |
| Complex Mixed and Stromal Neoplasms | An ICD-O-3 morphology category comprising neoplasms with complex mixed epithelial and stromal or mesenchymal components, such as adenomyoma, adenofibroma, and mixed mesodermal (Mullerian) tumors. | SNOMED:115229003 |
| Cystic; Mucinous and Serous Neoplasms | A benign or malignant neoplasm that contains a single or multiple cystic spaces. Examples include cystadenoma, mucinous cystadenocarcinoma, and serous cystadenocarcinoma. | NCIT:C6784 |
| Ductal and Lobular Neoplasms | An ICD-O-3 morphology category comprising neoplasms that arise from the ductal or lobular epithelium of glandular organs, most commonly the breast, including ductal carcinoma in situ, invasive ductal carcinoma, and lobular carcinoma. | SNOMED:115218002 |
| Epithelial Neoplasms; NOS | A neoplasm derived from epithelial cells, the cells lining the surfaces and cavities of the body. | NCIT:C3709 |
| Fibroepithelial Neoplasms | A benign, borderline, or malignant neoplasm characterized by the presence of an epithelial and a fibrous component. Representative examples are fibroadenoma and phyllodes tumor. | NCIT:C3743 |
| Fibromatous Neoplasms | A poorly circumscribed neoplasm arising from the soft tissues, characterized by the presence of spindle-shaped fibroblasts and an infiltrative growth pattern. | NCIT:C3042 |
| Germ Cell Neoplasms | A neoplasm arising from germ cells, the primordial cells that give rise to eggs and sperm. | NCIT:C3708 |
| Giant Cell Tumors | A neoplasm characterized by the presence of multinucleated giant cells intermixed with mononuclear stromal cells. | NCIT:C3055 |
| Gliomas | A neoplasm arising from glial cells of the central nervous system, including astrocytes, oligodendrocytes, and ependymal cells. | NCIT:C3059 |
| Granular Cell Tumors and Alveolar Soft Part Sarcomas | An ICD-O-3 morphology category comprising granular cell tumors, which are composed of cells with abundant granular eosinophilic cytoplasm, and alveolar soft part sarcoma, a rare malignant soft tissue neoplasm with a distinctive alveolar growth pattern. | SNOMED:115243008 |
| Immunoproliferative Diseases | A category of disorders characterized by the abnormal, uncontrolled proliferation of cells of the immune system, including conditions such as heavy chain disease and Waldenstrom macroglobulinemia. | NCIT:C194803 |
| Leukemias | A malignant clonal hematologic disorder involving hematopoietic stem cells, characterized by the presence of primitive or atypical myeloid or lymphoid cells in the bone marrow and blood. | NCIT:C3161 |
| Lipomatous Neoplasms | A neoplasm arising from adipose (fat) tissue, ranging from benign lipomas to malignant liposarcomas. | NCIT:C4248 |
| Lymphatic Vessel Tumors | A benign or malignant neoplasm arising from the lymphatic vessels. | NCIT:C3723 |
| Mast Cell Neoplasm | A heterogeneous group of disorders characterized by the abnormal growth and accumulation of mast cells in one or more organ systems; most variants of mast cell neoplasms are clonal disorders. (WHO, 2001) | NCIT:C9295 |
| Meningiomas | A usually benign neoplasm arising from the meninges, the membranes that cover and protect the brain and spinal cord. | NCIT:C3230 |
| Mesothelial Neoplasms | A neoplasm arising from mesothelial cells, which line the body cavities including the pleura, peritoneum, and pericardium. | NCIT:C3786 |
| Miscellaneous Bone Tumors | An ICD-O-3 morphology category comprising bone-derived neoplasms that do not fit into the major osseous, chondromatous, or fibrous tumor categories, such as adamantinoma of long bones and chordoma. | Not available |
| Miscellaneous Tumors | An ICD-O-3 morphology category comprising a heterogeneous group of neoplasms that do not fit into other defined histologic categories. | Not available |
| Mucoepidermoid Neoplasms | Neoplasms morphologically characterized by the presence of cuboidal mucous cells, goblet-like mucous cells, squamoid cells, cystic changes, and a fibrotic stromal formation; they can occur in several anatomic sites, including the parotid gland, oral cavity, paranasal sinus, skin, breast, lung, larynx, and lacrimal ducts. | NCIT:C3772 |
| Myelodysplastic Syndromes | A heterogeneous group of clonal hematopoietic stem cell disorders characterized by ineffective blood cell production, peripheral blood cytopenias, and risk of progression to acute myeloid leukemia. | NCIT:C3247 |
| Myomatous Neoplasms | A neoplasm arising from or exhibiting differentiation toward muscle tissue, encompassing tumors of smooth, skeletal, or cardiac muscle. | NCIT:C214799 |
| Myxomatous Neoplasms | An ICD-O-3 morphology category comprising benign and malignant neoplasms characterized by an abundant myxoid (mucin-rich) stroma, such as myxoma and myxosarcoma. | NCIT:C6577 |
| Neoplasms; NOS | An abnormal tissue growth resulting from uncontrolled and progressive cell proliferation; may be benign or malignant. | NCIT:C3262 |
| Nerve Sheath Tumors | A benign or malignant neoplasm arising from the perineural cells in the sheaths surrounding the nerves. Representative examples include neurofibroma, schwannoma, and malignant peripheral nerve sheath tumor. | NCIT:C4972 |
| Neuroepitheliomatous Neoplasms | A neoplasm of the nervous system that arises from the neuroepithelial tissues. Representative examples include astrocytic tumors, oligodendroglial tumors, ependymal tumors, and primitive neuroectodermal tumors. | NCIT:C3787 |
| Nevi and Melanomas | A neoplasm arising from melanocytes, the pigment-producing cells found primarily in the skin and eye; includes both benign lesions (nevi) and malignant melanomas. | NCIT:C7058 |
| Not Applicable | Determination of a value is not relevant in the current context. | NCIT:C48660 |
| Not Otherwise Specified | A term used to indicate that a specific type or category is not more precisely described or classified. | NCIT:C19594 |
| Not Reported | Not provided or available at the time of data submission. | NCIT:C43234 |
| Odontogenic Tumors | A neoplasm arising from tissues involved in tooth formation, including enamel organ, dental papilla, and dental follicle, most commonly arising in the jaw. | NCIT:C3286 |
| Osseous and Chondromatous Neoplasms | An ICD-O-3 morphology category comprising neoplasms of bone (osseous) and cartilage (chondromatous) origin, such as osteoma, osteosarcoma, chondroma, and chondrosarcoma. | SNOMED:115237006 |
| Paragangliomas and Glomus Tumors | A neoplasm arising from paraganglia, specialized clusters of neuroendocrine cells that are part of the autonomic nervous system, located at various sites outside the adrenal medulla. | NCIT:C3308 |
| Plasma Cell Neoplasm | A neoplasm characterized by the clonal proliferation of plasma cells, the antibody-secreting terminally differentiated B-cells. | NCIT:C4665 |
| Soft Tissue Tumors and Sarcomas; NOS | A neoplasm arising from the non-epithelial, non-osseous supporting tissues of the body, including fat, fibrous tissue, muscle, peripheral nerves, and blood and lymph vessels. | NCIT:C3377 |
| Squamous Cell Neoplasms | A neoplasm arising from or exhibiting the features of squamous epithelium, ranging from benign squamous papillomas to squamous cell carcinomas. | NCIT:C3792 |
| Synovial-like Neoplasms | A neoplasm arising from the synovial tissue lining joint cavities, tendon sheaths, and bursae. | NCIT:C8964 |
| Thymic Epithelial Neoplasms | A neoplasm arising from the epithelial cells of the thymus gland, spanning a spectrum from thymoma to thymic carcinoma. | NCIT:C6450 |
| Transitional Cell Papillomas and Carcinomas | An ICD-O-3 morphology category comprising benign transitional cell papillomas and malignant transitional cell (urothelial) carcinomas, which typically arise from the transitional epithelium lining the urinary tract. | UMLS:C1384509 |
| Trophoblastic neoplasms | A group of pregnancy-related proliferative disorders including non-neoplastic conditions and trophoblastic neoplasms such as invasive hydatidiform mole, gestational choriocarcinoma, and epithelioid trophoblastic tumor. | NCIT:C180633 |
| Unknown | Not known, observed, recorded, or reported as unknown by the data contributor. | NCIT:C17998 |
Attribute: Species¶
| Valid Value | Description | Ontology |
|---|---|---|
| African Bush Elephant | The African bush elephant (Loxodonta africana), the largest living terrestrial animal, native to sub-Saharan Africa; used as a source organism in comparative and veterinary research. | NCBITaxon:9785 |
| Armadillo | Any of several small, burrowing, chiefly nocturnal mammals with a body covered with strong horny plates. | NCIT:C14185 |
| Asian Elephant | The Asian elephant (Elephas maximus), native to South and Southeast Asia; used as a source organism in comparative and veterinary research. | NCBITaxon:9783 |
| Boar | The wild boar (Sus scrofa), the wild ancestor of the domestic pig; used as a source organism in comparative and veterinary research. | FOODON:00004286 |
| Cat | The domesticated feline mammal, Felis catus, which is kept as a house pet. | NCIT:C14191 |
| Chicken | The common domestic fowl, Gallus gallus. | NCIT:C14193 |
| Candida albicans | An opportunistic pathogenic yeast, Candida albicans, commonly used as a model organism in fungal biology and infection research. | NCBITaxon:5476 |
| Cow | Domesticated ungulates that are raised for beef, dairy products, and leather, and used for labor. | NCIT:C14192 |
| Dog | The domestic dog, Canis familiaris. | NCIT:C14201 |
| Escherichia coli | A common, gram negative gut bacterium that has been studied intensively by geneticists because of its small genome size, normal lack of pathogenicity, and ease of growth in the laboratory. | NCIT:C14206 |
| Guinea Pig | The domesticated guinea pig, Cavia porcellus. | NCIT:C14211 |
| Horse | The domestic horse, Equus caballus. | NCIT:C14222 |
| Human | The bipedal primate mammal, Homo sapiens; belonging to man or mankind; pertaining to man or to the race of man; use of man as experimental subject or unit of analysis in research. | NCIT:C14225 |
| Human Patient | A human patient enrolled in a clinical study who receives medical attention, care, or treatment. | NCIT:C16960 |
| Human Cell Line | A cell line established from human-derived cells that is maintained and propagated in vitro for research purposes. | NCIT:C20218 |
| Macaca nemestrina | The pig-tailed macaque (Macaca nemestrina), an Old World monkey native to Southeast Asia, used as a model organism in biomedical research. Distinct from Rhesus monkey (Macaca mulatta). | NCBITaxon:9545 |
| Mouse | Any of numerous species of small rodents belonging to the genus Mus and various related genera of the family Muridae. | NCIT:C14238 |
| Multispecies | A dataset or sample that is derived from or associated with more than one species. | FBcv:0003142 |
| Not Applicable | Determination of a value is not relevant in the current context. | NCIT:C48660 |
| Opossum | New World marsupials of the family Didelphidae. Opossums are omnivorous, largely nocturnal and arboreal mammals, and have an abdominal pouch in which the young are carried at birth. | MeSH:D009893 |
| Rabbit | Various members of the family Leporidae, especially those of the genus Sylvilagus. | NCIT:C14264 |
| Rat | Any of various rodent species of the genus Rattus, particularly Rattus norvegicus, that are widely used as model organisms in biomedical research. | NCIT:C160998 |
| Rhesus monkey | A pale brown macaque (Macaca mulatta) native to India, China, and other parts of Asia, often used in medical research owing to its relative ease of upkeep and physiological similarity to humans. | NCIT:C14233 |
| Schizosaccharomyces pombe | The fission yeast, Schizosaccharomyces pombe, a unicellular fungus widely used as a model organism in cell biology, distinct from the budding yeast Saccharomyces cerevisiae. | NCBITaxon:4896 |
| Sheep | Any one of several species of ruminants of the genus Ovis, native of the higher mountains of both hemispheres but most numerous in Asia; the domestic sheep, Ovis aries. | NCIT:C14273 |
| Trichoplax adhaerens | Trichoplax adhaerens, a simple multicellular marine organism belonging to the phylum Placozoa; used as a model organism in evolutionary and developmental biology. | NCBITaxon:10228 |
| Unknown | Not known, observed, recorded; or reported as unknown by the data contributor. | NCIT:C17998 |
| Unspecified | Not stated explicitly or in detail. | NCIT:C38046 |
| Worm | A roundworm, most commonly Caenorhabditis elegans, that is used as a model organism in biological research. | NCIT:C14303 |
| Yeast | Various single-celled members of the fungal families, ascomycetes, basidiomycetes and imperfect fungi that tend to be unicellular for the greater part of their life cycle. | NCIT:C14286 |
| Fruit Fly | Drosophila melanogaster, commonly known as the fruit fly, a small dipteran insect that has been extensively used in genetic and developmental biology studies. | NCIT:C14202 |
| Zebrafish | Brachydanio rerio, a species of small freshwater aquarium fish with a transparent embryo, making it possible to follow progeny of single cells until late stages of development; an important model for studies of vertebrate cell lineage and developmental biology. | NCIT:C14287 |
Attribute: Assay¶
| Valid Value | Description | Ontology |
|---|---|---|
| 10-cell RNA Sequencing | A procedure that can determine the RNA sequences for all or part of the poly-A tail-containing messenger RNA transcripts in an individual. | PMID:30894605 |
| 16S Ribosomal Gene Sequencing Assay | An amplicon sequencing assay in which universal primers are used to amplify the 16S ribosomal RNA gene from bacterial or archaeal samples for taxonomic identification and profiling. | OBI:0002763 |
| 3' RNA-seq | A method for profiling gene expression in which RNA-sequencing library preparation and sequencing are restricted to a short region at the 3' end of polyadenylated transcripts (typically captured via oligo-dT priming), rather than covering full-length transcripts. | EFO:0010188 |
| 3C | 3C ("chromosome conformation capture") is a molecular technique that measures the physical interaction frequency between genomic loci that are in close spatial proximity within the nucleus. | EFO:0007689 |
| 3C-qPCR | A chromosome conformation capture (3C) method that uses quantitative PCR to measure the interaction frequency between a single pair of genomic loci. | ECO:0000237 |
| 3D ATAC-PALM | A super-resolution imaging technique that combines ATAC-see (a fluorescence-based chromatin accessibility assay) with photoactivated localization microscopy (PALM) to visualize the 3D spatial organization of accessible chromatin in single cells. | Not available |
| 3D Bioprinting | A biofabrication technique that uses layer-by-layer deposition of cells, biomaterials, and growth factors to construct three-dimensional, tissue-like structures. | PMID:26724184 |
| 3D Cell Culture | A cultured cell population grown in a three-dimensional format that more closely mimics the in vivo growth environment than conventional two-dimensional culture. | MSIO:0000159 |
| 4C | 4C (chromosome conformation capture-on-chip) is an extension of 3C that combines chromosome conformation capture with high-throughput sequencing or microarray analysis to identify all genomic loci interacting with a single locus of interest. | EFO:0007690 |
| 5C | 5C ("chromosome conformation capture carbon copy") is an extension of the 3C technique that uses ligation-mediated amplification to study the 3-dimensional organization of multiple genomic loci in parallel. | EFO:0007692 |
| ATAC-Seq | A molecular genetic technique that isolates and sequences chromosomal regions that are rich in open chromatin. First, nuclei are harvested from a cellular sample. Then a hyperactive Tn5 transposase is added to the nuclei where it excises non-nucleosomal DNA strands and ligates co-administered high-throughput sequencing adapters (tagmentation). The tagged DNA fragments are isolated, amplified by PCR and sequenced. The number of reads for specific region of DNA correlate with increased chromatin accessibility and this method can identify regions of transcription factor and nucleosome binding. | NCIT:C156056 |
| ATP Bioluminescence Assay | An analyte assay that detects ATP concentration via light output when luciferase catalyzes the oxidation of luciferin in the presence of ATP, commonly used as a measure of cell viability. | OBI:0002175 |
| Affinity Purification Mass Spectrometry | An analytical technique wherein ions are separated according to their ratio of charge to mass. From the mass spectrum produced, the atomic weight of the particle can be deduced. | pmid:22611051 |
| Allograft | A graft transferred from a donor of one species to a recipient of the same species but different genetic makeup. | NCIT:C60701 |
| Amplicon Sequencing | A DNA sequencing technique that can differentiate cytosine from 5-methylcytosine in a DNA sample. First, a denatured DNA sample is treated with bisulfite which converts non-methylated cytosine to uracil. Next, the sample is amplified using a PCR method that does not discriminate between non-methylated and methylated sequences. The amplified DNA is subjected to nucleotide sequencing. The resulting sequence is compared to an identical control sample of DNA that was not treated with bisulfite. Unmethylated cytosines will be displayed as cytosines in the control sample and as thymines in the bisulfite-treated sample. | EFO:0003747 |
| Angiogenesis Assay | An assay used to measure the formation of new blood vessels from existing vasculature, typically by quantifying endothelial cell tube formation, migration, or sprouting in vitro or in vivo. | Not available |
| Apoptosis Assay | An assay used to detect or quantify cells undergoing apoptosis (programmed cell death), commonly via markers such as caspase activity, Annexin V staining, or DNA fragmentation. | ERO:0001182 |
| Atomic Absorption Spectrophotometry | A technique utilizing a scanning probe to image and analyze the surface of a material with atomic-level resolution. | BAO:0002529 |
| Atomic Absorption Spectroscopy | A spectrometric method that determines the type and concentration of metal elements in a sample, based upon the principle that each elemental metal absorbs a particular wavelength of ultraviolet light when exposed to heat. | NCIT:C85574 |
| Atomic Force Microscopy | A technique utilizing a scanning probe to image and analyze the surface of a material with atomic-level resolution. | NCIT:C17754 |
| Autoradiography | A technique used to locate radioactively labeled molecules, or fragments of molecules, by recording on a photographic or sensor plate the radiation emitted by radioactive material within a molecule. | NCIT:C16314 |
| Barcode-Seq | A molecular genetic technique that combines chromatin immunoprecipitation (ChIP) with massively parallel DNA sequencing to map the binding sites of DNA-associated proteins in a sample of cells. First, crosslinked protein-DNA complexes are isolated using ChIP. Next, the crosslinks are broken, the proteins are removed and the purified DNA is modified with adaptor oligonucleotides to facilitate massively parallel DNA sequencing. Following sequencing, the DNA sequences that are obtained can be mapped to their genomic locations. | EFO:0008655 |
| Bicinchoninic Acid Assay | A copper-based colorimetric assay for total protein quantification. This assay relies on the formation of a Cu2+-protein complex in a basic environment, followed by reduction of the Cu2+ to Cu+, causing a change of color from green to purple, with a strong absorbance at 562nm. | BAO:0002467 |
| Binding Assay | An assay that measures the interaction or binding affinity between two molecules, such as a ligand and its receptor or an antibody and its antigen. | PMID:21115850 |
| Bio-Layer Interferometry | A label-free optical technique that detects binding interactions by measuring shifts in the interference pattern of light reflected from a layer of immobilized biomolecules on a biosensor tip. | OBI:0002107 |
| Bioluminescence Imaging | An imaging technique that uses fluorescent dye to achieve the desired image. | WIKIDATA:Q4915066 |
| Bisulfite Sequencing | A DNA sequencing technique that can differentiate cytosine from 5-methylcytosine in a DNA sample. First, a denatured DNA sample is treated with bisulfite which converts non-methylated cytosine to uracil. Next, the sample is amplified using a PCR method that does not discriminate between non-methylated and methylated sequences. The amplified DNA is subjected to nucleotide sequencing. The resulting sequence is compared to an identical control sample of DNA that was not treated with bisulfite. Unmethylated cytosines will be displayed as cytosines in the control sample and as thymines in the bisulfite-treated sample. | NCIT:C106054 |
| Brightfield Microscopy | Brightfield microscopy is a type of light microscopy in which objects are seen against a bright background. | NCIT:C19827 |
| Brillouin Microscopy | The use of various technologies to resolve the structure or features of objects too small or fine to naturally be seen by eye. | PMID:29771749 |
| CASFISH | CRISPR/Cas9-mediated fluorescence in situ hybridization, a technique using a catalytically inactive Cas9 (dCas9) fused to a fluorescent tag to visualize specific genomic loci in fixed cells without denaturation. | PMID:26324940 |
| CITE-seq | A molecular genetic technique that combines chromatin immunoprecipitation (ChIP) with massively parallel DNA sequencing to map the binding sites of DNA-associated proteins in a sample of cells. First, crosslinked protein-DNA complexes are isolated using ChIP. Next, the crosslinks are broken, the proteins are removed and the purified DNA is modified with adaptor oligonucleotides to facilitate massively parallel DNA sequencing. Following sequencing, the DNA sequences that are obtained can be mapped to their genomic locations. | EFO:0009294 |
| CLIP-qPCR | A technique combining crosslinking immunoprecipitation (CLIP) of an RNA-binding protein with quantitative PCR to identify and quantify specific bound RNA sequences. | PMID:26721479 |
| CRISPR | A genome-editing and functional-screening technology based on the Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-Cas system, used here as a general assay category for CRISPR-based perturbation experiments. | Not available |
| CUT&RUN | Cleavage Under Targets and Release Using Nuclease (CUT&RUN), a method for mapping DNA-protein interactions using an antibody-targeted nuclease to selectively cleave DNA near a bound protein. | EFO:0009973 |
| CUT&Tag-Sequencing | Cleavage Under Targets and Tagmentation (CUT&Tag), a chromatin profiling method that uses antibody-targeted tagmentation to map the genome-wide location of a protein of interest. | EFO:0920004 |
| Cell Adhesion Assay | Any method to measure the number of dividing cells in a culture, or to measure the change in the proportion of cells that are dividing. | ERO:0001512 |
| Cell Proliferation Assay | Any method to measure the number of dividing cells in a culture, or to measure the change in the proportion of cells that are dividing. | NCIT:C116553 |
| Cell Viability Assay | A colorimetric assay that can assess the viability of cells by quantitation of the reduction of a yellow tetrazolium salt substrate to a product that has a purple color. This assay can measure the cytotoxicity of a chemical or drug by determining the affect of treatment on cell viability. | ERO:000132 |
| Cell-spreading Assay | Any method to measure the number of dividing cells in a culture, or to measure the change in the proportion of cells that are dividing. | PMID:15576905 |
| CellTiter-Glo Luminescent Cell Viability Assay | A colorimetric assay that can assess the viability of cells by quantitation of the reduction of a yellow tetrazolium salt substrate to a product that has a purple color. This assay can measure the cytotoxicity of a chemical or drug by determining the affect of treatment on cell viability. | BAO:0000682 |
| Cerenkov Luminescence Imaging | An imaging modality to study charged particles in tissue by detecting the Cerenkov luminescence produced, allowing the imaging of beta-emitting nuclear medicine probes by optical methods. | NCIT:C151895 |
| ChIA-PET | A molecular genetic technique that combines chromatin immunoprecipitation (ChIP) with paired end tagged (PET) DNA sequencing to identify the nucleotide sequences for the binding sites occupied by DNA-associated proteins in a sample. | NCIT:C172845 |
| ChIP-PCR | A molecular genetic technique that combines chromatin immunoprecipitation (ChIP) with massively parallel DNA sequencing to map the binding sites of DNA-associated proteins in a sample of cells. First, crosslinked protein-DNA complexes are isolated using ChIP. Next, the crosslinks are broken, the proteins are removed and the purified DNA is modified with adaptor oligonucleotides to facilitate massively parallel DNA sequencing. Following sequencing, the DNA sequences that are obtained can be mapped to their genomic locations. | ECO:0000227 |
| ChIP-Seq | A molecular genetic technique that combines chromatin immunoprecipitation (ChIP) with massively parallel DNA sequencing to map the binding sites of DNA-associated proteins in a sample of cells. First, crosslinked protein-DNA complexes are isolated using ChIP. Next, the crosslinks are broken, the proteins are removed and the purified DNA is modified with adaptor oligonucleotides to facilitate massively parallel DNA sequencing. Following sequencing, the DNA sequences that are obtained can be mapped to their genomic locations. | NCIT:C106048 |
| ChIP-qPCR assay | A molecular genetic technique that combines chromatin immunoprecipitation (ChIP) with massively parallel DNA sequencing to map the binding sites of DNA-associated proteins in a sample of cells. First, crosslinked protein-DNA complexes are isolated using ChIP. Next, the crosslinks are broken, the proteins are removed and the purified DNA is modified with adaptor oligonucleotides to facilitate massively parallel DNA sequencing. Following sequencing, the DNA sequences that are obtained can be mapped to their genomic locations. | OBI:0002169 |
| Chemiluminescent Assay | An assay that detects or quantifies an analyte by measuring light emitted from a chemiluminescent reaction. | PMID:28647912 |
| Chemotaxis Assay | An assay that measures the directional movement of cells in response to a chemical gradient (chemoattractant or chemorepellent). | BAO:0010269 |
| Circular Dichroism Spectroscopy | The technique of measuring the emission and absorption of different wavelengths (spectra) of visible and non-visible light. This can be done via a spectroscope, which consists of a slit, prism, collimator lens, object lens, and a grating. | CHMO:0000323 |
| Co-Immunoprecipitation | Co-immunoprecipitation (Co-IP) is a popular technique for protein interaction discovery. In a co-IP the target antigen precipitated by the antibody "co-precipitates" a binding partner/protein complex from a lysate. It is assumed that these proteins are related to the function of the target antigen at the cellular level. | NCIT:C19830 |
| Co-culture Assay | An assay in which two or more distinct cell types are cultured together to study their interactions. | PMID:4032528 |
| Collision-Induced Dissociation | A method by which fragmentation can be achieved. CID is accomplished by selecting an ion of interest with the mass analyzer and then subjecting that ion to collisions with neutral atoms or molecules. The resulting fragment ions are then mass analyzed. (from The Expanding Role of Mass Spectrometry in Biotechnology by Gary Siuzdak) | NCIT:C48061 |
| Colorimetric Cell Viability Assay | A colorimetric assay that can assess the viability of cells by quantitation of the reduction of a yellow tetrazolium salt substrate to a product that has a purple color. This assay can measure the cytotoxicity of a chemical or drug by determining the affect of treatment on cell viability. | NCIT:C95027 |
| Computational Modeling | The use of statistical analysis, computer analysis, or model organisms to predict outcomes of research. (doegenomes.org) | NCIT:C16461 |
| Computational Tool | A computer program or algorithm used to process, analyze, or interpret biological or experimental data. | mesh:D012984 |
| Computed Tomography | An imaging technique for examining structures within the body by scanning them with X rays and using a computer to construct a series of cross-sectional scans along a single axis. | NCIT:C17204 |
| Confocal Microscopy | A system of (usually) epifluorescence light microscopy in which a fine laser beam of light is scanned over the object through the objective lens. This technique is particularly good at rejecting light from outside the plane of focus and so produces higher effective resolution than other microscopy techniques. | NCIT:C17753 |
| Confocal Reflectance Quantitative Phase Microscopy | A system of (usually) epifluorescence light microscopy in which a fine laser beam of light is scanned over the object through the objective lens. This technique is particularly good at rejecting light from outside the plane of focus and so produces higher effective resolution than other microscopy techniques. | mesh:D000097913 |
| Cross-Linking Immunoprecipitation High-throughput Sequencing | A molecular biology method combining crosslinking-immunoprecipitation and high-throughput sequencing techniques to detect and map RNA-protein interactions. In CLIP, whole tissues, organisms or individual cell types are treated with UV irradiation, which introduces covalent bonds between RNA-protein complexes. This is followed by immunoprecipitation and removal of the protein component of the crosslinked complex. The purified RNAs are then fragmented, reduced in size and subjected to high-throughput sequencing for the identification of RNA binding sites. | NCIT:C116152 |
| Cross-Linking Mass Spectrometry | An analytical technique wherein ions are separated according to their ratio of charge to mass. From the mass spectrum produced, the atomic weight of the particle can be deduced. | PRIDE:0000430 |
| Cyclic Immunofluorescence | A method that enables simultaneous detection of multiple biomarkers on a single tissue section using immunofluorescence techniques. | PMID:27925668 |
| Cytochemical Stain | A staining technique used to visualize specific chemical components or structures within cells or tissues under a microscope. | UMLS:C4511272 |
| Cytokine Expression Profile | The identification and quantitation of all of the cytokines expressed in a biological sample. | NCIT:C129886 |
| Cytometric Bead Array Assay | An analyte assay in which a series of beads coated with antibodies, antigens, or other capture molecules are used in combination with flow cytometry to detect multiple analytes simultaneously. | OBI:0000920 |
| Cytotoxicity Assay | An assay that measures the degree to which a substance or treatment is toxic to cells, typically assessed via cell viability, membrane integrity, or metabolic activity. | BAO:0002993 |
| DBiT-Seq | A molecular genetic technique that combines chromatin immunoprecipitation (ChIP) with massively parallel DNA sequencing to map the binding sites of DNA-associated proteins in a sample of cells. First, crosslinked protein-DNA complexes are isolated using ChIP. Next, the crosslinks are broken, the proteins are removed and the purified DNA is modified with adaptor oligonucleotides to facilitate massively parallel DNA sequencing. Following sequencing, the DNA sequences that are obtained can be mapped to their genomic locations. | PMID:33188776 |
| DNA Gene-Expression Microarray | A process that allows thousands of pieces of DNA that are fixed to a glass slide to be analyzed at one time. It is used to identify the genes (pieces of DNA) in specific cells or tissue that are actively used to make RNA, which then may be used to make proteins. | NCIT:C93207 |
| DNA Methylation Array | The use of a high-throughput microarray where all of the known CpG islands either in a single specimen or all of the known promoter sequences of a specimen or a population group are coupled to beads or microwells to determine which are methylated. | NCIT:C165222 |
| DNA Sequencing | The determination of the sequence of purines and pyrimidines in deoxyribonucleic acid (DNA). | NCIT:C153598 |
| DNase-Seq | A molecular genetic technique where genome-wide sequencing is performed on DNA regions that are super sensitive to cleavage by DNase I to identify putative DNA regulatory sequences. | NCIT:C106052 |
| DRIP-seq | A molecular genetic technique that combines chromatin immunoprecipitation (ChIP) with massively parallel DNA sequencing to map the binding sites of DNA-associated proteins in a sample of cells. First, crosslinked protein-DNA complexes are isolated using ChIP. Next, the crosslinks are broken, the proteins are removed and the purified DNA is modified with adaptor oligonucleotides to facilitate massively parallel DNA sequencing. Following sequencing, the DNA sequences that are obtained can be mapped to their genomic locations. | Not available |
| Dark Field Microscopy | A microscopic technique in which the light that does not come into contact with the structure or details of interest is subtracted from the ocular image. This yields an image in which the structure or details are alight while the areas where the structures or details are absent are dark. | NCIT:C85837 |
| Deep Mutational Scanning | Technique of electron microscopy in which the specimen is coated with heavy metal and then scanned by an electron beam. The resolution is not as great as with transmission electron microscopy, but preparation is easier (often by fixation followed by critical point drying), the depth of focus is relatively enormous, the surface of a specimen can be seen (though not the interior unless the specimen is cracked open) and the image is aesthetically pleasing. | EFO:0010039 |
| Desorption Electrospray Ionization | An ionization method in which charged solvent droplets are sprayed at a sample surface under ambient conditions, desorbing and ionizing surface molecules for direct mass spectrometric analysis. | CHMO:0001660 |
| Dideoxy Chain Termination DNA Sequencing | A DNA sequencing technique in which a mixture of deoxynucleosidetriphosphates (dNTPs) and chain-terminating dNTPs, which are radioactively or fluorescently labeled, are combined within the reaction mixture. Once the reaction is complete, the DNA strands are separated by size, and the labeled chain terminating dNTPs can be read in sequence by the investigator or by a machine. | NCIT:C19641 |
| Differential Interference Contrast Microscopy | The use of various technologies to resolve the structure or features of objects too small or fine to naturally be seen by eye. | BAO:0002511 |
| Differential Scanning Fluorimetry | Technique of electron microscopy in which the specimen is coated with heavy metal and then scanned by an electron beam. The resolution is not as great as with transmission electron microscopy, but preparation is easier (often by fixation followed by critical point drying), the depth of focus is relatively enormous, the surface of a specimen can be seen (though not the interior unless the specimen is cracked open) and the image is aesthetically pleasing. | ECO:0006334 |
| Diffusion Weighted Imaging | A type of MRI technique in which diffusion-sensitizing gradients are applied to the imaging sequence. | NCIT:C111116 |
| Direct Long-Read RNA Sequencing | A sequencing method that determines RNA sequence directly from long native RNA molecules without prior conversion to cDNA. | OBI:0002629 |
| Drop-Seq | A molecular genetic technique that combines chromatin immunoprecipitation (ChIP) with massively parallel DNA sequencing to map the binding sites of DNA-associated proteins in a sample of cells. First, crosslinked protein-DNA complexes are isolated using ChIP. Next, the crosslinks are broken, the proteins are removed and the purified DNA is modified with adaptor oligonucleotides to facilitate massively parallel DNA sequencing. Following sequencing, the DNA sequences that are obtained can be mapped to their genomic locations. | EFO:0008722 |
| Droplet Digital PCR | A type of digital polymerase chain reaction technique in which the sample is fractionated into thousands of tiny droplets using a water-oil emulsion droplet technology, within which individual PCR reactions occur in each droplet. | NCIT:C166064 |
| Dual-Luciferase Reporter Assay | An assay that uses two different luciferase reporter enzymes (typically firefly and Renilla) to simultaneously measure experimental and internal-control reporter gene expression within the same sample. | BAO:0000680 |
| Dye Endocytosis Assay | An assay that measures cellular endocytic activity by quantifying the uptake of a fluorescent or otherwise detectable dye into cells. | Not available |
| Dynamic Contrast-Enhanced Magnetic Resonance Imaging | A type of contrast-enhanced MRI that allows observation of functional properties in addition to structural properties. | NCIT:C62665 |
| Dynamic Force Spectroscopy | The technique of measuring the emission and absorption of different wavelengths (spectra) of visible and non-visible light. This can be done via a spectroscope, which consists of a slit, prism, collimator lens, object lens, and a grating. | CHMO:0001122 |
| Dynamic Light Scattering | A type of spectroscopy that utilizes a laser beam to irradiate a sample containing particles in suspension, resulting in light scattering. Rapid fluctuations in scattering intensity, around a mean value at a certain angle, occur because of particle diffusion and are dependent upon on particle size. The calculated correlation function yields a diffusion coefficient, for a given temperature and viscosity, which can be used to calculate particle size. | NCIT:C62329 |
| Dynamic Susceptibility Contrast-Enhanced Magnetic Resonance Imaging | A type of magnetic resonance imaging that uses the transient signal reduction induced by the first pass of gadolinium chelate through the brain vessels to calculate cerebral blood flow maps, and to determine the ratio between the cerebral blood volume in the lesion and the cerebral blood volume in normal tissue. | NCIT:C116453 |
| ELISA | A type of enzyme immunoassay in which an antigen or antibody is bound to a solid substrate (e.g., microplate or beads) and interacts with an enzyme-linked antibody or antigen in solution. | NCIT:C16553 |
| Efferocytosis Assay | An assay that measures the phagocytic clearance of apoptotic cells by phagocytes (efferocytosis). | PMID:27815871 |
| Electron Diffraction | Any form of microscopy in which the interactions of electrons with the specimens are used to provide information about the final structure of that specimen. | CHMO:0000142 |
| Electron Microscopy | Any form of microscopy in which the interactions of electrons with the specimens are used to provide information about the final structure of that specimen. | NCIT:C16854 |
| Electron Paramagnetic Resonance Spectroscopy | The technique of measuring the emission and absorption of different wavelengths (spectra) of visible and non-visible light. This can be done via a spectroscope, which consists of a slit, prism, collimator lens, object lens, and a grating. | ERO:0001093 |
| Electrophoretic Mobility Shift Assay | A molecular biology technique used to detect the interaction of a DNA binding protein with its cognate binding sequence. Labeled DNAs were reacted with crude cell extracts and the complexes are run through a non-denaturing polyacrylamide gel. The migration of the labeled DNA through the gel will be slower by being bound. This shift in electrophoretic mobility indicates functional binding between the protein and the DNA. | NCIT:C19362 |
| Electrospray Ionization Time-of-Flight Mass Spectrometry | An analytical technique wherein ions are separated according to their ratio of charge to mass. From the mass spectrum produced, the atomic weight of the particle can be deduced. | CHMO:0000736 |
| Endotoxin Assay | An assay to detect and quantify endotoxin in a sample. | NCIT:C223372 |
| Energy-Dispersive X-Ray Spectroscopy | A technique in crystallography in which the pattern produced by the diffraction of x-rays through the closely spaced lattice of atoms in a crystal is recorded and then analyzed to reveal the nature of that lattice. | NCIT:C78869 |
| Enzyme Activity Assay | A procedure performed outside the living body to measure the catalytic activity of an enzyme. | MMO:0000444 |
| Enzyme-Linked Immunospot Assay | A cytometry-based assay in which cells are cultured on a surface coated with a capture antibody for a secreted analyte, which is then detected as discrete spots corresponding to individual secreting cells. | OBI:0600031 |
| Epidemiological Method | Epidemiological methods involve sophisticated statistics and higher mathematics. These methods allow epidemiologists to address issues like non-experimental studies of mechanistic questions in disease etiology, including studies of the impact of the social position of individuals in different social contexts. | NCIT:C16555 |
| FAIRE-Seq | A molecular genetic technique that depletes a biological sample of nucleosomal DNA and then subjects the non-nucleosome-associated DNA to next-generation sequencing. Since nucleosome disruption of chromatin is indicative of active sites of DNA transcription, this technique can isolate DNA sequences that are involved in transcriptional regulation. First, a sample is treated with formaldehyde to form DNA-protein crosslinks, followed by sample lysis and sonication. The processed sample is subjected to phenol/chloroform extraction and the DNA in the aqueous phase is analyzed using next-generation sequencing techniques. | NCIT:C106051 |
| FISH | Any jawed or jawless organisms in the phylum Chordata including the jawless fish, armored fish, cartilaginous fish, ray-finned fish and lobe-finned fish. | NCIT:C17563 |
| Flow Cytometry | A technique for counting, examining or sorting microscopic particles suspended in a stream of fluid. The cells are placed in a fluid (with or without light-sensitive dye) and passed in a stream before a laser or other type of light. | NCIT:C16585 |
| Fluorescence Activated Cell Sorting | Selection and deposition of individual cells of a particular phenotype from a mixed population into a separate tube or tissue culture plate by the use of a fluorescence-activated cell sorter (FACS) and fluorescently-labeled antibodies specific for surface molecules on the cells to be sorted. | NCIT:C17353 |
| Fluorescence Correlation Spectroscopy | The technique of measuring the emission and absorption of different wavelengths (spectra) of visible and non-visible light. This can be done via a spectroscope, which consists of a slit, prism, collimator lens, object lens, and a grating. | CHMO:0000288 |
| Fluorescence Imaging | An imaging technique that uses fluorescent dye to achieve the desired image. | NCIT:C116489 |
| Fluorescence Lifetime Imaging Microscopy | An imaging technique that produces spatially resolved images based on the differences in the excited state decay rates of fluorescent compounds in a sample. | NCIT:C154786 |
| Fluorescence Microscopy | The use of a special microscope to see objects that give off fluorescent light. For example, cells or tissue can be treated with a substance that contains a fluorescent dye. The dye lights up when viewed under a microscope with a special light. | NCIT:C16856 |
| Fluorescence Recovery After Photo-Bleaching | The use of a special microscope to see objects that give off fluorescent light. For example, cells or tissue can be treated with a substance that contains a fluorescent dye. The dye lights up when viewed under a microscope with a special light. | CHMO:0000065 |
| Fluorescent Antibody Procedure | An immunological procedure in which the antibodies are coupled with molecules which fluoresce under ultra violet (UV) light. This makes them particularly suitable for detection of specific antigens in tissues or on cells. | NCIT:C17370 |
| Fluorescent Cell Barcoding | An immunological procedure in which the antibodies are coupled with molecules which fluoresce under ultra violet (UV) light. This makes them particularly suitable for detection of specific antigens in tissues or on cells. | PMID:33960644 |
| Fluorescent In Situ Sequencing | Use of a DNA or RNA probe to detect the presence of complementary sequences in chromosomes, cells, or tissues. (NCI) | EFO:0008990 |
| Focused Ion Beam Scanning Electron Microscopy | Technique of electron microscopy in which the specimen is coated with heavy metal and then scanned by an electron beam. The resolution is not as great as with transmission electron microscopy, but preparation is easier (often by fixation followed by critical point drying), the depth of focus is relatively enormous, the surface of a specimen can be seen (though not the interior unless the specimen is cracked open) and the image is aesthetically pleasing. | FBbi:00050000 |
| Forster Resonance Energy Transfer | A method for determining the distance between two molecules by measuring the energy transfer between two chromophores (a donor and an acceptor) in close proximity. | CHMO:0000062 |
| Fourier Transform Ion Cyclotron Resonance Mass Spectrometry | A type of mass spectrometry that uses the cyclotron frequency of ions in a fixed magnetic field to determine their ionic mass-to-charge ratio. | NCIT:C116571 |
| Fourier-Transform Infrared Spectroscopy | A type of mass spectrometry that uses the cyclotron frequency of ions in a fixed magnetic field to determine their ionic mass-to-charge ratio. | CHMO:0000636 |
| Gas Chromatography Mass Spectrometry | An analytical technique wherein gas chromatography is coupled to mass spectrometry in order to separate, identify, and quantify substances in a sample. | NCIT:C111203 |
| Gelatin Zymography | An SDS-PAGE based procedure used to identify matrix metalloproteinases. | NCIT:C19835 |
| Genotyping | The determination of the nucleotide sequence of the genetic material at a specific locus. | NCIT:C45447 |
| Global Chromatin Profiling | A type of epigenetic modification assay that uses targeted quantitative mass spectrometry to profile post-translational modifications of core histone proteins in chromatin. | OBI:0002961 |
| Global Run-On Sequencing | Global run-on sequencing (GRO-seq), a sequencing-based assay derived from nuclear run-on assays that maps the position and orientation of actively transcribing RNA polymerases genome-wide. | EFO:0005227 |
| Graphite Furnace Atomic Absorption Spectrometry | A technique utilizing a scanning probe to image and analyze the surface of a material with atomic-level resolution. | CHMO:0000239 |
| HL-Chip | A molecular genetic technique that combines chromatin immunoprecipitation (ChIP) with massively parallel DNA sequencing to map the binding sites of DNA-associated proteins in a sample of cells. First, crosslinked protein-DNA complexes are isolated using ChIP. Next, the crosslinks are broken, the proteins are removed and the purified DNA is modified with adaptor oligonucleotides to facilitate massively parallel DNA sequencing. Following sequencing, the DNA sequences that are obtained can be mapped to their genomic locations. | pmid:32348757 |
| HPLC-MSMS | An analytical technique wherein high performance liquid chromatography is coupled to tandem mass spectrometry in order to separate, identify, and quantify substances in a sample. | NCIT:C120691 |
| Hematoxylin and Eosin Staining Method | Hematoxylin-and-eosin, or H&E, is a routine staining procedure of tissue sections. This staining method uses two separate dyes, one staining the nucleus and the other staining the cytoplasm and connective tissue. Hematoxylin is a dark purplish dye that stains the chromatin (nuclear material) within the nucleus. Eosin is an orangish-pink to red dye that stains the cytoplasmic material including connective tissue and collagen. | NCIT:C23011 |
| Hi-C | Hi-C is a method for analyzing the 3-dimensional organization and genome-wide interaction frequencies of chromatin, belonging to the class of chromosome conformation capture techniques. | EFO:0007693 |
| HiChIP | A method that combines chromosome conformation capture, proximity ligation and chromatin immunoprecipitation to isolate DNA from a biospecimen, create a genomic library and analyze 3D chromatin organization. | NCIT:C179435 |
| High Throughput Screening | Use of robots and other automated techniques to screen large numbers of samples. | NCIT:C18472 |
| High-Content Screen | An image analysis technique combining automated fluorescence microscopy with multi-parameter quantitative image analysis for large-scale study of cellular phenotypes. | EFO:0007550 |
| Hydrogels | A three-dimensional network of hydrophilic polymer chains that can absorb and retain large amounts of water, commonly used as a scaffold material in 3D cell culture and tissue engineering. | ENVO:01001562 |
| Hydrophilic Interaction Chromatography | A liquid chromatography technique in which the stationary phase is hydrophilic and the mobile phase is largely organic, separating polar compounds based on their differential partitioning. | CHMO:0002262 |
| Image Cytometry | A flow cytometry technique that utilizes mass spectrometry to detect antibodies labeled with heavy metal ion tags that are bound to antigens of interest on single cells. | mesh:D019044 |
| Imaging | An imaging technique that uses fluorescent dye to achieve the desired image. | NCIT:C17369 |
| Immobilized Metal Affinity Chromatography | A method to purify proteins or peptides from a mixture that leverages their affinity to positively charged ions immobilized on NTA-agarose beads. | NCIT:C161789 |
| ImmunoFISH | A method combining immunolabeling with fluorescent in situ hybridization (FISH) to simultaneously detect the nuclear distribution of a protein and specific DNA or RNA sequences. | EFO:0011016 |
| Immunoassay | An immunological procedure used for the microscopic examination of tissues. It involves the usage of enzyme-antibody or enzyme-antigen conjugates, antienzyme antibodies, or enzyme-antienzyme complexes. | MMO:0000098 |
| Immunocytochemistry | A method for the detection of proteins or antigens on samples of cells that are grown in monolayers or in suspension and deposited on slides, using antibodies or other biomolecules that bind the target and can be visualized through a chemical process. | NCIT:C17731 |
| Immunohistochemistry Staining Method | Immunohistochemical staining techniques allow for the visualization of antigens via the sequential application of a specific antibody to the antigen (primary antibody), a secondary antibody to the primary antibody and an enzyme complex with a chromogenic substrate. The enzymatic activation of the chromogen results in a visible reaction product at the antigen site. The specimen may then be counterstained and coverslipped. Results are interpreted using a light microscope and aid in the differential diagnosis of pathophysiological processes, which may or may not be associated with a particular antigen. | NCIT:C23020 |
| Immunoprecipitation | Antigen aggregation with antibody, in the right ratios, to cause precipitation. (NCI) | NCIT:C16724 |
| In Situ Hybridization | Use of a DNA or RNA probe to detect the presence of complementary sequences in chromosomes, cells, or tissues. (NCI) | NCIT:C17562 |
| In Vitro Cell Killing Assay | A cell killing assay that measures whether, and to what extent, target cells are actively killed by other cells in a cell culture. | OBI:0000903 |
| In Vitro Model | A laboratory model system, such as cultured cells or tissue, used to study biological processes or disease outside of a living organism. | NCIT:C19146 |
| In Vitro Selection | An iterative laboratory process for isolating molecules (e.g., nucleic acids or proteins) with desired properties from a large pool through repeated rounds of selection and amplification outside a living organism. | operation:3795 |
| In Vitro Translation | A cell-free system that synthesizes protein from an RNA or DNA template using cellular translation machinery (ribosomes, tRNAs, and associated factors) extracted from cells. | ERO:0000906 |
| In Vivo Bioluminescence | An imaging technique that detects light emitted by luciferase-expressing cells or tissues within a living organism, used to monitor biological processes such as tumor growth or gene expression over time. | ERO:0000651 |
| In-Cell Western Assay | Any method to measure the number of dividing cells in a culture, or to measure the change in the proportion of cells that are dividing. | BAO:0002423 |
| Inductively-Coupled Plasma Mass Spectrometry | A mass spectrometry technique that uses inductively-coupled plasma generated from argon gas to atomize and ionize a sample. The resulting ions are separated and analyzed using a mass spectrometer. | NCIT:C62328 |
| Interference Reflection Microscopy | The use of various technologies to resolve the structure or features of objects too small or fine to naturally be seen by eye. | CHMO:0002437 |
| Intravital Microscopy | The use of various technologies to resolve the structure or features of objects too small or fine to naturally be seen by eye. | ERO:0001638 |
| Invasion Assay | An in vitro assay, commonly using a reconstituted basement membrane (e.g., Matrigel), that assesses the ability of cells to degrade and migrate through tissue barriers. | NCIT:C16216 |
| Karyotyping | The preparation, analysis, and interpretation of a karyotype, the representation of the chromosome set of a cell. | NCIT:C16768 |
| Knife-Edge Scanning Microscopy | Technique of electron microscopy in which the specimen is coated with heavy metal and then scanned by an electron beam. The resolution is not as great as with transmission electron microscopy, but preparation is easier (often by fixation followed by critical point drying), the depth of focus is relatively enormous, the surface of a specimen can be seen (though not the interior unless the specimen is cracked open) and the image is aesthetically pleasing. | PMID:18638197 |
| L1000 mRNA Profiling Assay | A high-throughput gene expression profiling assay in which cultured cells are treated with chemical or genetic perturbations and the transcriptional response of ~1,000 landmark genes is measured, with the remaining transcriptome inferred computationally. | BAO:0010046 |
| Lattice Light Sheet Microscopy | The use of a special microscope to see objects that give off fluorescent light. For example, cells or tissue can be treated with a substance that contains a fluorescent dye. The dye lights up when viewed under a microscope with a special light. | OBI:0003098 |
| Liquid Chromatography Mass Spectrometry | LC/MS is a hyphenated technique, combining the separation power of liquid chromatography (LC), an analytical chromatographic technique for separating ions or molecules dissolved in a solvent, with the detection power of mass spectrometry(MS), a technique to separate gas phase ions according their m/z (mass to charge ratio) value. Used for drug screening, pharmacology studies, environmental analyses and forensics. | NCIT:C18475 |
| Liquid Chromatography/Tandem Mass Spectrometry | An analytical technique wherein liquid chromatography is coupled to tandem mass spectrometry in order to separate, identify, and quantify substances in a sample. | CHMO:0000701 |
| Low-Vacuum Scanning Electron Microscopy | Technique of electron microscopy in which the specimen is coated with heavy metal and then scanned by an electron beam. The resolution is not as great as with transmission electron microscopy, but preparation is easier (often by fixation followed by critical point drying), the depth of focus is relatively enormous, the surface of a specimen can be seen (though not the interior unless the specimen is cracked open) and the image is aesthetically pleasing. | PMID:29546719 |
| Luciferase Reporter Assay | An assay that uses a luciferase reporter gene under the control of a regulatory element of interest to measure gene expression or promoter/enhancer activity via light output. | BAO:0002661 |
| Luminescent Cell Viability Assay | A colorimetric assay that can assess the viability of cells by quantitation of the reduction of a yellow tetrazolium salt substrate to a product that has a purple color. This assay can measure the cytotoxicity of a chemical or drug by determining the affect of treatment on cell viability. | BAO:0000682 |
| MALDI-TOF Mass Spectrometry | An analytical technique wherein ions are separated according to their ratio of charge to mass. From the mass spectrum produced, the atomic weight of the particle can be deduced. | NCIT:C19935 |
| MEMA Cell Growth Assay | Any method to measure the number of dividing cells in a culture, or to measure the change in the proportion of cells that are dividing. | BAO:0010060 |
| MNase-Seq | A molecular genetic technique that combines chromatin immunoprecipitation (ChIP) with massively parallel DNA sequencing to map the binding sites of DNA-associated proteins in a sample of cells. First, crosslinked protein-DNA complexes are isolated using ChIP. Next, the crosslinks are broken, the proteins are removed and the purified DNA is modified with adaptor oligonucleotides to facilitate massively parallel DNA sequencing. Following sequencing, the DNA sequences that are obtained can be mapped to their genomic locations. | EFO:0003751 |
| MULTI-Seq | A molecular genetic technique that combines chromatin immunoprecipitation (ChIP) with massively parallel DNA sequencing to map the binding sites of DNA-associated proteins in a sample of cells. First, crosslinked protein-DNA complexes are isolated using ChIP. Next, the crosslinks are broken, the proteins are removed and the purified DNA is modified with adaptor oligonucleotides to facilitate massively parallel DNA sequencing. Following sequencing, the DNA sequences that are obtained can be mapped to their genomic locations. | EFO:0030077 |
| Macrophage Polarization Assay | An assay that measures the differentiation of macrophages into functional phenotypes (e.g., M1 pro-inflammatory or M2 anti-inflammatory) in response to specific stimuli, typically via marker expression or cytokine profiling. | Not available |
| Magnetic Resonance Imaging | Imaging that uses radiofrequency waves and a strong magnetic field rather than x-rays to provide detailed pictures of internal organs and tissues. The technique is valuable for the diagnosis of many pathologic conditions, including cancer, heart and vascular disease, stroke, and joint and musculoskeletal disorders. | NCIT:C16809 |
| Magnetic Tweezers | A technique that utilizes light waves to exert minute forces as well as transmit energy to isolate and manipulate nanoparticles. | CHMO:0002474 |
| Magnetic Twisting Cytometry | A flow cytometry technique that utilizes mass spectrometry to detect antibodies labeled with heavy metal ion tags that are bound to antigens of interest on single cells. | PMID:11509510 |
| Magnetically Activated Cell Sorting | Selection and deposition of individual cells of a particular phenotype from a mixed population into a separate tube or tissue culture plate by the use of a fluorescence-activated cell sorter (FACS) and fluorescently-labeled antibodies specific for surface molecules on the cells to be sorted. | NCIT:C116641 |
| Mammosphere Formation Assay | An in vitro assay that measures the ability of mammary epithelial or stem/progenitor cells to form free-floating spherical colonies (mammospheres) under non-adherent culture conditions. | PMID:25867607 |
| Mass Cytometry | A flow cytometry technique that utilizes mass spectrometry to detect antibodies labeled with heavy metal ion tags that are bound to antigens of interest on single cells. | NCIT:C187898 |
| Mass Spectrometry | An analytical technique wherein ions are separated according to their ratio of charge to mass. From the mass spectrum produced, the atomic weight of the particle can be deduced. | NCIT:C17156 |
| Mathematical Modeling | The use of statistical analysis, computer analysis, or model organisms to predict outcomes of research. (doegenomes.org) | NCIT:C16870 |
| MeDIP | A DNA methylation profiling assay (methylated DNA immunoprecipitation) that uses an antibody against 5-methylcytosine to enrich for methylated DNA fragments prior to sequencing. | OBI:0000693 |
| MeRIP-Seq | A molecular genetic technique that combines chromatin immunoprecipitation (ChIP) with massively parallel DNA sequencing to map the binding sites of DNA-associated proteins in a sample of cells. First, crosslinked protein-DNA complexes are isolated using ChIP. Next, the crosslinks are broken, the proteins are removed and the purified DNA is modified with adaptor oligonucleotides to facilitate massively parallel DNA sequencing. Following sequencing, the DNA sequences that are obtained can be mapped to their genomic locations. | EFO:0008803 |
| Methyl Binding Domain Sequencing | An assay in which DNA is enriched using a methyl-binding domain protein to isolate methylated genomic fractions prior to sequencing. | EFO:0003750 |
| Methylation-Specific PCR | Polymerase chain reaction that uses two sets of primers, in two sequential runs of amplification, with the second set intended to amplify a target within the first run product. | PMID:21913069 |
| Micro-computed Tomography | An imaging technique for examining structures within the body by scanning them with X rays and using a computer to construct a series of cross-sectional scans along a single axis. | MMO:0000570 |
| MicroRNA Expression Array | A molecular biology device that utilizes a set of defined cDNA clones attached in a specific grid arrangement to a solid support for nucleic acid hybridization assays in gene mapping studies or in determining gene sequences, sequence variations, or gene expression patterns. | OBI:0001335 |
| MicroRNA Sequencing | A next-generation or massively parallel high-throughput DNA sequencing-based procedure that can identify and quantify the microRNA sequences present in a biological sample. | NCIT:C156057 |
| Microcontact Printing | A synthesis method for transferring a molecular pattern onto a substrate surface, typically by coating a patterned stamp with a molecule of interest and bringing it into contact with the surface. | CHMO:0001440 |
| Microfluidics | A technology that manipulates small volumes of fluid (nanoliter to microliter scale) through networks of miniaturized channels, used for high-throughput single-cell or biochemical assays. | mesh:D046210 |
| Micropipette Adhesion Assay | A biophysical assay that uses a micropipette to apply and measure adhesive forces between individual cells or between a cell and a substrate. | PMID:22083316 |
| Micropipette Aspiration | A biophysical technique that uses a fine glass micropipette and controlled suction pressure to measure the mechanical properties (e.g., membrane tension, cortical stiffness) of individual cells. | Not available |
| Microscopy | The use of various technologies to resolve the structure or features of objects too small or fine to naturally be seen by eye. | NCIT:C16853 |
| Migration Assay | An in vitro assay in which cultured cells are monitored and analyzed for their ability to move into an acellular area of a culture material. | NCIT:C19425 |
| Mint-ChIP | A molecular genetic technique that combines chromatin immunoprecipitation (ChIP) with massively parallel DNA sequencing to map the binding sites of DNA-associated proteins in a sample of cells. First, crosslinked protein-DNA complexes are isolated using ChIP. Next, the crosslinks are broken, the proteins are removed and the purified DNA is modified with adaptor oligonucleotides to facilitate massively parallel DNA sequencing. Following sequencing, the DNA sequences that are obtained can be mapped to their genomic locations. | EFO:0008813 |
| Modeling | The use of statistical analysis, computer analysis, or model organisms to predict outcomes of research. (doegenomes.org) | NCIT:C16063 |
| Molecular Simulations | The use of computational methods to simulate the physical motions and interactions of atoms or molecules over time. | NCIT:C18097 |
| Monolayer Stress Microscopy | The use of various technologies to resolve the structure or features of objects too small or fine to naturally be seen by eye. | Not available |
| Multi-Angle Light Scattering | A method for determining particle size and molecular weight by measuring the intensity of light scattered from a sample at multiple angles. | CHMO:0000168 |
| Multi-Isotope Mass Spectrometry | An analytical technique wherein ions are separated according to their ratio of charge to mass. From the mass spectrum produced, the atomic weight of the particle can be deduced. | PMID:22246326 |
| Multiparametric Magnetic Resonance Imaging | The combination of multiple magnetic resonance techniques, including diffusion weighted imaging, dynamic contrast-enhanced imaging, and spectroscopy, to achieve an image that will allow for better identification of tumor size and location, as well as possibly identifying cancer spread and aggressiveness. | NCIT:C116458 |
| Multiphoton Microscopy | An imaging technique that uses multiple photons to absorb infrared light, thereby minimizing phototoxicty and photobleaching, making it an ideal method for imaging living specimens, especially those involving deep tissue. | NCIT:C116504 |
| Multiplexed Error-Robust Fluorescence In Situ Hybridization | Use of a DNA or RNA probe to detect the presence of complementary sequences in chromosomes, cells, or tissues. (NCI) | EFO:0008992 |
| Multiplexed Immunofluorescence | A method that enables simultaneous detection of multiple biomarkers on a single tissue section using immunofluorescence techniques. | NCIT:C181928 |
| Multiplexed Immunohistochemistry | A method that enables simultaneous detection of multiple biomarkers on a single tissue section using immunohistochemistry techniques. | NCIT:C181927 |
| Multiplexed Ion Beam Imaging | A method for multiplexed immunohistochemistry that uses secondary ion mass spectrometry to image antibodies tagged with isotopically pure elemental metal reporters. Multiplexed ion beam imaging (MIBI) is capable of analyzing up to 100 targets simultaneously over a five-log dynamic range. This technique enables comprehensive phenotypic profiling and spatial analysis of the tissue microenvironment. | NCIT:C181930 |
| Murine Model | An experimental model that uses mice to study biological processes, disease mechanisms, or the effects of treatments in vivo. | NCIT:C94604 |
| Nano-hmC-Seal | A chemical labeling and capture approach for genome-wide profiling of 5-hydroxymethylcytosine (5hmC) using selective chemical tagging followed by sequencing. | EFO:0010040 |
| NanoString Digital Spatial Profiling | A spatial transcriptomics technique that enables analysis of RNA and protein expression in tissue specimens on slides using multiplexed probe hybridization and digital counting. | EFO:0030029 |
| Nanopatterning | A fabrication technique that creates nanoscale surface features or patterns, used e.g. to control cell adhesion, shape, or substrate mechanics in cell-biology experiments. | Not available |
| Nanopore Sequencing | A proprietary next-generation DNA sequencing technology from Oxford Nanopore Technologies that can directly identify and sequence a DNA molecule as it passes through a nanopore, driven by electrophoresis. | NCIT:C146818 |
| Nanowire | A nanometer-scale wire consisting of metal atoms, silicon or other materials that conduct electricity. Nanowires are one-dimensional, and exhibit unique electrical and optical properties. They are built atom by atom on a solid surface, often as part of a microfluidic device. In addition, they can be coated with molecules such as antibodies that will bind to proteins for both basic science and clinical applications. | NCIT:C62376 |
| Nested PCR | Polymerase chain reaction that uses two sets of primers, in two sequential runs of amplification, with the second set intended to amplify a target within the first run product. | NCIT:C127880 |
| Next Generation Sequencing | Technologies that facilitate the rapid determination of the nucleotide sequence of large numbers of strands or segments of DNA or RNA. | NCIT:C101293 |
| Nm-seq | A molecular genetic technique that combines chromatin immunoprecipitation (ChIP) with massively parallel DNA sequencing to map the binding sites of DNA-associated proteins in a sample of cells. First, crosslinked protein-DNA complexes are isolated using ChIP. Next, the crosslinks are broken, the proteins are removed and the purified DNA is modified with adaptor oligonucleotides to facilitate massively parallel DNA sequencing. Following sequencing, the DNA sequences that are obtained can be mapped to their genomic locations. | EFO:0008828 |
| Not Applicable | Determination of a value is not relevant in the current context. (NCI) | NCIT:C48660 |
| Nuclear Magnetic Resonance | A physical phenomenon involving the interaction of atomic nuclei placed in an external magnetic field with an applied electromagnetic field oscillating at a particular frequency. Magnetic conditions within the material are measured by monitoring the radiation absorbed and emitted by the atomic nuclei. It is the underlying principle of Magnetic Resonance Imaging (MRI). | NCIT:C16921 |
| Optical Coherence Tomography | Optical Coherence Tomography (OCT) combines the principles of ultrasound with the imaging performance of a microscope. OCT uses infrared light waves that reflect off the internal microstructure within the biological tissues. The frequencies and bandwidths of infrared light are orders of magnitude higher than medical ultrasound signals, resulting in greatly increased image resolution, 8-25 times greater than any existing modality. In addition to providing high-level resolutions for the evaluation of microanatomic structures OCT is also able to provide information regarding tissue composition. (NCI) | NCIT:C20828 |
| Optical Emission Spectroscopy | The technique of measuring the emission and absorption of different wavelengths (spectra) of visible and non-visible light. This can be done via a spectroscope, which consists of a slit, prism, collimator lens, object lens, and a grating. | CHMO:0000251 |
| Optical Mapping | A technique used for constructing the ordered and high-resolution genome or chromosome sized restriction enzyme map of an organism from a single, stained DNA molecule, digested by the restriction enzyme and imaged by an optical microscope. | NCIT:C116162 |
| Optical Stretcher | A technique that utilizes light waves to exert minute forces as well as transmit energy to isolate and manipulate nanoparticles. | PMID:30404265 |
| Optical Tweezers | A technique that utilizes light waves to exert minute forces as well as transmit energy to isolate and manipulate nanoparticles. | NCIT:C62320 |
| Optogenetic Assay | The combination of genetic and optical methods to control specific cellular events with temporal precision in targeted cells of a functioning biological system. | mesh:D062308 |
| Organoid | A three dimensional mass comprised of a cultured cell or tissue sample that resembles an in vivo tissue or organ. Organoids are grown in vitro from a combination of cells or tissue fragments cultured in medium containing a variety of biochemical factors. | NCIT:C172259 |
| PCR | Polymerase chain reaction that uses two sets of primers, in two sequential runs of amplification, with the second set intended to amplify a target within the first run product. | NCIT:C17003 |
| PET-CT | An imaging technique that combines positron emission tomography and computed tomography acquisition in a single machine to provide co-registered functional and anatomical images. | NCIT:C103512 |
| Paraquat Survival Assay | A survival assay that exposes an organism (commonly Caenorhabditis elegans) to the oxidative-stress-inducing herbicide paraquat to measure resistance to oxidative stress and longevity. | Not available |
| Partial Wave Spectroscopy | The technique of measuring the emission and absorption of different wavelengths (spectra) of visible and non-visible light. This can be done via a spectroscope, which consists of a slit, prism, collimator lens, object lens, and a grating. | Not available |
| Patient Derived Xenograft | A mouse model for human cancer studies in which a human-derived tumor sample is transplanted into an immunodeficient mouse. | NCIT:C122936 |
| Pending Annotation | A placeholder value indicating that the appropriate assay annotation for this record has not yet been determined or curated. | NCIT:C53470 |
| Permeability Assay | An assay that measures the rate or extent to which a substance passes through a biological or synthetic semi-permeable barrier, such as a cell monolayer or membrane. | BAO:0010083 |
| Phagocytosis Assay | An assay that measures the ability of phagocytic cells to engulf and internalize particles, pathogens, or other cells. | SNOMED:45101000 |
| Photoacoustic Imaging | An imaging technique during which non-ionizing pulses are delivered into tissue and the resulting ultrasonic waves are detected and converted into images. | NCIT:C116749 |
| Photolithography | A synthesis method that uses light to transfer a pattern onto a substrate, typically via a light-sensitive photoresist layer. | CHMO:0001410 |
| Plasmid Construction | The process of assembling or engineering a plasmid vector, typically by inserting a DNA sequence of interest into a plasmid backbone using molecular cloning techniques. | ERO:0001308 |
| PlateSeq | A genome-wide mRNA profiling methodology designed to complement high-throughput screening assays by enabling low-cost, plate-based transcriptomic readouts. | EFO:0008863 |
| Point Accumulation for Imaging in Nanoscale Topography | A super-resolution microscopy technique (PAINT) that achieves nanoscale spatial resolution by imaging the transient, stochastic binding of fluorescently labeled probes to a target structure over time. | FBbi:00000339 |
| Positron Emission Tomography | An imaging technique for measuring the gamma radiation produced by collisions of electrons and positrons (anti-electrons) within living tissue. In positron emission tomography (PET), a subject is given a dose of a positron-emitting radionuclide attached to a metabolically active substance. A scanner reveals the tissue location of the metabolically-active substance administered. | NCIT:C17007 |
| Precision Run-On Sequencing | Precision nuclear run-on and sequencing (PRO-seq), a technique that maps the genome-wide position of actively engaged RNA polymerases at nucleotide resolution, including polymerase pause sites. | EFO:0008869 |
| Proteomics Assay | A mass spectrometry assay that identifies and measures proteins in a sample. | OBI:0003781 |
| Proximity Ligation Assay | A technique that leverages immunoassay and DNA amplification technology to detect protein-protein interactions with high specificity and sensitivity. A sample is prepared and then exposed to primary antibodies raised in different species recognizing the target epitopes on the proteins of interest. Then, secondary antibodies that are tagged with short oligonucleotides and that target each primary antibody are added. Next, a mixture comprised of a ligase, PCR components and a connector oligonucleotide, which hybridizes to both oligonucleotide tags and can prime rolling DNA circle synthesis, are added and the sample is subjected to real-time PCR to amplify the DNA circles. Rolling circle synthesis and amplification is only possible if the protein epitopes are in close proximity (i.e. in a protein complex). Finally, a labeled complementary nucleotide probe is added to detect and/or visualize the amplified DNA. | NCIT:C156754 |
| Pull-Down Assay | An in vitro assay used to detect or confirm a physical interaction between two or more proteins (or a protein and another molecule) by using an immobilized bait molecule to capture binding partners from a lysate. | PMID:28667618 |
| QFISH | Quantitative fluorescence in situ hybridization, a technique combining FISH with quantitative fluorescence measurement, commonly used to measure telomere length. | PMID:18228343 |
| Quantitative Multiplex Immunofluorescence | A method that enables simultaneous detection of multiple biomarkers on a single tissue section using immunofluorescence techniques. | EFO:0022989 |
| Quantitative Point Accumulation for Imaging in Nanoscale Topography | A quantitative variant of the PAINT super-resolution microscopy technique that enables counting or quantification of molecules based on transient, stochastic probe-binding events. | PMID:27018580 |
| Questionnaire | A set of questions or items shown to a respondent in order to get answers for research purposes. [PRO Draft Guidance] See also instrument, survey. | NCIT:C17048 |
| RAS Protein Family Activation Assay | An in vitro assay that can indirectly detect the activation of small GTPases in the RAS family through the staining of phosphorylated forms of MEK (MAP2K) family proteins (pMEK). A farnesylated RAS family protein is anchored to an in vitro model of the plasma membrane and, under different conditions, is co-incubated with both a RAF family protein, which binds to and is activated by active RAS proteins, and a MEK family protein, which is phosphorylated by active RAF proteins. pMEK is detected using a donor bead coated with anti-MEK antibodies that is capable of oxidizing an acceptor molecule attached to an anti-pMEK antibody. When the donor and acceptor are in close proximity, the acceptor molecule is oxidized and can be visualized using electron microscopy. | NCIT:C139305 |
| RIP | RNA immunoprecipitation (RIP), a technique used to investigate protein-RNA interactions in the cell by immunoprecipitating an RNA-binding protein along with its bound RNAs. | EFO:0005033 |
| RIP-Seq | A molecular genetic technique that combines chromatin immunoprecipitation (ChIP) with massively parallel DNA sequencing to map the binding sites of DNA-associated proteins in a sample of cells. First, crosslinked protein-DNA complexes are isolated using ChIP. Next, the crosslinks are broken, the proteins are removed and the purified DNA is modified with adaptor oligonucleotides to facilitate massively parallel DNA sequencing. Following sequencing, the DNA sequences that are obtained can be mapped to their genomic locations. | EFO:0005310 |
| RNA Sequencing | A procedure that can determine the RNA sequences for all or part of the poly-A tail-containing messenger RNA transcripts in an individual. | NCIT:C124261 |
| RNAi Screen | An assay that uses a panel of RNA interference (RNAi) reagents to systematically knock down a large set of genes, one at a time, to identify those involved in a biological process of interest. | FBcv:0003077 |
| RT-PCR | Polymerase chain reaction that uses two sets of primers, in two sequential runs of amplification, with the second set intended to amplify a target within the first run product. | NCIT:C18136 |
| RT-qPCR | Real-time PCR in which an RNA sample is first reverse transcribed into complementary DNA (cDNA) and then quantified by real-time PCR. | MMO:0000462 |
| Raman Spectroscopy | Emission of electromagnetic energy with a shorter frequency (longer wavelength) than that of the incident monochromatic light. Arises from the low probability absorption of quanta with a higher energy than that required for a transition: the difference in energy is emitted as a lower frequency (energy) photon. Allows analysis of vibrational and rotational energy levels using visible incident light. | NCIT:C17157 |
| Reduced Representation Bisulfite Sequencing | A DNA sequencing technique that can differentiate cytosine from 5-methylcytosine in a DNA sample. First, a denatured DNA sample is treated with bisulfite which converts non-methylated cytosine to uracil. Next, the sample is amplified using a PCR method that does not discriminate between non-methylated and methylated sequences. The amplified DNA is subjected to nucleotide sequencing. The resulting sequence is compared to an identical control sample of DNA that was not treated with bisulfite. Unmethylated cytosines will be displayed as cytosines in the control sample and as thymines in the bisulfite-treated sample. | NCIT:C167284 |
| Reverse Phase Protein Array | An antibody-based functional proteomic microarray that can characterize basal protein expression and levels of protein modifications in a series of samples of body fluids or those derived from tissue or cellular lysates. | OBI:0002957 |
| Reverse-Phase High-Performance liquid Chromatography | Liquid chromatography in which the mobile phase is significantly more polar than the nonpolar stationary phase, commonly used to separate small molecules based on hydrophobicity. | CHMO:0001259 |
| Rheometry | The measurement of the flow and deformation behavior of fluids or soft materials in response to applied stress. | CHMO:0000915 |
| Ribo-Seq | A molecular genetic technique that combines chromatin immunoprecipitation (ChIP) with massively parallel DNA sequencing to map the binding sites of DNA-associated proteins in a sample of cells. First, crosslinked protein-DNA complexes are isolated using ChIP. Next, the crosslinks are broken, the proteins are removed and the purified DNA is modified with adaptor oligonucleotides to facilitate massively parallel DNA sequencing. Following sequencing, the DNA sequences that are obtained can be mapped to their genomic locations. | EFO:0008891 |
| Ribosomal P Protein Antibody Measurement | The determination of the ribosomal P protein antibody present in a sample. | NCIT:C120659 |
| Scanning Angle Interference Microscopy | Technique of electron microscopy in which the specimen is coated with heavy metal and then scanned by an electron beam. The resolution is not as great as with transmission electron microscopy, but preparation is easier (often by fixation followed by critical point drying), the depth of focus is relatively enormous, the surface of a specimen can be seen (though not the interior unless the specimen is cracked open) and the image is aesthetically pleasing. | Not available |
| Scanning Electron Microscopy | Technique of electron microscopy in which the specimen is coated with heavy metal and then scanned by an electron beam. The resolution is not as great as with transmission electron microscopy, but preparation is easier (often by fixation followed by critical point drying), the depth of focus is relatively enormous, the surface of a specimen can be seen (though not the interior unless the specimen is cracked open) and the image is aesthetically pleasing. | NCIT:C16855 |
| Second-Harmonic Imaging Microscopy | An imaging technique that produces spatially resolved images based on the differences in the excited state decay rates of fluorescent compounds in a sample. | mesh:D000073798 |
| Shotgun Mass Spectrometry | An analytical technique wherein ions are separated according to their ratio of charge to mass. From the mass spectrum produced, the atomic weight of the particle can be deduced. | PRIDE:0000429 |
| Single Cell ATAC-Seq | A molecular genetic technique where DNA is isolated from single cell (sc) samples and amplified to create a genomic library. Then the library is subjected to ATAC-seq, which isolates and sequences regions rich in open chromatin. | NCIT:C179458 |
| Single Cell Cytokine Detection Chip Assay | A molecular genetic technique that combines chromatin immunoprecipitation (ChIP) with massively parallel DNA sequencing to map the binding sites of DNA-associated proteins in a sample of cells. First, crosslinked protein-DNA complexes are isolated using ChIP. Next, the crosslinks are broken, the proteins are removed and the purified DNA is modified with adaptor oligonucleotides to facilitate massively parallel DNA sequencing. Following sequencing, the DNA sequences that are obtained can be mapped to their genomic locations. | BAO:0010005 |
| Single Cell DNA Sequencing | The determination of the sequence of purines and pyrimidines in deoxyribonucleic acid (DNA). | NCIT:C223894 |
| Single Cell Gel Electrophoresis | A rapid, simple, visual and sensitive technique for measuring DNA breakage in individual mammalian cells in response to a test agent. A cell is immobilized in agarose and made permeable and the broken DNA migrates out under the influence of the electric field. A damaged cell has the appearance of a comet with a brightly fluorescent cell body and a tail whose length and fluorescence intensity are related to the number of DNA-strand breaks induced by the test agent. | NCIT:C96515 |
| Single Cell RNA-Sequencing | A procedure that determines the nucleotide sequence of RNA transcripts from an amplified sample derived from a single cell, enabling transcriptomic profiling at single-cell resolution. | NCIT:C171152 |
| Single Molecule Forster Resonance Energy Transfer | A single-molecule variant of Forster Resonance Energy Transfer (FRET) that measures the distance-dependent energy transfer between two fluorophores on individual molecules to study conformational dynamics and interactions in real time. | ECO:0008187 |
| Single Nucleotide Polymorphism Array | A genomic microarray-based method able to detect single nucleotide polymorphisms. | NCIT:C116151 |
| Single Nucleus RNA-Sequencing | Single nucleus RNA sequencing examines RNA transcript sequence information from individual nuclei rather than whole cells, using optimized next-generation sequencing technologies, useful for tissues difficult to dissociate into intact single cells. | EFO:0009809 |
| Single-Cell BCR Sequencing | A molecular genetic technique where DNA is isolated from single cell (sc) samples and amplified to create a genomic library. Then the library is subjected to ATAC-seq, which isolates and sequences regions rich in open chromatin. | PMID:31428692 |
| Single-Cell Barcode Chip | A molecular genetic technique that combines chromatin immunoprecipitation (ChIP) with massively parallel DNA sequencing to map the binding sites of DNA-associated proteins in a sample of cells. First, crosslinked protein-DNA complexes are isolated using ChIP. Next, the crosslinks are broken, the proteins are removed and the purified DNA is modified with adaptor oligonucleotides to facilitate massively parallel DNA sequencing. Following sequencing, the DNA sequences that are obtained can be mapped to their genomic locations. | Not available |
| Single-Cell TCR Sequencing | A molecular genetic technique where DNA is isolated from single cell (sc) samples and amplified to create a genomic library. Then the library is subjected to ATAC-seq, which isolates and sequences regions rich in open chromatin. | PMID:30072991 |
| Single-Molecule Tracking | A microscopy technique that follows the spatial position of individual fluorescently labeled molecules over time to study their movement, diffusion, or interaction dynamics within a cell. | mesh:D000072760 |
| Sirius Red Staining | A histological staining technique that uses Sirius Red dye to selectively stain collagen fibers in tissue sections, commonly used to assess fibrosis. | PMID:25023614 |
| Size Exclusion Chromatography | Gel permeation or sieve chromatography that is performed on porous gels that separate solutes on the basis of size. Smaller solutes are included within the particles of the gel matrix more frequently than larger solutes, thus affecting elution rates. | NCIT:C16433 |
| Small-Angle X-ray Scattering | A technique in crystallography in which the pattern produced by the diffraction of x-rays through the closely spaced lattice of atoms in a crystal is recorded and then analyzed to reveal the nature of that lattice. | CHMO:0000204 |
| Soft Agar Assay | Soft agar colony formation assay is performed to assay for anchorage independent growth. | NCIT:C16215 |
| Southern Blotting | Electrophoresis-based technique used in genetic testing to detect large deletions in DNA that can be missed by PCR-based genetic testing methods. | NCIT:C16356 |
| Spectroscopy | The technique of measuring the emission and absorption of different wavelengths (spectra) of visible and non-visible light. This can be done via a spectroscope, which consists of a slit, prism, collimator lens, object lens, and a grating. | NCIT:C17155 |
| Statistical Modeling | The statistical characterization of a system to estimate its future behavior based on past behavior and extrapolation. | NCIT:C16869 |
| Stimulated Emission Depletion Microscopy | The use of various technologies to resolve the structure or features of objects too small or fine to naturally be seen by eye. | PMID:3635273 |
| Stimulated Raman Scattering | Emission of electromagnetic energy with a shorter frequency (longer wavelength) than that of the incident monochromatic light. Arises from the low probability absorption of quanta with a higher energy than that required for a transition: the difference in energy is emitted as a lower frequency (energy) photon. Allows analysis of vibrational and rotational energy levels using visible incident light. | CHMO:0000675 |
| Stochastic Optical Reconstruction Microscopy | The use of various technologies to resolve the structure or features of objects too small or fine to naturally be seen by eye. | FBbi:00000336 |
| Super-Resolution Microscopy | The use of various technologies to resolve the structure or features of objects too small or fine to naturally be seen by eye. | MI:2213 |
| Surface Plasmon Resonance | A quantum optical-electrical phenomena consisting of an alteration in light reflectance as a result of binding of molecules to a surface from which total internal reflection is occurring. Used to detect macromolecular interactions, SPR can be used as the basis for a sensor which is capable of sensitive and quantitative measurement of a broad spectrum of chemical and biological entities. | NCIT:C18117 |
| Surveyor Nuclease Assay | An assay that uses the Surveyor nuclease to detect and cleave DNA at sites of sequence mismatch, commonly used to quantify genome-editing efficiency (e.g., after CRISPR/TALEN treatment). | Not available |
| Synaptophysin Staining Method | This is an immunohistochemical technique utilizing antibody to synaptophysin, an integral membrane glycoprotein present in presynaptic vesicles in neurons. The antibody labels neuroendocrine cells and neurons of the brain, spinal cord and retina. Used to detect neuroendocrine neoplasms including neuroblastomas, ganglioneuroblastomas, ganglioneuromas, pheochromocytomas, chromaffin, and non-chromaffin paragangliomas. | NCIT:C23029 |
| Synthetic Genetic Array | A molecular biology device that utilizes a set of defined cDNA clones attached in a specific grid arrangement to a solid support for nucleic acid hybridization assays in gene mapping studies or in determining gene sequences, sequence variations, or gene expression patterns. | Not available |
| TAB-Seq | A molecular genetic technique that combines chromatin immunoprecipitation (ChIP) with massively parallel DNA sequencing to map the binding sites of DNA-associated proteins in a sample of cells. First, crosslinked protein-DNA complexes are isolated using ChIP. Next, the crosslinks are broken, the proteins are removed and the purified DNA is modified with adaptor oligonucleotides to facilitate massively parallel DNA sequencing. Following sequencing, the DNA sequences that are obtained can be mapped to their genomic locations. | PMID:23196972 |
| TCR Sequencing | A DNA sequencing technique that can differentiate cytosine from 5-methylcytosine in a DNA sample. First, a denatured DNA sample is treated with bisulfite which converts non-methylated cytosine to uracil. Next, the sample is amplified using a PCR method that does not discriminate between non-methylated and methylated sequences. The amplified DNA is subjected to nucleotide sequencing. The resulting sequence is compared to an identical control sample of DNA that was not treated with bisulfite. Unmethylated cytosines will be displayed as cytosines in the control sample and as thymines in the bisulfite-treated sample. | NCIT:C189102 |
| TIRF Microscopy | The use of various technologies to resolve the structure or features of objects too small or fine to naturally be seen by eye. | CHMO:0000094 |
| TRAP Staining | A staining method used to demonstrate the presence of acid phosphatase and tartrate resistant acid phosphatase (TRAP) in osteoclasts. | NCIT:C118401 |
| TUNEL assay | A method to detect apoptosis. | NCIT:C19815 |
| Tandem Mass Spectrometry | Mass spectrometers coupled in series. The targeted compound is selectively ionized, and its characteristic ions are separated from others in the mixture in the first mass spectrometer. The selected primary ions are then decomposed by collision, and from the resulting products the final mass analyzer selects secondary ions characteristic of the targeted compound. Tandem mass spectrometry can achieve specificities and sensitivities equivalent of those of methods such as radioimmunoassay and gas chromatography/mass spectrometry, while performing analyses in much shorter times. | NCIT:C18142 |
| Tandem Mass Tagging | Mass spectrometers coupled in series. The targeted compound is selectively ionized, and its characteristic ions are separated from others in the mixture in the first mass spectrometer. The selected primary ions are then decomposed by collision, and from the resulting products the final mass analyzer selects secondary ions characteristic of the targeted compound. Tandem mass spectrometry can achieve specificities and sensitivities equivalent of those of methods such as radioimmunoassay and gas chromatography/mass spectrometry, while performing analyses in much shorter times. | NCIT:C18142 |
| Target Engagement Assay | An assay type that examines the interaction of ligands with their target biomolecules. | NCIT:C181182 |
| Targeted Genome Sequencing | A DNA sequencing technique in which selected regions of an individual's genome are sequenced. | NCIT:C158253 |
| Targeted Transcriptome Sequencing | An RNA sequencing technique in which selected RNA transcripts of an individual's genome are sequenced. | NCIT:C158252 |
| Thermal Shift Assay | A molecular biology technique used to detect the interaction of a DNA binding protein with its cognate binding sequence. Labeled DNAs were reacted with crude cell extracts and the complexes are run through a non-denaturing polyacrylamide gel. The migration of the labeled DNA through the gel will be slower by being bound. This shift in electrophoretic mobility indicates functional binding between the protein and the DNA. | BAO:0010261 |
| Thin-Layer Chromatography | A planar chromatography technique in which the stationary phase is a thin layer of sorbent applied to a rigid backing (e.g., glass or aluminum), used to separate mixtures of compounds. | CHMO:0001007 |
| Tiling Array | A molecular biology device that utilizes a set of defined cDNA clones attached in a specific grid arrangement to a solid support for nucleic acid hybridization assays in gene mapping studies or in determining gene sequences, sequence variations, or gene expression patterns. | EFO:0002704 |
| Time Lapse Microscopy | The use of various technologies to resolve the structure or features of objects too small or fine to naturally be seen by eye. | CHMO:0001074 |
| Time-Correlated Single Photon Counting | A fluorescence detection technique that measures the relaxation (decay) rate of excited fluorescent molecules by timing individual detected photons relative to an excitation laser pulse. | CHMO:0001963 |
| Tissue Engineering | Application of the principles of bioengineering to combining scaffolds, cells, and biologically active molecules into functional tissues. The goal of tissue engineering is to assemble functional constructs that restore, maintain, or improve damaged tissues or whole organs. | NCIT:C18075 |
| Tissue Microarray | A device for use in high-throughput molecular analysis/screening of clinical tissue specimens. Tissue microarrays spatially arrange 500-1000 tumor biopsies or other tissue onto a microarray block, which is then sliced into sections for probing DNA, RNA or protein targets to provide coincident analysis of all specimens in the array. Subsequent sections can be analyzed with additional probes. | NCIT:C19922 |
| Total Internal Reflection Fluorescence Microscopy | The use of a special microscope to see objects that give off fluorescent light. For example, cells or tissue can be treated with a substance that contains a fluorescent dye. The dye lights up when viewed under a microscope with a special light. | CHMO:0000094 |
| Traction Force Microscopy | A technique utilizing a scanning probe to image and analyze the surface of a material with atomic-level resolution. | Not available |
| Transmission Electron Microscopy | An electron microscopy imaging technique that is utilized to examine structural components of a sample by passing electrons through the specimen. | NCIT:C18216 |
| Transwell Assay | An assay that uses a porous membrane insert (Transwell) to separate two cell compartments, commonly used to measure cell migration, invasion, or barrier permeability. | BAO:0020015 |
| UPLC-MSMS | An analytical technique combining ultra-performance liquid chromatography (UPLC) with tandem mass spectrometry (MS/MS) to separate, identify, and quantify compounds such as metabolites or proteins in complex biological samples. | PMID:20061193 |
| UV Photocrosslinking | A technique that covalently crosslinks nucleic acids to interacting proteins using ultraviolet light, used to capture and study protein-nucleic acid interactions. | MI:0430 |
| Unspecified | Not stated explicitly or in detail. | NCIT:C38046 |
| Vibrational Spectroscopy | The technique of measuring the emission and absorption of different wavelengths (spectra) of visible and non-visible light. This can be done via a spectroscope, which consists of a slit, prism, collimator lens, object lens, and a grating. | CHMO:0000628 |
| Virus Plaque Assay | An assay that is used to determine viral quantity by infecting monolayers of host cells with serially diluted virus, covering the monolayers with an immobilizing overlay after a period of incubation to restrict the spread of the virus to neighboring cells, and counting the resulting visible plaques of infected cells. | NCIT:C174336 |
| Von Kossa Staining | A histochemical staining method that detects calcium deposits (e.g., in bone or calcified tissue) using silver nitrate to precipitate calcium phosphates and carbonates. | SNOMED:117008001 |
| Western Blotting | A method for the detection or identification of proteins or peptides that have been separated by gel electrophoresis and transferred onto nitrocellulose or other type of paper or nylon membrane. The proteins are then detected by reaction with enzymatically labeled or radiolabeled antibody probes. | NCIT:C16357 |
| Whole Exome Sequencing | A procedure that can determine the DNA sequence for all of the exons in an individual. | NCIT:C101295 |
| Whole Genome Bisulfite Sequencing | A procedure that can determine the DNA sequence for nearly the entire genome of an individual. | OBI:0001863 |
| Whole Genome Sequencing | A procedure that can determine the DNA sequence for nearly the entire genome of an individual. | NCIT:C101294 |
| Widefield Fluorescence Microscopy | The use of a special microscope to see objects that give off fluorescent light. For example, cells or tissue can be treated with a substance that contains a fluorescent dye. The dye lights up when viewed under a microscope with a special light. | OBI:0002437 |
| Wound-Healing Assay | A cell-based assay that measures cell motility by creating a 'wound' (gap) in a confluent cell monolayer and capturing the migration of cells to close the gap over time. | ECO:0001099 |
| X-Ray Crystallography | A technique in crystallography in which the pattern produced by the diffraction of x-rays through the closely spaced lattice of atoms in a crystal is recorded and then analyzed to reveal the nature of that lattice. | NCIT:C17672 |
| X-Ray Diffraction | A technique in crystallography in which the pattern produced by the diffraction of x-rays through the closely spaced lattice of atoms in a crystal is recorded and then analyzed to reveal the nature of that lattice. | CHMO:0000156 |
| X-Ray Micro-Computed Tomography | An imaging technique for examining structures within the body by scanning them with X rays and using a computer to construct a series of cross-sectional scans along a single axis. | PMID:28419369 |
| Xenograft | Cells, tissues, or organs from a donor that are transplanted into a recipient of another species. | NCIT:C12932 |
| cDNA Array | A molecular biology device that utilizes a set of defined cDNA clones attached in a specific grid arrangement to a solid support for nucleic acid hybridization assays in gene mapping studies or in determining gene sequences, sequence variations, or gene expression patterns. | NCIT:C19819 |
| eCLIP-Seq | A molecular genetic technique that combines chromatin immunoprecipitation (ChIP) with massively parallel DNA sequencing to map the binding sites of DNA-associated proteins in a sample of cells. First, crosslinked protein-DNA complexes are isolated using ChIP. Next, the crosslinks are broken, the proteins are removed and the purified DNA is modified with adaptor oligonucleotides to facilitate massively parallel DNA sequencing. Following sequencing, the DNA sequences that are obtained can be mapped to their genomic locations. | EFO:0009998 |
| mRNA Sequencing | A procedure that can determine the RNA sequences for all or part of the poly-A tail-containing messenger RNA transcripts in an individual. | NCIT:C129432 |
| qPCR | An application of PCR that measures the products generated during each cycle of the polymerase chain reaction process in order to determine the starting amount of template in the reaction. | NCIT:C51962 |
| scCGI-seq | A molecular genetic technique that combines chromatin immunoprecipitation (ChIP) with massively parallel DNA sequencing to map the binding sites of DNA-associated proteins in a sample of cells. First, crosslinked protein-DNA complexes are isolated using ChIP. Next, the crosslinks are broken, the proteins are removed and the purified DNA is modified with adaptor oligonucleotides to facilitate massively parallel DNA sequencing. Following sequencing, the DNA sequences that are obtained can be mapped to their genomic locations. | Not available |
| scNT-Seq | A molecular genetic technique that combines chromatin immunoprecipitation (ChIP) with massively parallel DNA sequencing to map the binding sites of DNA-associated proteins in a sample of cells. First, crosslinked protein-DNA complexes are isolated using ChIP. Next, the crosslinks are broken, the proteins are removed and the purified DNA is modified with adaptor oligonucleotides to facilitate massively parallel DNA sequencing. Following sequencing, the DNA sequences that are obtained can be mapped to their genomic locations. | PMID:32868927 |
| scSLAM-seq | A molecular genetic technique that combines chromatin immunoprecipitation (ChIP) with massively parallel DNA sequencing to map the binding sites of DNA-associated proteins in a sample of cells. First, crosslinked protein-DNA complexes are isolated using ChIP. Next, the crosslinks are broken, the proteins are removed and the purified DNA is modified with adaptor oligonucleotides to facilitate massively parallel DNA sequencing. Following sequencing, the DNA sequences that are obtained can be mapped to their genomic locations. | PMID:31292545 |
| seqFISH | seqFISH is an in situ multiplexed imaging method that uses sequential rounds of fluorescence in situ hybridization to identify large numbers of RNA species within intact cells. | EFO:0008991 |
| shRNA | An artificial RNA molecule with a tight hairpin turn that can be used to silence target gene expression via RNA interference (RNAi). | NCIT:C123893 |
| siRNA | A 20 to 25-nucleotide double-stranded RNA which is involved in a sequence-specific messenger RNA degradation process known as RNA interference. | NCIT:C2191 |
| smFISH | Single-molecule RNA FISH, a method for detecting and localizing individual RNA molecules within cells using short, fluorescently labeled oligonucleotide probes. | EFO:0009918 |
| smRNA-seq | A molecular genetic technique that combines chromatin immunoprecipitation (ChIP) with massively parallel DNA sequencing to map the binding sites of DNA-associated proteins in a sample of cells. First, crosslinked protein-DNA complexes are isolated using ChIP. Next, the crosslinks are broken, the proteins are removed and the purified DNA is modified with adaptor oligonucleotides to facilitate massively parallel DNA sequencing. Following sequencing, the DNA sequences that are obtained can be mapped to their genomic locations. | OBI:0002112 |
| snRNA-seq | A molecular genetic technique that combines chromatin immunoprecipitation (ChIP) with massively parallel DNA sequencing to map the binding sites of DNA-associated proteins in a sample of cells. First, crosslinked protein-DNA complexes are isolated using ChIP. Next, the crosslinks are broken, the proteins are removed and the purified DNA is modified with adaptor oligonucleotides to facilitate massively parallel DNA sequencing. Following sequencing, the DNA sequences that are obtained can be mapped to their genomic locations. | EFO:0009809 |
| Isothermal Titration Calorimetry | The measurement of thermodynamic parameters (e.g. enthalpy) at constant temperature during a titration. | CHMO:0000683 |
| Suspended Microchannel Resonator | Particles are weighed in real-time with the suspended microchannel resonator (SMR) as they flow through a hollow cantilever. In addition to weighing particles with femtogram precision, the SMR can also measure mass density with a resolution of 10-4 g/mL. This is possible since the microchannel resonant frequency is determined by the difference in mass of the particle with respect to that of the displaced fluid. Thus, the particle's density is determined by measuring its mass in two fluids of different densities. The SMR can measure the growth of single cells as well as the absorption of biomolecules to microchannel walls. Scaling the current SMR design by ten-fold will result in a thousand-fold improvement in mass resolution (attogram) and thereby enable single viruses to be weighed with high precision. | PMID:17460669 |
| 10x Multiome | A single-cell multiomic assay that simultaneously profiles gene expression (RNA) and chromatin accessibility (ATAC) from the same individual cell. | EFO:0030059 |
| Visium Spatial Gene Expression | A spatial transcriptomics method developed by 10x Genomics that measures the whole transcriptome or a defined set of transcripts within intact tissue sections while preserving spatial context. | EFO:0010961 |
| Antitumor Drug Screening Assay | A technique used to assess the effectiveness of a potential antineoplastic agent against tumor cells. | NCIT:C15229 |
| Bioelectrochemical Analysis | The use of an electrochemical cell to measure a qualitative or quantitative response of a biological system. | CHMO:0002504 |
| Chimeric Antigen Receptor T-Cell Therapy | Treatment that uses T-cells engineered to express a chimeric antigen receptor (CAR) that specifically targets a particular antigen, most commonly used in cancer immunotherapy. | NCIT:C126102 |
| Cell Cycle Assay | An assay that measures the distribution of cells across different phases of the cell cycle (G0/G1, S, G2/M) to evaluate proliferation status or cell cycle perturbations. | BAO:0002041 |
| Clonality Analysis | A molecular analysis performed to determine whether a population of cells is descended from a single progenitor cell. | NCIT:C63327 |
| Comparative Genomic Hybridization | A technique that detects losses and gains in DNA copy number across an entire genome without the need for cell culturing. | NCIT:C18084 |
| Cryo-Electron Microscopy | Electron microscopy performed on an aqueous sample suspension that is applied as an extremely thin film to a grid and rapidly frozen, preserving its near-native structure for imaging. | NCIT:C18113 |
| Cryo-Electron Tomography | A form of electron tomography in which a cryo-preserved specimen is tilted incrementally in a cryogenic transmission electron microscope to acquire a series of images used to reconstruct its 3D structure. | FBbi:00100015 |
| Data Integration | The process of combining data from multiple sources or of different types into a unified, consistent representation for analysis. | T4FS:0000487 |
| Field-Emission Scanning Electron Microscopy | Scanning electron microscopy that uses a field-emission electron source to produce a finely focused, high-resolution electron beam. | CHMO:0000074 |
| Label-free Protein Quantification by LC/MS | A method for quantitating proteins in samples subjected to liquid chromatography-mass spectrometry (LC/MS) without the use of isotopic or chemical labels. | NCIT:C161825 |
| Metabolite Profiling Assay | An assay that detects and identifies small-molecule chemical entities resulting from biochemical and cellular metabolism. | OBI:0000366 |
| Reporter Gene Assay | An assay that uses a reporter gene (e.g., luciferase, GFP, beta-galactosidase) whose measurable expression serves as a readout of the activity of a promoter, enhancer, or other regulatory element. | BAO:0003006 |
| Single-Molecule Localization Microscopy | A super-resolution fluorescence microscopy technique that localizes individual fluorophore molecules with high precision over many imaging cycles to reconstruct an image beyond the diffraction limit. | Not available |
| Synthesis | The process of producing a chemical compound, usually by the union of simpler chemical compounds. | NCIT:C61408 |
| Targeted Therapy Agent | Any agent that specifically targets or interferes with the synthesis or function of a molecule expressed specifically in or on cells relevant to a disease process, such as a tumor. | NCIT:C163758 |
| Trichrome Staining Method | A histological staining method that uses acid dyes and washes to selectively stain structural elements in tissue samples in three or more contrasting colors, commonly used to visualize collagen and muscle fibers. | NCIT:C23012 |
| Ultrasound Imaging | The use of high-frequency sound waves to generate images of internal body structures. | NCIT:C17230 |
| Transcription profiling by NanoString | A gene expression profiling technique that uses the NanoString nCounter system's multiplexed probe hybridization to capture and digitally count individual mRNA transcripts. | EFO:0030058 |
| Alcian Blue Staining Method | A microscopy staining method that uses Alcian Blue, a cationic copper-containing dye, to detect acidic mucosubstances and glycosaminoglycans in tissue. | NCIT:C92299 |
| Artificial Intelligence | The branch of computer science concerned with creating systems that can perform tasks normally requiring human intelligence, such as learning, reasoning, and problem-solving. | NCIT:C16309 |
| Cell Culture | The maintenance and growth of cells, derived from a strain or cell line, in a controlled laboratory environment outside their original organism. | NCIT:C16396 |
| Clinical Study | Research conducted with human subjects or human-derived material in which an investigator directly interacts with subjects, encompassing clinical trials as well as epidemiologic, behavioral, and health services research. | NCIT:C71104 |
| Cell-free Circulating Tumor DNA Assay | An assay used to detect cell-free circulating tumor DNA in a biological sample, for identification of molecular residual disease and assessment of treatment response. | NCIT:C182622 |
| Co-Immunoprecipitation Mass Spectrometry | A method that combines co-immunoprecipitation (using an antibody to pull down a protein and its binding partners) with mass spectrometry to identify protein-protein interaction partners. | Not available |
| Deep Learning | A subset of machine learning based on artificial neural networks with multiple layers, capable of learning complex representations directly from data. | NCIT:C176258 |
| Gene Ontology Enrichment Analysis | A statistical method that determines whether genes annotated with particular Gene Ontology (GO) terms are significantly over- or under-represented within a gene list of interest, relative to a background set. | EDAM:operation_3501 |
| Gene Set Enrichment Analysis | An inferential statistical data analysis that determines whether an a priori defined set of genes shows statistically significant, concordant differences in expression between two biological states. | OBCS:0000147 |
| Gene Silencing | The process by which the expression of a specific gene is suppressed, occurring naturally (e.g., via RNA interference or DNA methylation) or induced experimentally as a research tool. | NCIT:C39200 |
| Human Induced Pluripotent Stem Cell-derived Cardiomyocytes Culture | The in vitro culture of cardiomyocytes (heart muscle cells) that have been differentiated from human induced pluripotent stem cells (iPSCs), used to model cardiac biology and disease. | Not available |
| Imaging Mass Cytometry | A method that combines laser ablation of tissue specimens with mass spectrometry to image antibodies tagged with isotopically pure metals, enabling highly multiplexed spatial protein detection. | NCIT:C182027 |
| Immunofluorescent Staining Method | A microscopy staining method that uses fluorescently labeled antibodies to detect specific target antigens in preserved cells or tissue. | NCIT:C142337 |
| Immunotherapy | Therapy designed to induce changes in a patient's immune status in order to treat disease, such as cancer. | NCIT:C15262 |
| Viral Transduction | The transfer of genetic material into a cell using a viral vector. | NCIT:C142787 |
| Metastatic Colonization Assay | An in vivo assay that measures the ability of tumor cells to establish and grow secondary colonies at a distant site after introduction into a host organism, modeling the colonization step of metastasis. | Not available |
| Phylogenetic Analysis | The study of evolutionary relationships among organisms or sequences, typically represented as a branching tree (phylogeny) inferred from molecular or morphological data. | NCIT:C18940 |
| Picrosirius Staining | A histochemical staining method using picric acid and Sirius Red dye to selectively stain collagen fibers, commonly used to assess fibrosis and collagen organization in tissue sections. | SNOMED:51567006 |
| Scratch Assay | A cell-based assay, synonymous with the wound-healing assay, in which a 'scratch' is made in a confluent cell monolayer and the subsequent migration of cells to close the gap is measured over time. | ECO:0001099 |
| Structural Variant Analysis | The computational analysis of sequencing or array data to detect large-scale genomic alterations such as deletions, duplications, insertions, inversions, and translocations. | Not available |
| Survival Analysis | A statistical method that analyzes the duration of time until an event of interest occurs, such as death, disease recurrence, or treatment failure. | NCIT:C53372 |
| Targeted Error Correction Sequencing | A targeted sequencing approach that incorporates molecular barcoding or redundant sequencing of the same DNA molecule to computationally distinguish true low-frequency variants from sequencing errors. | Not available |
| Tuba-Seq | Tumor barcoding with ultradeep barcode sequencing | EFO:0008979 |
| SDS-PAGE | A protein assay that allows protein separation by mass in a polyacrylamide-based discontinuous gel. | EFO:0010936 |
| Cell Fractionation | A technique in which sub-cellular components are separated based on their physical properties, such as density in a sucrose density gradient. | MMO:0000679 |
| Multiscale Light Sheet Microscopy | A light-sheet fluorescence microscopy approach that combines imaging at multiple spatial scales (e.g., whole-organism to subcellular) within the same experiment. | OBI:0003098 |
| Light Sheet Microscopy | A fluorescence microscopy technique that captures photons emitted by fluorophores excited with a thin sheet of laser light, illuminating only a thin region of the sample at a time. | OBI:0003098 |
| CODEX | A highly multiplexed cytometric imaging approach that iteratively visualizes many protein targets in a single tissue staining reaction. | NCIT:C181931 |
| in vivo tumor growth | Monitoring of tumor growth (e.g. volume/size over time) in a live animal model, typically as a functional readout rather than a molecular assay. | Not available |
| in silico synthesis | Computational/simulation-based synthesis of a molecule or construct rather than a wet-lab technique. | Not available |
| RNA array | A microarray platform used to measure RNA expression levels. | Not available |
| shRNA-seq | A pooled shRNA screening assay read out by sequencing to identify short hairpin RNA constructs enriched or depleted under a selection condition. | Not available |
| spatial transcriptomics | A general term for assays that measure RNA expression while preserving spatial location information within a tissue section. | Not available |
| in vivo PDX viability | A functional viability readout from a patient-derived xenograft (PDX) model. | Not available |
| histology | Microscopic examination of tissue structure via sectioning and staining. | Not available |
| proximity extension assay | An antibody-based protein detection method (e.g. Olink) in which paired antibodies with attached DNA oligonucleotides bind a target protein, allowing proximity-dependent DNA amplification and readout. | Not available |
| compound screen | A screening assay testing multiple chemical compounds for a biological effect. | Not available |
| metabolic screening | A screening assay assessing metabolic activity or metabolite profiles. | Not available |
Attribute: Tissue¶
| Valid Value | Description | Ontology |
|---|---|---|
| Gonad | The part of the reproductive system that produces and releases eggs (ovaries) or sperm (testicles/testes). | NCIT:C12725 |
| Abdominal Esophagus | Clinical esophageal segment composed of smooth muscle. It corresponds to the inferior part of the lower third topographic segment of the esophagus. (NCI) | NCIT:C12252 |
| Adipose Tissue | Connective tissue consisting primarily of adipocytes (fat cells) and supporting structural matrix. | NCIT:C12472 |
| Adrenal Gland | The endocrine glands adjacent to the kidneys that consist of the outer adrenal cortex and the inner adrenal medulla in mammals. | NCIT:C12666 |
| Alveolus | Tiny air sacs at the end of the bronchioles (tiny branches of air tubes) in the lungs. The alveoli are where the lungs and the bloodstream exchange carbon dioxide and oxygen. Carbon dioxide in the blood passes into the lungs through the alveoli. Oxygen in the lungs passes through the alveoli into the blood. | NCIT:C12986 |
| Aorta | The major artery of the body; it arises from the left ventricle of the heart and terminally bifurcates into the common iliac arteries. | NCIT:C12669 |
| Artery | A blood vessel that carries blood from the heart to tissues and organs in the body. | NCIT:C12372 |
| Ascending Colon | The first part of the colon (large intestine) that starts in the right lower quadrant of the abdomen and ends at the transverse colon in the right upper quadrant of the abdomen. (NCI) | NCIT:C12265 |
| Bile Duct | Any of the ducts conveying bile between the liver and the intestine, including hepatic, cystic, and common bile duct. | NCIT:C12376 |
| Bladder | The organ that stores urine. | NCIT:C12414 |
| Blood | A tissue with red blood cells, white blood cells, platelets, and other substances suspended in fluid called plasma. Blood takes oxygen and nutrients to the tissues, and carries away wastes. | NCIT:C12434 |
| Blood Vessel | A tubular structure through which the blood circulates in the body. Blood vessels constitute a network composed of arteries, arterioles, capillaries, venules, and veins. (NCI) | NCIT:C12679 |
| Bone | The structural organ comprised of specialized connective tissue that forms the skeletal components of the body. | NCIT:C12366 |
| Bone Marrow | The tissue occupying the spaces of some bones. It consists of blood vessel sinuses and a network of hematopoietic cells. | NCIT:C12431 |
| Brain | An organ composed of grey and white matter containing billions of neurons that is the center for intelligence and reasoning. It is protected by the bony cranium. | NCIT:C12439 |
| Breast | One of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest. (NCI) | NCIT:C12971 |
| Caecum | The blind pouch forming the beginning of the large intestine, located at its junction with the ileum (small intestine), from which the vermiform appendix arises. | NCIT:C12381 |
| Cancer-Associated Fibroblast | A fibroblast found proximal to or within cancerous tissue. | NCIT:C168534 |
| Cardia | The region of the stomach immediately surrounding the gastroesophageal junction, where the esophagus empties into the stomach. | NCIT:C12256 |
| Cartilage | A type of connective tissue composed of chondrocytes and an extracellular matrix, composed of collagen, elastin, and ground substance. There are three types of cartilage; namely elastic, hyaline, and fibrocartilage. | NCIT:C12373 |
| Cervix Uteri | The portion of the uterus (or uterine horns) that empties into the vagina. | NCIT:C12311 |
| Choroid | A thin layer of tissue that is part of the middle layer of the wall of the eye, between the sclera (white outer layer of the eye) and the retina (the inner layer of nerve tissue at the back of the eye). The choriod is filled with blood vessels that bring oxygen and nutrients to the eye. | NCIT:C12344 |
| Colon | The portion of the large intestine which extends from the cecum (or small intestine in animals that don't have a cecum) to the rectum. | NCIT:C12382 |
| Connective and Soft Tissue | The supporting connective tissue of an organ. | NCIT:C12964 |
| Cornea | The transparent, avascular tissue covering the front of the eye and is continuous with the sclera. | NCIT:C12342 |
| Duodenum | The portion of the small intestine between the stomach and jejunum. | NCIT:C12263 |
| Ear | A sensory organ that contains auditory and vestibular apparatuses. | NCIT:C12394 |
| Embryo | Early stage in the prenatal development of an animal. This stage occurs from implantation until closure of the hard palate. | NCIT:C28147 |
| Embryonic Heart | The rudimentary heart found in the human embryo that begins development during the third week of gestation, and which is formed by paired endocardial heart tubes derived from splanchnic mesenchyme, which subsequently fuse to form the primitive heart. | NCIT:C34153 |
| Endocervix | The portion of the cervix which is lined by single columnar epithelium (mucosa). (NCI) | NCIT:C12309 |
| Endometrium | The mucous membrane comprising the inner layer of the uterine wall; it consists of a simple columnar epithelium and a lamina propria that contains simple tubular uterine glands. The structure, thickness, and state of the endometrium undergo marked change with the menstrual cycle. | NCIT:C12313 |
| Endothelium | The layer of cells that lines the cavities of the heart and of the blood vessels (Endothelium, Vascular) and lymph vessels (Endothelium, Lymphatic), and the serous cavities of the body, originating from the mesoderm. | NCIT:C12481 |
| Epithelium | The avascular cellular layers that cover body surfaces and cavities and may form glands. | NCIT:C12710 |
| Esophagus | The portion of the digestive tract between the pharynx and stomach. | NCIT:C12389 |
| Eye | The sensory organ of vision. | NCIT:C12401 |
| Fallopian Tube | The tube through which eggs pass from an ovary. | NCIT:C12403 |
| Foreskin | The loose skin that covers the head of the penis. | NCIT:C33049 |
| Frontal Lobe | The part of the brain located anterior to the parietal lobes at the front of each cerebral hemisphere. (NCI) | NCIT:C12352 |
| Gastroesophageal Junction | The place where the esophagus is connected to the stomach. | NCIT:C32668 |
| Gastrointestinal Tract | The upper gastrointestinal (GI) tract is comprised of mouth, pharynx, esophagus and stomach while the lower GI tract consists of intestines and anus. The primary function of the GI tract is to ingest, digest, absorb and ultimately excrete food stuff. (NCI) | NCIT:C34082 |
| Genitourinary | Of or related to the genital and urinary organs or their functions. | NCIT:C12810 |
| Hair Follicle | A tube-like invagination of the epidermis from which the hair shaft develops and into which the sebaceous glands open; the follicle is lined by a cellular inner and outer root sheath of epidermal origin and is invested with a fibrous sheath derived from the dermis. (NCI) | NCIT:C13317 |
| Head and Neck | The area of the body comprising the skull, facial bones and the cervical vertebrae, sinuses, orbits, salivary glands, oral cavity, oropharynx, larynx, thyroid, facial and neck musculature, soft tissue and lymph nodes draining these areas. | NCIT:C12418 |
| Heart | A hollow organ located slightly to the left of the middle portion of the chest. It is composed of muscle and it is divided by a septum into two sides: the right side which receives de-oxygenated blood from the body and the left side which sends newly oxygenated blood to the body. Each side is composed of two chambers: the atrium (receiving blood) and ventricle (ejecting blood). | NCIT:C12727 |
| Heart Muscle | The muscle tissue of the HEART composed of striated, involuntary muscle known as cardiac muscle. | NCIT:C12371 |
| Hematopoietic System | The bodily system of organs and tissues, primarily the bone marrow, spleen, tonsils, and lymph nodes, involved in the production of blood. | NCIT:C12909 |
| Hippocampus | A curved gray matter structure of the temporal lobe lying on the floor of the lateral ventricle of the brain. | NCIT:C12444 |
| Intestine | The portion of the gastrointestinal tract that includes the small and large intestines. | NCIT:C12736 |
| Intra-Abdominal Lymph Nodes | Any lymph node within the abdomen. | NCIT:C12360 |
| Intrathoracic Lymph Nodes | Any lymph node within the thoracic cavity. | NCIT:C12359 |
| Joint | is an organ that constitutes an anatomical junction; it consists of two or more adjacent bones, parts of which are interconnected by organ parts that consist of various types of connective tissue. Together with other joints and bones, a joint constitutes the skeletal system. Example(s): pubic symphysis, knee joint, temporomandibular joint. | NCIT:C13044 |
| Kidney | The organs of the urinary tract located in the retroperitoneal cavity adjacent to the spine and composed of the renal cortex and the renal medulla. | NCIT:C12415 |
| Larynx | The cartilaginous structure of the respiratory tract between the pharynx and the trachea. It contains elastic vocal cords required for sound production. | NCIT:C12420 |
| Ligament | Band of fibrous tissue connecting bone to bone or cartilage to bone thereby supporting or strengthening a joint. (NCI) | NCIT:C13046 |
| Liver | An abdominal organ that has variable lobation which are composed mainly of hepatic lobules. | NCIT:C12392 |
| Lung | One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border. | NCIT:C12468 |
| Lymph | The clear fluid that travels through the lymphatic system and carries cells that help fight infections and other diseases. | NCIT:C13252 |
| Lymph Node | Secondary lymphoid organ associated with lymphatic vessels and consisting of an outer cortex, inner medulla and sinuses. | NCIT:C12745 |
| Lymph Nodes of Axilla or Arm | One of approximately 20-30 lymph nodes in chain formation that traverse the concavity of the underarm to the clavicle. | NCIT:C12904 |
| Lymph Nodes of Inguinal Region or Leg | Any lymph node that is located in the inguinal region or in either leg. | NCIT:C32801 |
| Lymphatic System | The tissues and organs that produce, store, and carry white blood cells that fight infections and other diseases. This system includes the bone marrow, spleen, thymus, lymph nodes, and lymphatic vessels (a network of thin tubes that carry lymph and white blood cells). Lymphatic vessels branch, like blood vessels, into all the tissues of the body. | NCIT:C12746 |
| Lymphoid Tissue | Tissue characterized by the presence of large numbers of lymphocytes in different stages of transformation. Connective tissue cells including fibroblasts and macrophages may be present. Lymphoid tissue is framed by a network of reticular fibers and may be diffuse, or densely aggregated. | NCIT:C13049 |
| Main Bronchus | The left and right main bronchi considered as a group. | NCIT:C12284 |
| Mammary Gland | The exocrine glands of the mammae that produce milk in females, and are composed of lobules, alveolar ducts and alveoli. | NCIT:C12367 |
| Meninges | The three thin layers of tissue that cover and protect the brain and spinal cord. | NCIT:C12348 |
| Mesenchyme | Embryonic tissue of mesodermal origin. Develops into connective tissue, blood vessels, and lymphatic tissue. | NCIT:C13301 |
| Mucosa | Mucous membrane. | NCIT:C13166 |
| Muscle | One of the contractile organs of the body. | NCIT:C13056 |
| Nasal Cavity | The upper respiratory tract extending from the nares to the pharynx. | NCIT:C12424 |
| Nervous System | The organized network of nerve tissue in the body. It includes the central nervous system (the brain and spinal cord), the peripheral nervous system (nerves that extend from the spinal cord to the rest of the body), and other nerve tissue. | NCIT:C12755 |
| Not Applicable | Determination of a value is not relevant in the current context. (NCI) | NCIT:C48660 |
| Olfactory Mucosa | The part of the nasal mucosa composed of neuroepithelial tissue and mucus-producing Bowman's glands. The mucus moistens the epithelium and helps dissolve odor-containing gases. | NCIT:C33205 |
| Omentum | A fold of the peritoneum (the thin tissue that lines the abdomen) that surrounds the stomach and other organs in the abdomen. | NCIT:C33209 |
| Oral Cavity | The cavity of the mouth. | NCIT:C12421 |
| Oral Mucosa | The mucosal membranes that line the oral cavity. | NCIT:C77637 |
| Ovary | The pair of female reproductive glands in which the ova, or eggs, are formed. The ovaries are located in the pelvis, one on each side of the uterus. | NCIT:C12404 |
| Pancreas | An organ behind the lower part of the stomach that is the shape of a fish and about the size of a hand. It is a compound gland composed of both exocrine and endocrine tissues. The endocrine pancreas makes insulin so that the body can use glucose (sugar) for energy. The exocrine pancreas makes enzymes that help the body digest food. Spread all over the pancreas are areas called the Islets of Langerhans. The cells in these areas each have a special purpose. The alpha cells make glucagon, which raises the level of glucose in the blood; the beta cells make insulin; the delta cells make somatostatin. There are also PP cells and D1 cells, about which little is known. | NCIT:C12393 |
| Pelvic Lymph Nodes | Any lymph node within the pelvic region. (NCI) | NCIT:C12363 |
| Pending Annotation | A placeholder value indicating that the tissue annotation for this record has not yet been finalized and is pending curator review. | NCIT:C53470 |
| Periodontal Ligament | The fibrous connective tissue surrounding the root of a tooth that separates it from and attaches it to the alveolar bone. | BTO:0001020 |
| Peripheral Nerves | The nerves outside of the brain and spinal cord, including the autonomic, cranial, and spinal nerves. Peripheral nerves contain non-neuronal cells and connective tissue as well as axons. The connective tissue layers include, from the outside to the inside, the epineurium, the perineurium, and the endoneurium. | NCIT:C12465 |
| Peritoneum | The tissue that lines the wall of the abdominal cavity, intestine, mesentery, and pelvic organs. It consists of the parietal peritoneum and the visceral peritoneum. | NCIT:C12770 |
| Pharynx | The hollow tube inside the neck that starts behind the nose and ends at the top of the trachea (windpipe) and esophagus (the tube that goes to the stomach). The pharynx is about 5 inches long, depending on body size. | NCIT:C12425 |
| Pituitary Gland | The main endocrine gland. It produces hormones that control other glands and many body functions, especially growth. | NCIT:C12399 |
| Placenta | The organ that nourishes the developing fetus in the uterus. | NCIT:C13272 |
| Pleura | The tissue that lines the wall of the thoracic cavity and the surface of the lungs. | NCIT:C12469 |
| Prostate Gland | The walnut shaped accessory sex gland of the male reproductive system. It is located in the pelvis just below the bladder, surrounding the prostatic part of the urethra. The prostate gland secretes a fluid which is part of the semen. | NCIT:C12410 |
| Rectum | The terminal portion of the large intestine extending from the terminus of the colon to the anus or anal canal. | NCIT:C12390 |
| Reproductive System | The organs and tissues involved in the production and maturation of gametes and in their union and subsequent development as offspring. | NCIT:C12841 |
| Respiratory System | The organs that are involved in breathing. These include the nose, throat, larynx, trachea, bronchi, and lungs. | NCIT:C12779 |
| Salivary Gland | Any number of exocrine glands that secrete saliva into the oral cavity. | NCIT:C12426 |
| Sclera | The white, opaque, fibrous, outer tunic of the eyeball, covering it entirely excepting the segment covered anteriorly by the cornea. It is essentially avascular but contains apertures for vessels, lymphatics, and nerves. It receives the tendons of insertion of the extraocular muscles and at the corneoscleral junction contains the canal of Schlemm. (From Cline et al., Dictionary of Visual Science, 4th ed) | NCIT:C12784 |
| Sinonasal Tract | The area of the head comprised of the nasal cavity and paranasal sinuses. | NCIT:C54292 |
| Skin | An organ that constitutes the external surface of the body. It consists of the epidermis, dermis, and skin appendages. (NCI) | NCIT:C12470 |
| Small Intestine | The villous section of the intestine extending from the pylorus to the proximal large intestine. | NCIT:C12386 |
| Spinal Cord | The portion of the central nervous system that lies within the vertebral canal and from which the spinal nerves emerge. | NCIT:C12464 |
| Spleen | An organ that is part of the lymphatic system. The spleen produces lymphocytes, filters the blood, stores blood cells, and destroys old blood cells. It is located on the left side of the abdomen near the stomach. | NCIT:C12432 |
| Stomach | The portion of the gastrointestinal tract located between the esophagus and the proximal duodenum. | NCIT:C12391 |
| Synovial Membrane | The inner layer of the connective tissue that seals the joint. | NCIT:C12473 |
| Tendon | Tough, fibrous, cord-like tissue that connects muscle to bone or another structure, such as an eyeball. Tendons help the bone or structure to move. | NCIT:C13045 |
| Testis | The male gonad. | NCIT:C12412 |
| Thymus | An organ that is part of the lymphatic system, in which T lymphocytes grow and multiply. The thymus is in the chest behind the breastbone. | NCIT:C12433 |
| Thyroid Gland | Endocrine gland(s) adjacent to the trachea in mammals that produce thyroxine and other hormones. | NCIT:C12400 |
| Tongue | The muscular organ located in the floor of the mouth and serving as the principal organ of taste and modification of the voice in speech. | NCIT:C12422 |
| Tonsil | excludes lingual tonsil C02.4 and pharyngeal tonsil C11.1 | NCIT:C12802 |
| Trachea | The fibrocartilaginous, mucous-lined tube passing from the larynx to the bronchi. | NCIT:C12428 |
| Umbilical Cord | Extraembryonic structure that connects the fetus to the placenta. It contains two arteries and one vein. | NCIT:C34320 |
| Unspecified | Not stated explicitly or in detail. | NCIT:C38046 |
| Uterus | The small, hollow, pear-shaped organ in a woman's pelvis. This is the organ in which a fetus develops. | NCIT:C12405 |
| Vagina | The muscular canal extending from the uterus to the exterior of the body. | NCIT:C12407 |
| Vascular Endothelium | The layer of simple squamous epithelial tissue that lines the luminal surface of the entire circulatory system. | NCIT:C13053 |
| Vein | A blood vessel that carries blood towards the heart. | NCIT:C12814 |
| Vertebra | Any of the ring-shaped bony structures that constitute the spinal column and surround the spinal cord. | NCIT:C12933 |
| Peripheral Blood Mononuclear Cell | A peripheral blood cell with a single nucleus. This category includes lymphocytes and monocytes. | NCIT:C12954 |
Attribute: Tumor Type¶
| Valid Value | Description | Ontology |
|---|---|---|
| Cutaneous Melanoma | A primary melanoma arising from atypical melanocytes in the skin. Precursor lesions include acquired and congenital melanocytic nevi, and dysplastic nevi. Several histologic variants have been recognized, including superficial spreading melanoma, acral lentiginous melanoma, nodular melanoma, and lentigo maligna melanoma. | NCIT:C3510 |
| Acinar Cell Carcinoma | A malignant glandular epithelial neoplasm consisting of secretory cells forming acinar patterns. Representative examples include the acinar cell carcinoma of the pancreas and the acinar adenocarcinoma of the prostate gland. | NCIT:C3768 |
| Acute Lymphoblastic Leukemia | Leukemia with an acute onset, characterized by the presence of lymphoblasts in the bone marrow and the peripheral blood. It includes the acute B lymphoblastic leukemia and acute T lymphoblastic leukemia. | NCIT:C3167 |
| Acute Monocytic Leukemia | An acute myeloid leukemia in which the majority of monocytic cells are promonocytes. (WHO, 2001) | NCIT:C4861 |
| Acute Myeloid Leukemia | An aggressive (fast-growing) disease in which too many myeloblasts (immature white blood cells that are not lymphoblasts) are found in the bone marrow and blood. | NCIT:C3171 |
| Acute Promyelocytic Leukemia | An acute myeloid leukemia characterized by the predominance of abnormal promyelocytes, most often driven by translocations involving the retinoic acid receptor-alpha (RARA) gene. Over 95% of cases show the reciprocal balanced translocation t(15;17)(q24.1;q21.2), which fuses the PML and RARA genes. | NCIT:C208352 |
| Adenocarcinoma | Cancer that begins in cells that line certain internal organs and that have gland-like (secretory) properties. | NCIT:C2852 |
| Angiosarcoma | A type of cancer that begins in the cells that line blood vessels. | NCIT:C3088 |
| Astrocytoma | A tumor that begins in the brain or spinal cord in small, star-shaped cells called astrocytes. | NCIT:C60781 |
| Atypical Teratoid/Rhabdoid Tumor | An aggressive malignant embryonal neoplasm arising from the central nervous system. It is composed of cells with a large eccentric nucleus, prominent nucleolus, and abundant cytoplasm. Mutations of the SMARCB1 gene or very rarely SMARCA4 (BRG1) gene are present. The vast majority of cases occur in childhood. Symptoms include lethargy, vomiting, cranial nerve palsy, headache, and hemiplegia. | NCIT:C6906 |
| B Acute Lymphoblastic Leukemia | The most frequent type of acute lymphoblastic leukemia. Approximately 75% of cases occur in children under six years of age. This is a good prognosis leukemia. In the pediatric age group the complete remission rate is approximately 95% and the disease free survival rate is 70%. Approximately 80% of children appear to be cured. In the adult age group the complete remission rate is 60-85%. (WHO, 2001) | NCIT:C8644 |
| B-Cell Non-Hodgkin Lymphoma | The most common type of non-Hodgkin lymphoma. It includes the most frequently seen morphologic variants which are: diffuse large B-cell lymphoma, follicular lymphoma, small lymphocytic lymphoma and marginal zone B-cell lymphoma. | NCIT:C3457 |
| Barrett Esophagus | Esophageal lesion lined with columnar metaplastic epithelium which is flat or villiform. Barrett epithelium is characterized by two different types of cells: goblet cells and columnar cells. The symptomatology of Barrett esophagus is that of gastro-esophageal reflux. It is the precursor of most esophageal adenocarcinomas. (WHO) | NCIT:C2891 |
| Basal Cell Neoplasm | A neoplastic proliferation of basal cells in the epidermis (part of the skin) or other anatomic sites (most frequently the salivary glands). The basal cell neoplastic proliferation in the epidermis results in basal cell carcinomas. The basal cell neoplastic proliferation in the salivary glands can be benign, resulting in basal cell adenomas or malignant, resulting in basal cell adenocarcinomas. | NCIT:C3784 |
| Basal-Like Breast Carcinoma | A biologic subset of breast carcinoma defined by high expression of genes characteristic of basal epithelial cells, including KRT5 and KRT17, annexin 8, CX3CL1, and TRIM29, and usually by lack of expression of the estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2). It is the most common subtype of breast cancer associated with BRCA1 mutations, and is associated with a poor prognosis. | NCIT:C53558 |
| Biliary Tract Carcinoma | A carcinoma arising from the intrahepatic bile ducts, hepatic ducts, common bile duct, cystic duct, or gallbladder. | NCIT:C156781 |
| Bladder Carcinoma | Cancer that forms in tissues of the bladder (the organ that stores urine). Most bladder cancers are transitional cell carcinomas (cancer that begins in cells that normally make up the inner lining of the bladder). Other types include squamous cell carcinoma (cancer that begins in thin, flat cells) and adenocarcinoma (cancer that begins in cells that make and release mucus and other fluids). The cells that form squamous cell carcinoma and adenocarcinoma develop in the inner lining of the bladder as a result of chronic irritation and inflammation. | NCIT:C4912 |
| Bladder Neoplasm | A benign or malignant, primary or metastatic neoplasm of the bladder. | NCIT:C2901 |
| Bone Neoplasm | A benign, intermediate, or malignant neoplasm involving the bone or articular cartilage. | NCIT:C9343 |
| Brain Neoplasm | The growth of abnormal cells in the tissues of the brain. Brain tumors can be benign (not cancer) or malignant (cancer). | NCIT:C2907 |
| Breast Adenocarcinoma | The most common histologic type of breast carcinoma. Representative examples include invasive ductal carcinoma not otherwise specified, ductal carcinoma in situ, inflammatory carcinoma, secretory carcinoma, signet ring cell carcinoma, tubular carcinoma, invasive lobular carcinoma, and lobular carcinoma in situ. | NCIT:C5214 |
| Breast Carcinoma | Cancer that forms in tissues of the breast, usually the ducts (tubes that carry milk to the nipple) and lobules (glands that make milk). It occurs in both men and women, although male breast cancer is rare. | NCIT:C4872 |
| Breast Neoplasm | A benign or malignant neoplasm of the breast parenchyma. It can originate from the ducts, lobules or the breast adipose tissue. Breast neoplasms are much more common in females than males. | NCIT:C2910 |
| Carcinoma | Cancer that begins in the skin or in tissues that line or cover internal organs. | NCIT:C2916 |
| Carcinoma In Situ | A malignant epithelial neoplasm which is confined to the epithelial layer without evidence of further tissue invasion. | NCIT:C2917 |
| Castration-Resistant Prostate Carcinoma | Prostate carcinoma that grows and continues to spread despite the surgical removal of the testes or medical intervention to block androgen production. | NCIT:C130234 |
| Cellular Schwannoma | A morphologic variant of schwannoma characterized by hypercellularity, Antoni A pattern, and the absence of well-formed Verocay bodies. | NCIT:C4724 |
| Central Nervous System Cavernous Hemangioma | A cavernous hemangioma arising from the central nervous system. | NCIT:C84621 |
| Central Nervous System Neoplasm | A tumor of the central nervous system, including brain stem glioma, craniopharyngioma, medulloblastoma, and meningioma. | NCIT:C9293 |
| Cerebellar Neoplasm | A benign or malignant (primary or metastatic) tumor involving the cerebellum. | NCIT:C2935 |
| Cervical Carcinoma | Cancer that forms in tissues of the cervix (the organ connecting the uterus and vagina). It is usually a slow-growing cancer that may not have symptoms but can be found with regular Pap tests (a procedure in which cells are scraped from the cervix and looked at under a microscope). Cervical cancer is almost always caused by human papillomavirus (HPV) infection. | NCIT:C9039 |
| Cervical Neoplasm | A benign, malignant, or precancerous neoplasm that affects the cervix. | NCIT:C2940 |
| Cervical Small Cell Carcinoma | A small cell neuroendocrine carcinoma arising from the cervix. | NCIT:C7982 |
| Cholangiocarcinoma | A rare type of cancer that develops in cells that line the bile ducts in the liver. Cancer that forms where the right and left ducts meet is called Klatskin tumor. | NCIT:C4436 |
| Chondroblastoma | A benign, chondroid-producing, well-circumscribed, lytic neoplasm usually arising from the epiphysis of long bones. It is characterized by the presence of chondroblasts, osteoclast-like giant cells, chondroid formation, calcification, and mitotic activity. In aggressive cases, there is rearrangement of the 8q21 chromosome band. It occurs most frequently in children and young adults and rarely metastasizes. | NCIT:C2945 |
| Choriocarcinoma | An aggressive malignant tumor arising from trophoblastic cells. The vast majority of cases arise in the uterus and represent gestational choriocarcinomas that derive from placental trophoblastic cells. Approximately half of the cases develop from a complete hydatidiform mole. A minority of cases arise in the testis or the ovaries. There is often marked elevation of human chorionic gonadotropin (hCG) in the blood. Choriocarcinomas disseminate rapidly through the hematogenous route; the lungs are most frequently affected. | NCIT:C2948 |
| Chronic Lymphocytic Leukemia | The most common type of chronic lymphoid leukemia. It comprises 90% of chronic lymphoid leukemias in the United States. Morphologically, the neoplastic cells are small, round B-lymphocytes. This type of leukemia is not considered to be curable with available therapy. (WHO, 2001) | NCIT:C3163 |
| Chronic Myeloid Leukemia | A chronic myeloproliferative neoplasm characterized by the expression of the BCR-ABL1 fusion gene. It presents with neutrophilic leukocytosis. It can appear at any age, but it mostly affects middle aged and older individuals. Patients usually present with fatigue, weight loss, anemia, night sweats, and splenomegaly. | NCIT:C3174 |
| Clear Cell Renal Cell Carcinoma | The most common type of kidney cancer. It begins in the lining of the renal tubules in the kidney. The renal tubules filter the blood and produce urine. | NCIT:C4033 |
| Colon Adenocarcinoma | An adenocarcinoma arising from the colon. It is more frequently seen in populations with a Western type diet and in patients with a history of chronic inflammatory bowel disease. Signs and symptoms include intestinal bleeding, anemia, and change in bowel habits. According to the degree of cellular differentiation, colonic adenocarcinomas are divided into well, moderately, and poorly differentiated. Histologic variants include mucinous adenocarcinoma, signet ring cell carcinoma, medullary carcinoma, serrated adenocarcinoma, cribriform comedo-type adenocarcinoma, and micropapillary adenocarcinoma. | NCIT:C4349 |
| Colon Carcinoma | Cancer that forms in the tissues of the colon (the longest part of the large intestine). Most colon cancers are adenocarcinomas (cancers that begin in cells that make and release mucus and other fluids). | NCIT:C4910 |
| Colorectal Adenocarcinoma | The most common type of colorectal carcinoma. It is characterized by the presence of malignant glandular epithelial cells invading through the muscularis mucosa into the submucosa. Histologic variants include mucinous adenocarcinoma, signet ring cell carcinoma, medullary carcinoma, serrated adenocarcinoma, cribriform comedo-type adenocarcinoma, and micropapillary adenocarcinoma. | NCIT:C5105 |
| Colorectal Adenoma | An adenoma that arises from the colon or rectum. The group of colorectal adenomas includes tubular, villous, and tubulovillous adenomas, traditional serrated adenomas, sessile serrated adenomas/polyps, and familial adenomatous polyposis. | NCIT:C5673 |
| Colorectal Carcinoma | Cancer that develops in the colon (the longest part of the large intestine) and/or the rectum (the last several inches of the large intestine before the anus). | NCIT:C2955 |
| Colorectal Neoplasm | A benign or malignant neoplasm that affects the colon or rectum. Representative examples of benign neoplasms include lipoma and leiomyoma. Representative examples of malignant neoplasms include carcinoma, lymphoma, and sarcoma. Colorectal adenomas always exhibit epithelial dysplasia and are considered premalignant neoplasms. | NCIT:C2956 |
| Combined Hepatocellular Carcinoma and Cholangiocarcinoma | A rare tumor containing unequivocal elements of both hepatocellular and cholangiocarcinoma that are intimately admixed. This tumor should be distinguished from separate hepatocellular carcinoma and cholangiocarcinoma arising in the same liver. The prognosis of this tumor is poor. | NCIT:C3828 |
| Craniopharyngioma | A histologically benign, but locally destructive, partly cystic, epithelial tumor of the sellar region, derived from Rathke pouch epithelium. | NCIT:C2964 |
| Cutaneous T Cell Lymphoma | Any of a group of T-cell non-Hodgkin lymphomas that begins in the skin as an itchy, red rash that can thicken or form a tumor. The most common types are mycosis fungoides and Sezary syndrome. | NCIT:C3467 |
| Diffuse Large B-Cell Lymphoma | A type of B-cell non-Hodgkin lymphoma (cancer of the immune system) that is usually aggressive (fast-growing). It is the most common type of non-Hodgkin lymphoma, and is marked by rapidly growing tumors in the lymph nodes, spleen, liver, bone marrow, or other organs. Other symptoms include fever, night sweats, and weight loss. There are several subtypes of diffuse large B-cell lymphoma. | NCIT:C8851 |
| Ductal Breast Carcinoma In Situ | A noninvasive condition in which abnormal cells are found in the lining of a breast duct. The abnormal cells have not spread outside the duct to other tissues in the breast. In some cases, ductal carcinoma in situ may become invasive cancer and spread to other tissues, although it is not known at this time how to predict which lesions will become invasive. | NCIT:C2924 |
| Dysembryoplastic Neuroepithelial Neoplasm | A neoplasm of the nervous system that arises from the neuroepithelial tissues. Representative examples include astrocytic tumors, oligodendroglial tumors, ependymal tumors, and primitive neuroectodermal tumors. | NCIT:C9505 |
| Endometrial Carcinoma | Cancer that forms in the tissue lining the uterus (the small, hollow, pear-shaped organ in a woman's pelvis in which a fetus develops). Most endometrial cancers are adenocarcinomas (cancers that begin in cells that make and release mucus and other fluids). | NCIT:C7558 |
| Endometrial Neoplasm | A benign, borderline, or malignant neoplasm that affects the endometrium. | NCIT:C3012 |
| Ependymoma | A type of brain tumor that begins in cells lining the spinal cord central canal (fluid-filled space down the center) or the ventricles (fluid-filled spaces of the brain). Ependymomas may also form in the choroid plexus (tissue in the ventricles that makes cerebrospinal fluid). | NCIT:C3017 |
| Esophageal Adenocarcinoma | A malignant tumor with glandular differentiation arising predominantly from Barrett mucosa in the lower third of the esophagus. Rare examples of esophageal adenocarcinoma deriving from ectopic gastric mucosa in the upper esophagus have also been reported. Grossly, esophageal adenocarcinomas are similar to esophageal squamous cell carcinomas. Microscopically, adenocarcinomas arising in the setting of Barrett esophagus are typically papillary and/or tubular. The prognosis is poor. | NCIT:C4025 |
| Esophageal Carcinoma | Cancer that forms in tissues lining the esophagus (the muscular tube through which food passes from the throat to the stomach). Two types of esophageal cancer are squamous cell carcinoma (cancer that begins in flat cells lining the esophagus) and adenocarcinoma (cancer that begins in cells that make and release mucus and other fluids). | NCIT:C3513 |
| Esophageal Squamous Cell Carcinoma | A squamous cell carcinoma arising from the esophagus. It is associated with a long history of tobacco and alcohol abuse and is exceedingly rare before the age of 30. The median age is around 65 in both males and females. It is located mostly in the middle and lower third of the esophagus. Grossly, polypoid, ulcerated, plaque-like and occult lesions have been described. The microscopic features are the same as in other squamous cell carcinomas. Any degree of differentiation may occur, and variation within a single tumor is common. The prognosis is poor. | NCIT:C4024 |
| Ewing Sarcoma | A type of cancer that forms in bone or soft tissue. | NCIT:C4817 |
| Extraventricular Neurocytoma | A WHO grade 2 neoplasm that arises from the brain parenchyma. Morphologically it is characterized by the presence of neoplastic uniform, round cells with neuronal differentiation. Unlike central neurocytoma, it does not involve the lateral ventricles. It usually affects young adults and has a favorable prognosis. | NCIT:C92555 |
| Fibroepithelial Polyp | A polypoid lesion composed of fibrous tissue and epithelium. Representative examples include skin tag, anal fibroepithelial polyp, and gingival fibroepithelial polyp. | NCIT:C3337 |
| Fibrolamellar Carcinoma | A distinctive type of liver cell carcinoma that arises in non-cirrhotic livers and is seen predominantly in young patients. The tumor cells are polygonal and deeply eosinophilic, and are embedded in a fibrous stroma. The prognosis is similar to classical hepatocellular carcinoma that arises in non-cirrhotic livers, and better than hepatocellular carcinoma that arises in cirrhotic livers. | NCIT:C4131 |
| Fibrosarcoma | A malignant mesenchymal neoplasm of the soft tissue and bone. | NCIT:C3043 |
| Follicular Lymphoma | A type of B-cell non-Hodgkin lymphoma (cancer of the immune system) that is usually indolent (slow-growing). The tumor cells grow as groups to form nodules. There are several subtypes of follicular lymphoma. | NCIT:C3209 |
| Gallbladder Carcinoma | Cancer that forms in tissues of the gallbladder. The gallbladder is a pear-shaped organ below the liver that collects and stores bile (a fluid made by the liver to digest fat). Gallbladder cancer begins in the innermost layer of tissue and spreads through the outer layers as it grows. | NCIT:C3844 |
| Gastric Adenocarcinoma | An adenocarcinoma arising from the stomach glandular epithelium. Gastric adenocarcinoma is primarily a disease of older individuals. It most commonly develops after a long period of atrophic gastritis and is strongly associated with Helicobacter pylori infection. The lack of early symptoms often delays the diagnosis of gastric cancer. The majority of patients present with advanced tumors which have poor rates of curability. Microscopically, two important histologic types of gastric adenocarcinoma are recognized: the intestinal and diffuse type. The overall prognosis of gastric adenocarcinomas is poor, even in patients who receive a "curative" resection (adapted from Sternberg's Surgical Pathology, 3rd ed., 1999). | NCIT:C4004 |
| Gastric Carcinoma | Cancer that forms in tissues lining the stomach. | NCIT:C4911 |
| Gastric Neoplasm | A benign or malignant neoplasm involving the stomach. | NCIT:C3387 |
| Gastroesophageal Adenocarcinoma | A malignant epithelial neoplasm composed of glandular (adenocarcinoma) cells arising at or near the junction of the esophagus and stomach. It encompasses tumors previously classified as distal esophageal, gastroesophageal junction, or gastric cardia adenocarcinomas. | DOID:0080375 |
| Gastroesophageal Junction Adenocarcinoma | An adenocarcinoma that arises from and straddles the junction of the stomach and esophagus. The category of adenocarcinomas of the gastroesophageal junction also includes the majority of adenocarcinomas previously called gastric cardia adenocarcinomas. Squamous cell carcinomas that affect or cross the junction of the stomach and esophagus are classified as carcinomas of the distal esophagus. Adenocarcinoma of the gastroesophageal junction occurs more often in Caucasian middle aged and elderly males. Clinical signs and symptoms include dysphagia, abdominal pain, and weight loss. The prognosis depends on the completeness of the surgical resection, the number of lymph nodes involved by cancer, and the presence or absence of postoperative complications. The presence of TP53 mutations indicates worse prognosis. | NCIT:C9296 |
| Gastrointestinal Stromal Neoplasm | A type of tumor that usually begins in cells in the wall of the gastrointestinal tract. It can be benign or malignant. | NCIT:C3868 |
| Giant Cell Tumor | A benign, intermediate, or malignant tumor that arises from the bone or soft tissue. It is characterized by the presence of multinucleated osteoclast-like giant cells. | NCIT:C3055 |
| Glioblastoma | The most malignant astrocytic tumor (WHO grade 4). It is composed of poorly differentiated neoplastic astrocytes and is characterized by the presence of cellular polymorphism, nuclear atypia, brisk mitotic activity, vascular thrombosis, microvascular proliferation, and necrosis. It typically affects adults and is preferentially located in the cerebral hemispheres. (Adapted from WHO) | NCIT:C3058 |
| Glioma | A general term for tumors of the central nervous system, including astrocytomas, ependymal tumors, glioblastoma multiforme, and primitive neuroectodermal tumors. | NCIT:C3059 |
| Head and Neck Carcinoma | A carcinoma that arises from the head and neck region. Representative examples include oral cavity squamous cell carcinoma, laryngeal squamous cell carcinoma, and salivary gland carcinoma. | NCIT:C35850 |
| Head and Neck Neoplasm | A carcinoma that arises from the head and neck region. Representative examples include oral cavity squamous cell carcinoma, laryngeal squamous cell carcinoma, and salivary gland carcinoma. | NCIT:C3077 |
| Head and Neck Squamous Cell Carcinoma | Cancer of the head and neck that begins in squamous cells (thin, flat cells that form the surface of the skin, eyes, various internal organs, and the lining of hollow organs and ducts of some glands). Squamous cell carcinoma of the head and neck includes cancers of the nasal cavity, sinuses, lips, mouth, salivary glands, throat, and larynx (voice box). Most head and neck cancers are squamous cell carcinomas. | NCIT:C34447 |
| Hepatocellular Carcinoma | A type of adenocarcinoma and the most common type of liver tumor. | NCIT:C3099 |
| High Grade Ovarian Serous Adenocarcinoma | A rapidly growing serous adenocarcinoma that arises from the ovary. It is characterized by the presence of high grade cytologic features and frequent mitotic figures. | NCIT:C105555 |
| Histiocytic Sarcoma | An aggressive malignant neoplasm with a poor response to therapy, usually presenting as stage III/IV disease. It is characterized by the presence of neoplastic cells with morphologic and immunophenotypic characteristics similar to those seen in mature histiocytes. | NCIT:C27349 |
| Hodgkin Lymphoma | A malignant neoplasm of the lymphatic system that is comprised of abnormal lymphocytes and is characterized by the presence of Reed-Sternberg cells. | NCIT:C9357 |
| Intestinal Neoplasm | A benign or malignant neoplasm involving the small or large intestine. | NCIT:C3141 |
| Intrahepatic Cholangiocarcinoma | A malignant neoplasm of the liver arising from/comprising cells resembling those of bile ducts. | NCIT:C35417 |
| Invasive Ductal Breast Carcinoma | The most common type of invasive breast cancer. It starts in the cells that line the milk ducts in the breast, grows outside the ducts, and often spreads to the lymph nodes. | NCIT:C4194 |
| Kaposi Sarcoma | A type of cancer characterized by the abnormal growth of blood vessels that develop into skin lesions or occur internally. | NCIT:C9087 |
| Leiomyoma | A well-circumscribed benign smooth muscle neoplasm characterized by the presence of spindle cells with cigar-shaped nuclei, interlacing fascicles, and a whorled pattern. | NCIT:C6510 |
| Leukemia | Cancer that starts in blood-forming tissue such as the bone marrow and causes large numbers of blood cells to be produced and enter the bloodstream. | NCIT:C3161 |
| Liver and Intrahepatic Bile Duct Carcinoma | Primary liver cancer is cancer that forms in the tissues of the liver. Secondary liver cancer is cancer that spreads to the liver from another part of the body. | NCIT:C7927 |
| Liver and Intrahepatic Bile Duct Neoplasm | A benign or malignant neoplasm that affects the liver parenchyma or intrahepatic bile ducts. Representative examples of benign neoplasms include hepatocellular adenoma, and bile duct adenoma. Representative examples of malignant neoplasms include hepatocellular carcinoma, intrahepatic cholangiocarcinoma, and lymphoma. | NCIT:C7103 |
| Low Grade Glioma | A grade I or grade II glioma arising from the central nervous system. This category includes pilocytic astrocytoma, diffuse astrocytoma, subependymal giant cell astrocytoma, ependymoma, oligodendroglioma, oligoastrocytoma, and angiocentric glioma. | NCIT:C132067 |
| Luminal A Breast Carcinoma | A biologic subset of breast carcinoma defined by high expression of genes characteristic of luminal epithelial cells, including estrogen receptor (ER), estrogen regulated protein LIV-1, and the transcription factors hepatocyte nuclear factor 3, HNF3A, XBP1, and GATA 3. This subtype of breast cancer is associated with a good prognosis. | NCIT:C53554 |
| Lung Adenocarcinoma | A carcinoma that arises from the lung and is characterized by the presence of malignant glandular epithelial cells. There is a male predilection with a male to female ratio of 2:1. Usually lung adenocarcinoma is asymptomatic and is identified through screening studies or as an incidental radiologic finding. If clinical symptoms are present they include shortness of breath, cough, hemoptysis, chest pain, and fever. Tobacco smoke is a known risk factor. | NCIT:C3512 |
| Lung Carcinoma | Cancer that forms in tissues of the lung, usually in the cells lining air passages. The two main types are small cell lung cancer and non-small cell lung cancer. These types are diagnosed based on how the cells look under a microscope. | NCIT:C4878 |
| Lung Neoplasm | A benign or malignant, primary or metastatic neoplasm involving the lungs. Representative examples of benign neoplasms include adenoma, papilloma, chondroma, and endobronchial lipoma. Representative examples of malignant neoplasms include carcinoma, carcinoid tumor, sarcoma, and lymphoma. | NCIT:C3200 |
| Lung Non-Small Cell Carcinoma | A group of lung cancers that are named for the kinds of cells found in the cancer and how the cells look under a microscope. The three main types of non-small cell lung cancer are squamous cell carcinoma, large cell carcinoma, and adenocarcinoma. Non-small cell lung cancer is the most common kind of lung cancer. | NCIT:C2926 |
| Lung Small Cell Carcinoma | An aggressive (fast-growing) cancer that forms in tissues of the lung and can spread to other parts of the body. The cancer cells look small and oval-shaped when looked at under a microscope. | NCIT:C4917 |
| Lung Squamous Cell Carcinoma | A carcinoma arising from squamous bronchial epithelial cells. It may be keratinizing or non-keratinizing. Keratinizing squamous cell carcinoma is characterized by the presence of keratinization, pearl formation, and/or intercellular bridges. Non-keratinizing squamous cell carcinoma is characterized by the absence of keratinization, pearl formation, and intercellular bridges. Cigarette smoking and arsenic exposure are strongly associated with squamous cell lung carcinoma. | NCIT:C3493 |
| Lymphoid Leukemia | A type of cancer in which the bone marrow makes too many lymphocytes (white blood cells). | NCIT:C7539 |
| Lymphoma | Cancer that begins in cells of the immune system. There are two basic categories of lymphomas. One kind is Hodgkin lymphoma, which is marked by the presence of a type of cell called the Reed-Sternberg cell. The other category is non-Hodgkin lymphomas, which includes a large, diverse group of cancers of immune system cells. Non-Hodgkin lymphomas can be further divided into cancers that have an indolent (slow-growing) course and those that have an aggressive (fast-growing) course. These subtypes behave and respond to treatment differently. Both Hodgkin and non-Hodgkin lymphomas can occur in children and adults, and prognosis and treatment depend on the stage and the type of cancer. | NCIT:C3208 |
| Malignant Brain Neoplasm | An abnormal solid mass arising within the brain with histologic features suggesting the potential to metastasize. | NCIT:C3568 |
| Malignant Digestive System Neoplasm | A primary or metastatic malignant neoplasm involving any part of the digestive system. | NCIT:C4890 |
| Malignant Genitourinary System Neoplasm | A primary or metastatic malignant neoplasm that affects the genitourinary system. | NCIT:C156484 |
| Malignant Glioma | A malignant neuroglial neoplasm. The term can apply to several primary neoplasm of the brain and spinal cord, including astrocytoma and oligodendroglioma in addition to others. | NCIT:C4822 |
| Malignant Neoplasm | Uncontrolled growth of abnormal cells with potential for metastatic spread. | NCIT:C9305 |
| Malignant Ovarian Neoplasm | Cancer that forms in tissues of the ovary (one of a pair of female reproductive glands in which the ova, or eggs, are formed). Most ovarian cancers are either ovarian epithelial carcinomas (cancer that begins in the cells on the surface of the ovary) or malignant germ cell tumors (cancer that begins in egg cells). | NCIT:C7431 |
| Malignant Pancreatic Neoplasm | A primary or metastatic malignant tumor involving the pancreas. Representative examples include carcinoma and lymphoma. | NCIT:C9005 |
| Malignant Peripheral Nerve Sheath Tumor | An uncommon, highly aggressive malignant tumor, arising from the peripheral nerves and affecting mostly adults in their third to sixth decades of life. It usually occurs in medium-sized and large nerves of the buttock, thigh, upper arm, or the paraspinal region. It may be associated with neurofibromatosis 1 (NF1). | NCIT:C3798 |
| Malignant Peritoneal Neoplasm | Cancer of the tissue that lines the abdominal wall and covers organs in the abdomen. | NCIT:C3538 |
| Malignant Skin Neoplasm | Cancer that forms in the tissues of the skin. There are several types of skin cancer. Skin cancer that forms in melanocytes (skin cells that make pigment) is called melanoma. Skin cancer that forms in the lower part of the epidermis (the outer layer of the skin) is called basal cell carcinoma. Skin cancer that forms in squamous cells (flat cells that form the surface of the skin) is called squamous cell carcinoma. Skin cancer that forms in neuroendocrine cells (cells that release hormones in response to signals from the nervous system) is called neuroendocrine carcinoma of the skin. Most skin cancers form in older people on parts of the body exposed to the sun or in people who have weakened immune systems. | NCIT:C2920 |
| Mantle Cell Lymphoma | An aggressive, usually diffuse non-Hodgkin lymphoma composed of small to medium sized B-lymphocytes (centrocytes). Most patients present with advanced stage disease with lymphadenopathy, hepatosplenomegaly, and bone marrow involvement. The gastrointestinal tract is the most commonly affected extranodal site by this type of non-Hodgkin lymphoma. The vast majority of cases express the t(11;14)(q13;q32) resulting in the rearrangement of the BCL-1 gene and the overexpression of cyclin D1 mRNA. | NCIT:C4337 |
| Marginal Zone Lymphoma | An indolent (slow-growing) type of B-cell non-Hodgkin lymphoma that begins forming in certain areas (the marginal zones) of lymph tissue. There are three types based on whether it forms in the spleen, lymph nodes, or other lymphoid tissue that contains a lot of B cells (a type of white blood cell). | NCIT:C4341 |
| Medulloblastoma | A rapidly progressive cancer of the brain that originates in the cerebellum. | NCIT:C3222 |
| Melanoma | A malignant, usually aggressive tumor composed of atypical, neoplastic melanocytes. Most often, melanomas arise in the skin (cutaneous melanomas) and include the following histologic subtypes: superficial spreading melanoma, nodular melanoma, acral lentiginous melanoma, and lentigo maligna melanoma. Cutaneous melanomas may arise from acquired or congenital melanocytic or dysplastic nevi. Melanomas may also arise in other anatomic sites including the gastrointestinal system, eye, urinary tract, and reproductive system. Melanomas frequently metastasize to lymph nodes, liver, lungs, and brain. | NCIT:C3224 |
| Meningioma | A usually benign tumor that develops in the meninges. | NCIT:C3230 |
| Mesothelioma | A usually malignant and aggressive neoplasm of the mesothelium which is often associated with exposure to asbestos. | NCIT:C4456 |
| Multiple Myeloma | A type of cancer that begins in plasma cells (white blood cells that produce antibodies). | NCIT:C3242 |
| Mycosis Fungoides | A type of non-Hodgkin's lymphoma that first appears on the skin and can spread to the lymph nodes or other organs such as the spleen, liver, or lungs. | NCIT:C3246 |
| Myeloid Leukemia | A progressive, proliferative disease of blood cells, originating from immature granulocytes. | NCIT:C3172 |
| Myeloid Neoplasm | Proliferation of myeloid cells originating from a primitive stem cell. | NCIT:C9290 |
| Myeloproliferative Neoplasm | A group of slow growing blood cancers, including chronic myelogenous leukemia, in which large numbers of abnormal red blood cells, white blood cells, or platelets grow and spread in the bone marrow and the peripheral blood. | NCIT:C4345 |
| Myoepithelioma | A tumor composed predominantly of myoepithelial cells, the contractile cells that normally surround the secretory acini of glandular tissue such as the salivary or breast glands. It is usually benign, though malignant myoepithelial tumors (myoepithelial carcinoma) also occur. | NCIT:C40392 |
| Nasopharyngeal Carcinoma | Cancer that forms in tissues of the nasopharynx (upper part of the throat behind the nose). Most nasopharyngeal cancers are squamous cell carcinomas (cancer that begins in flat cells lining the nasopharynx). | NCIT:C3871 |
| Neuroblastoma | Cancer that arises in immature nerve cells and affects mostly infants and children. | NCIT:C3270 |
| Neuroendocrine Neoplasm | An epithelial neoplasm with neuroendocrine differentiation. This category includes neuroendocrine tumors, neuroendocrine carcinomas, and paragangliomas. | NCIT:C3809 |
| Neuroepithelial Neoplasm | A neoplasm of the nervous system that arises from the neuroepithelial tissues. Representative examples include astrocytic tumors, oligodendroglial tumors, ependymal tumors, and primitive neuroectodermal tumors. | NCIT:C3787 |
| Neurofibroma | An intraneural or extraneural neoplasm arising from nerve tissues and neural sheaths. It is composed of perineurial-like fibroblasts and Schwann cells. It usually presents as a localized cutaneous lesion and less often as a circumscribed peripheral nerve mass. Patients with neurofibromatosis type 1 present with multiple masses. Neurofibromas which arise from major nerves and plexiform neurofibromas are precursor lesions to malignant peripheral nerve sheath tumors. | NCIT:C3272 |
| Non-Functioning Pituitary Gland Adenoma | A hormone producing or non-producing pituitary neuroendocrine tumor not associated with a hormonal syndrome. | NCIT:C4348 |
| Non-Hodgkin Lymphoma | Distinct from Hodgkin lymphoma both morphologically and biologically, non-Hodgkin lymphoma (NHL) is characterized by the absence of Reed-Sternberg cells, can occur at any age, and usually presents as a localized or generalized lymphadenopathy associated with fever and weight loss. The clinical course varies according to the morphologic type. NHL is clinically classified as indolent, aggressive, or having a variable clinical course. NHL can be of B-or T-/NK-cell lineage. | NCIT:C3211 |
| Not Applicable | Determination of a value is not relevant in the current context. (NCI) | NCIT:C48660 |
| Oral Cavity Neoplasm | A benign or malignant neoplasm that affects the oral cavity. | NCIT:C7606 |
| Oral Cavity Squamous Cell Carcinoma | A type of mass spectrometry that uses the cyclotron frequency of ions in a fixed magnetic field to determine their ionic mass-to-charge ratio. | NCIT:C4833 |
| Oropharyngeal Neoplasm | A benign or malignant neoplasm that affects the oropharynx. | NCIT:C3291 |
| Osteosarcoma | A usually aggressive malignant bone-forming mesenchymal neoplasm, predominantly affecting adolescents and young adults. It usually involves bones and less frequently extraosseous sites. It often involves the long bones (particularly distal femur, proximal tibia, and proximal humerus). Pain with or without a palpable mass is the most frequent clinical symptom. It may spread to other anatomic sites, particularly the lungs. | NCIT:C9145 |
| Ovarian Adenosarcoma | A biphasic neoplasm that arises from the ovary and is characterized by the presence of mullerian-type epithelial tissue in a mesenchymal sarcomatous stroma. The presence of a high grade sarcomatous component is associated with recurrences and metastases. | NCIT:C7317 |
| Ovarian Carcinoma | Cancer that occurs in the cells lining the ovaries. | NCIT:C4908 |
| Ovarian Neoplasm | A benign, borderline, or malignant neoplasm involving the ovary. | NCIT:C4984 |
| Ovarian Serous Adenocarcinoma | An adenocarcinoma that arises from the ovary and is characterized by the presence of malignant epithelial cells that, in well differentiated tumors, resemble the epithelium of the fallopian tube or, in poorly differentiated tumors, show anaplastic features and marked nuclear atypia. | NCIT:C7550 |
| Pan-cancer | A term describing analyses, datasets, or studies that span and compare multiple different cancer/tumor types together, rather than being limited to a single cancer type, in order to identify shared or distinguishing molecular and clinical features across cancers. | Not available |
| Pancreatic Adenocarcinoma | An adenocarcinoma which arises from the exocrine pancreas. Ductal adenocarcinoma and its variants are the most common types of pancreatic adenocarcinoma. | NCIT:C8294 |
| Pancreatic Carcinoma | A disease in which malignant (cancer) cells are found in the tissues of the pancreas. | NCIT:C207229 |
| Pancreatic Ductal Adenocarcinoma | An infiltrating adenocarcinoma that arises from the epithelial cells of the pancreas. It affects males more often than females and the patients are usually over 50 years of age. Microscopically it is characterized by the presence of glandular (ductal) differentiation and desmoplastic stroma formation. Signs and symptoms include pain, loss of weight, and jaundice. It grows rapidly and is usually detected after it has metastasized to other anatomic sites. The prognosis is usually poor. | NCIT:C9120 |
| Pancreatic Neoplasm | A benign or malignant neoplasm involving the pancreas. | NCIT:C3305 |
| Pancreatic Neuroendocrine Carcinoma | Cancer arising from cells in the islets of Langerhans, which are found in the pancreas. | NCIT:C3770 |
| Pending Annotation | An administrative placeholder value indicating that a definitive tumor/cancer type has not yet been curated or assigned for this record; the classification is awaiting manual annotation review. | NCIT:C53470 |
| Penile Carcinoma | A rare cancer that forms in the penis (an external male reproductive organ). Most penile cancers are squamous cell carcinomas (cancer that begins in flat cells lining the penis). | NCIT:C9061 |
| Pheochromocytoma | Tumor that forms in the center of the adrenal gland (gland located above the kidney) that causes it to make too much adrenaline. Pheochromocytomas are usually benign (not cancer) but can cause high blood pressure, pounding headaches, heart palpitations, flushing of the face, nausea, and vomiting. | NCIT:C3326 |
| Pilocytic Astrocytoma | A WHO grade 1, relatively circumscribed, slowly growing, often cystic astrocytoma occurring in children and young adults. Histologically it is characterized by a biphasic pattern with compacted bipolar cells associated with Rosenthal fibers and multipolar cells associated with microcysts and eosinophilic bodies/hyaline droplets. (WHO) | NCIT:C4047 |
| Pituitary Gland Adenoma | A well-differentiated neuroendocrine neoplasm that arises from the adenohypophysial cells of the anterior lobe of the pituitary gland. The tumor can be hormonally functioning or not. It has a low frequency of metastatic spread. When metastatic, the term metastatic pituitary neuroendocrine tumor is endorsed instead of pituitary carcinoma. (WHO) | NCIT:C3329 |
| Plasmablastic Lymphoma | An aggressive diffuse large B-cell lymphoma frequently arising in the setting of HIV infection and characterized by the presence of large neoplastic cells resembling B-immunoblasts which have the immunophenotypic profile of plasma cells. Sites of involvement include the oral cavity, sinonasal cavity, skin, soft tissues, gastrointestinal tract, and bone. | NCIT:C7224 |
| Plasmacytoma | A type of cancer that begins in plasma cells (white blood cells that produce antibodies). A plasmacytoma may turn into multiple myeloma. | NCIT:C9349 |
| Plexiform Schwannoma | A schwannoma characterized by a plexiform or multinodular growth pattern. It usually arises from the skin or subcutaneous tissues in the extremities, trunk, and head and neck. | NCIT:C6969 |
| Precursor B-cell lymphoblastic leukemia | The most frequent type of acute lymphoblastic leukemia. Approximately 75% of cases occur in children under six years of age. This is a good prognosis leukemia. In the pediatric age group the complete remission rate is approximately 95% and the disease free survival rate is 70%. Approximately 80% of children appear to be cured. In the adult age group the complete remission rate is 60-85%. (WHO, 2001) | NCIT:C8936 |
| Primary Central Nervous System Lymphoma | Primary CNS lymphomas are extranodal malignant lymphomas arising in the CNS in the absence of obvious lymphoma outside the nervous system at the time of diagnosis. They should be differentiated from secondary involvement of the nervous system in systemic lymphomas. The incidence of primary CNS lymphomas has recently increased markedly worldwide from about 1% to over 6% of primary intracranial neoplasms due mainly as a consequence of the AIDS epidemic. Primary CNS lymphomas affect all ages, with a peak incidence in immunocompetent subjects during the sixth and seventh decade of life and a male:female ratio of 3:2. In immunocompromised patients, the age at manifestation is lowest in individuals who have an inherited immunodeficiency (10 years), followed by transplant recipients (37 years) and AIDS patients (39 years, 90% males). About 60% of primary CNS lymphomas involve the supratentorial space, including the frontal (15%), temporal (8%), parietal (7%) and occipital (3%) lobes, basal ganglia/periventricular regions (10%) and corpus callosum (5%), the posterior fossa (13%), and the spinal cord (1%). The majority of primary CNS lymphomas are large B-cell lymphomas, often associated with the Epstein-Barr virus. (Adapted from WHO.) | NCIT:C9301 |
| Primary Myelofibrosis | A progressive, chronic disease in which the bone marrow is replaced by fibrous tissue and blood is made in organs such as the liver and the spleen, instead of in the bone marrow. This disease is marked by an enlarged spleen and progressive anemia. | NCIT:C2862 |
| Prostate Adenocarcinoma | An adenocarcinoma arising from the prostate gland. It is one of the most common malignant tumors afflicting men. The majority of adenocarcinomas arise in the peripheral zone and a minority occurs in the central or the transitional zone of the prostate gland. Grading of prostatic adenocarcinoma predicts disease progression and correlates with survival. Several grading systems have been proposed, of which the Gleason system is the most commonly used. Gleason sums of 2 to 4 represent well-differentiated disease, 5 to 7 moderately differentiated disease and 8 to 10 poorly differentiated disease. Prostatic-specific antigen (PSA) serum test is widely used as a screening test for the early detection of prostatic adenocarcinoma. Treatment options include radical prostatectomy, radiation therapy, androgen ablation and cryotherapy. Watchful waiting or surveillance alone is an option for older patients with low-grade or low-stage disease. | NCIT:C2919 |
| Prostate Carcinoma | One of the most common malignant tumors afflicting men. The majority of carcinomas arise in the peripheral zone and a minority occur in the central or the transitional zone of the prostate gland. Grossly, prostatic carcinomas appear as ill-defined yellow areas of discoloration in the prostate gland lobes. Adenocarcinomas represent the overwhelming majority of prostatic carcinomas. Prostatic-specific antigen (PSA) serum test is widely used as a screening test for the early detection of prostatic carcinoma. Treatment options include radical prostatectomy, radiation therapy, androgen ablation and cryotherapy. Watchful waiting or surveillance alone is an option for older patients with low-grade or low-stage disease. | NCIT:C4863 |
| Prostate Neoplasm | A benign, borderline, or malignant neoplasm that affects the prostate gland. Representative examples include benign prostate phyllodes tumor, prostatic intraepithelial neoplasia, prostate carcinoma, and prostate sarcoma. | NCIT:C3343 |
| Rectal Adenocarcinoma | An adenocarcinoma arising from the rectum. It is more frequently seen in populations with a Western type diet and in patients with a history of chronic inflammatory bowel disease. Signs and symptoms include intestinal bleeding, anemia, and change in bowel habits. According to the degree of cellular differentiation, rectal adenocarcinomas are divided into well, moderately, and poorly differentiated. Histologic variants include mucinous adenocarcinoma, signet ring cell carcinoma, medullary carcinoma, serrated adenocarcinoma, cribriform comedo-type adenocarcinoma, and micropapillary adenocarcinoma. | NCIT:C9383 |
| Renal Cell Carcinoma | The most common type of kidney cancer. It begins in the lining of the renal tubules in the kidney. The renal tubules filter the blood and produce urine. | NCIT:C9385 |
| Retinoblastoma | Cancer that forms in the tissues of the retina (the light-sensitive layers of nerve tissue at the back of the eye). Retinoblastoma usually occurs in children younger than 5 years. It may be hereditary or nonhereditary (sporadic). | NCIT:C7541 |
| Rhabdomyosarcoma | Cancer that forms in the soft tissues in a type of muscle called striated muscle. Rhabdomyosarcoma can occur anywhere in the body. | NCIT:C3359 |
| Rosette-Forming Glioneuronal Tumor | A central nervous system neoplasm mostly occurring in the fourth ventricle region. It is characterized by the presence of neurocytes forming pseudorosettes and astrocytes which contain Rosenthal fibers. Cytologic atypia is minimal. | NCIT:C129431 |
| Salivary Gland Adenoid Cystic Carcinoma | An adenoid cystic carcinoma arising from the salivary gland. It is characterized by the presence of epithelial and myoepithelial cells forming tubular, cribriform, and solid patterns. It usually presents as a slow growing mass. Patients may experience pain because of the tumor propensity for perineural invasion. The tumor may follow an aggressive clinical course with recurrences and mestastases to distant sites including lungs, bones, brain, and liver. | NCIT:C8026 |
| Sarcoma | A usually aggressive malignant neoplasm of the soft tissue or bone. It arises from muscle, fat, fibrous tissue, bone, cartilage, and blood vessels. Sarcomas occur in both children and adults. The prognosis depends largely on the degree of differentiation (grade) of the neoplasm. Representative subtypes are liposarcoma, leiomyosarcoma, osteosarcoma, and chondrosarcoma. | NCIT:C9118 |
| Schwannoma | A tumor of the peripheral nervous system that arises in the nerve sheath (protective covering). It is almost always benign, but rare malignant schwannomas have been reported. | NCIT:C3269 |
| Serous Tubal Intraepithelial Carcinoma | A non-invasive serous carcinoma arising from the fallopian tube. | NCIT:C126449 |
| Sinonasal Squamous Cell Carcinoma | A rare, keratinizing or non-keratinizing squamous cell carcinoma arising from the mucosal epithelium of the nasal cavity or the paranasal sinuses. It affects most often the maxillary sinus. Less frequently, it arises from the nasal cavity, ethmoid sinus, sphenoid sinus, and frontal sinus. Symptoms include nasal fullness, epistaxis, rhinorhea, pain, and paresthesia. Patients with nasal squamous cell carcinoma usually present earlier than patients with maxillary sinus carcinoma and have a better prognosis compared to the latter group. | NCIT:C68611 |
| Skin Carcinoma | Skin cancer that arises in basal cells or squamous cells but not in melanocytes (pigment-producing cells of the skin). | NCIT:C4914 |
| Skin Neoplasm | A benign, intermediate, or malignant neoplasm involving the skin. | NCIT:C3372 |
| Soft Tissue Sarcoma | A solid, malignant neoplasm originating in muscle, tendon, fat, blood vessels, nerves, connective or joint tissue. | NCIT:C9306 |
| Squamous Cell Carcinoma | Cancer that begins in squamous cells, which are thin, flat cells that look like fish scales. Squamous cells are found in the tissue that forms the surface of the skin, the lining of the hollow organs of the body, and the passages of the respiratory and digestive tracts. | NCIT:C2929 |
| Synovial Sarcoma | A malignant tumor that develops in the synovial membrane of the joints. | NCIT:C3400 |
| T Acute Lymphoblastic Leukemia | An aggressive (fast-growing) type of leukemia (blood cancer) in which too many T-cell lymphoblasts (immature white blood cells) are found in the bone marrow and blood. | NCIT:C3183 |
| T-Cell Lymphoma | A non-Hodgkin lymphoma of T-cell lineage. It includes the T lymphoblastic lymphoma and the mature T- and NK-cell lymphomas. | NCIT:C3466 |
| Teratoma | A type of germ cell tumor that may contain several different types of tissue, such as hair, muscle, and bone. Teratomas occur most often in the ovaries in women, the testicles in men, and the tailbone in children. Not all teratomas are malignant. | NCIT:C3403 |
| Testicular Embryonal Carcinoma | A malignant germ cell neoplasm arising from the testis. It is composed of primitive epithelial cells arranged in solid, papillary, and glandular configurations. Most patients present with a testicular mass, which may be associated with pain. More than half of the patients have metastatic disease at diagnosis. The form of treatment following radical orchiectomy is stage dependent. | NCIT:C6341 |
| Thyroid Gland Anaplastic Carcinoma | An aggressive carcinoma of the thyroid gland composed of undifferentiated cells. | NCIT:C3878 |
| Thyroid Gland Carcinoma | Cancer that forms in the thyroid gland (an organ at the base of the throat that makes hormones that help control heart rate, blood pressure, body temperature, and weight). Four main types of thyroid cancer are papillary, follicular, medullary, and anaplastic thyroid cancer. The four types are based on how the cancer cells look under a microscope. | NCIT:C4815 |
| Thyroid Gland Noninvasive Follicular Neoplasm with Papillary-Like Nuclear Features | A non-invasive neoplasm of thyroid follicular cells with a follicular growth pattern and nuclear features of papillary thyroid carcinoma that has an extremely low malignant potential. These tumors were formerly classified as non-invasive encapsulated follicular variant of papillary thyroid carcinoma or well-differentiated tumor of uncertain malignant potential. (WHO) | NCIT:C126598 |
| Triple-Negative Breast Carcinoma | An invasive breast carcinoma which is negative for expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2). | NCIT:C71732 |
| Urothelial Carcinoma | A malignant neoplasm derived from the transitional epithelium of the urinary tract (urinary bladder, ureter, urethra, or renal pelvis). It is frequently papillary. | NCIT:C4030 |
| Uterine Adenosarcoma | A primary malignant neoplasm of the uterine corpus characterized by a sarcomatous (malignant) mesenchymal component combined with a benign glandular epithelial component. It is generally a low-grade tumor that can recur locally following resection. | NCIT:C6336 |
| Uveal Melanoma | A rare cancer of melanocytes (cells that produce the pigment melanin) found in the eye. | NCIT:C7712 |
| Uveal Neoplasm | A neoplasm that affects the uvea. Uveal melanoma is a representative example. | NCIT:C3436 |
| Vascular Neoplasm | A benign, intermediate, or malignant neoplasm arising from vascular tissue including arteries, veins, venous sinuses, lymphatic vessels, arterioles and capillaries. It may occur in essentially any body location and is characterized by the presence of vascular channel formation and endothelial cells. | NCIT:C7388 |
| Not-Applicable | Determination of a value is not relevant in the current context. (NCI) | NCIT:C48660 |
| Plexiform Neurofibroma | An elongated and multinodular neurofibroma that forms when the tumor involves either multiple trunks of a nerve plexus or multiple fascicles of a large nerve. Some plexiform neurofibromas resemble a 'bag of worms', while others produce a massive ropy enlargement of the nerve. (Adapted from WHO) | NCIT:C3797 |
Attribute: License¶
| Valid Value | Description | Ontology |
|---|---|---|
| AAL | Attribution Assurance License | SPDX:AAL |
| ADSL | Amazon Digital Services License | SPDX:ADSL |
| AFL-1.1 | Academic Free License v1.1 | SPDX:AFL-1.1 |
| AFL-1.2 | Academic Free License v1.2 | SPDX:AFL-1.2 |
| AFL-2.0 | Academic Free License v2.0 | SPDX:AFL-2.0 |
| AFL-2.1 | Academic Free License v2.1 | SPDX:AFL-2.1 |
| AFL-3.0 | Academic Free License v3.0 | SPDX:AFL-3.0 |
| AGPL-1.0 | Affero General Public License v1.0 | SPDX:AGPL-1.0 |
| AGPL-3.0 | GNU Affero General Public License v3.0 | SPDX:AGPL-3.0 |
| AMDPLPA | AMD's plpa_map.c License | SPDX:AMDPLPA |
| AML | Apple MIT License | SPDX:AML |
| AMPAS | Academy of Motion Picture Arts and Sciences BSD | SPDX:AMPAS |
| ANTLR-PD | ANTLR Software Rights Notice | SPDX:ANTLR-PD |
| APAFML | Adobe Postscript AFM License | SPDX:APAFML |
| APL-1.0 | Adaptive Public License 1.0 | SPDX:APL-1.0 |
| APSL-1.0 | Apple Public Source License 1.0 | SPDX:APSL-1.0 |
| APSL-1.1 | Apple Public Source License 1.1 | SPDX:APSL-1.1 |
| APSL-1.2 | Apple Public Source License 1.2 | SPDX:APSL-1.2 |
| APSL-2.0 | Apple Public Source License 2.0 | SPDX:APSL-2.0 |
| Abstyles | Abstyles License | SPDX:Abstyles |
| Adobe-2006 | Adobe Systems Incorporated Source Code License Agreement | SPDX:Adobe-2006 |
| Adobe-Glyph | Adobe Glyph List License | SPDX:Adobe-Glyph |
| Afmparse | Afmparse License | SPDX:Afmparse |
| Aladdin | Aladdin Free Public License | SPDX:Aladdin |
| Apache-1.0 | Apache License 1.0 | SPDX:Apache-1.0 |
| Apache-1.1 | Apache License 1.1 | SPDX:Apache-1.1 |
| Apache-2.0 | Apache License 2.0 | SPDX:Apache-2.0 |
| Artistic-1.0 | Artistic License 1.0 | SPDX:Artistic-1.0 |
| Artistic-1.0-Perl | Artistic License 1.0 (Perl) | SPDX:Artistic-1.0-Perl |
| Artistic-1.0-cl8 | Artistic License 1.0 w/clause 8 | SPDX:Artistic-1.0-cl8 |
| Artistic-2.0 | Artistic License 2.0 | SPDX:Artistic-2.0 |
| BSD-2-Clause | BSD 2-Clause "Simplified" License | SPDX:BSD-2-Clause |
| BSD-2-Clause-FreeBSD | BSD 2-Clause FreeBSD License | SPDX:BSD-2-Clause-FreeBSD |
| BSD-2-Clause-NetBSD | BSD 2-Clause NetBSD License | SPDX:BSD-2-Clause-NetBSD |
| BSD-3-Clause | BSD 3-Clause "New" or "Revised" License | SPDX:BSD-3-Clause |
| BSD-3-Clause-Attribution | BSD with attribution | SPDX:BSD-3-Clause-Attribution |
| BSD-3-Clause-Clear | BSD 3-Clause Clear License | SPDX:BSD-3-Clause-Clear |
| BSD-3-Clause-LBNL | Lawrence Berkeley National Labs BSD variant license | SPDX:BSD-3-Clause-LBNL |
| BSD-3-Clause-No-Nuclear-License | BSD 3-Clause No Nuclear License | SPDX:BSD-3-Clause-No-Nuclear-License |
| BSD-3-Clause-No-Nuclear-License-2014 | BSD 3-Clause No Nuclear License 2014 | SPDX:BSD-3-Clause-No-Nuclear-License-2014 |
| BSD-3-Clause-No-Nuclear-Warranty | BSD 3-Clause No Nuclear Warranty | SPDX:BSD-3-Clause-No-Nuclear-Warranty |
| BSD-4-Clause | BSD 4-Clause "Original" or "Old" License | SPDX:BSD-4-Clause |
| BSD-4-Clause-UC | BSD-4-Clause (University of California-Specific) | SPDX:BSD-4-Clause-UC |
| BSD-Protection | BSD Protection License | SPDX:BSD-Protection |
| BSD-Source-Code | BSD Source Code Attribution | SPDX:BSD-Source-Code |
| BSD-style | A license similar in structure and permissiveness to the BSD license family, but not itself a registered SPDX license identifier (e.g. a project-specific or lightly modified variant). | SPDX:BSD-style |
| BSL-1.0 | Boost Software License 1.0 | SPDX:BSL-1.0 |
| Bahyph | Bahyph License | SPDX:Bahyph |
| Barr | Barr License | SPDX:Barr |
| Beerware | Beerware License | SPDX:Beerware |
| BitTorrent-1.0 | BitTorrent Open Source License v1.0 | SPDX:BitTorrent-1.0 |
| BitTorrent-1.1 | BitTorrent Open Source License v1.1 | SPDX:BitTorrent-1.1 |
| Borceux | Borceux license | SPDX:Borceux |
| CATOSL-1.1 | Computer Associates Trusted Open Source License 1.1 | SPDX:CATOSL-1.1 |
| CC-BY-1.0 | Creative Commons Attribution 1.0 Generic | SPDX:CC-BY-1.0 |
| CC-BY-2.0 | Creative Commons Attribution 2.0 Generic | SPDX:CC-BY-2.0 |
| CC-BY-2.5 | Creative Commons Attribution 2.5 Generic | SPDX:CC-BY-2.5 |
| CC-BY-3.0 | Creative Commons Attribution 3.0 Unported | SPDX:CC-BY-3.0 |
| CC-BY-4.0 | Creative Commons Attribution 4.0 International | SPDX:CC-BY-4.0 |
| CC-BY-NC-1.0 | Creative Commons Attribution Non Commercial 1.0 Generic | SPDX:CC-BY-NC-1.0 |
| CC-BY-NC-2.0 | Creative Commons Attribution Non Commercial 2.0 Generic | SPDX:CC-BY-NC-2.0 |
| CC-BY-NC-2.5 | Creative Commons Attribution Non Commercial 2.5 Generic | SPDX:CC-BY-NC-2.5 |
| CC-BY-NC-3.0 | Creative Commons Attribution Non Commercial 3.0 Unported | SPDX:CC-BY-NC-3.0 |
| CC-BY-NC-4.0 | Creative Commons Attribution Non Commercial 4.0 International | SPDX:CC-BY-NC-4.0 |
| CC-BY-NC-ND-1.0 | Creative Commons Attribution Non Commercial No Derivatives 1.0 Generic | SPDX:CC-BY-NC-ND-1.0 |
| CC-BY-NC-ND-2.0 | Creative Commons Attribution Non Commercial No Derivatives 2.0 Generic | SPDX:CC-BY-NC-ND-2.0 |
| CC-BY-NC-ND-2.5 | Creative Commons Attribution Non Commercial No Derivatives 2.5 Generic | SPDX:CC-BY-NC-ND-2.5 |
| CC-BY-NC-ND-3.0 | Creative Commons Attribution Non Commercial No Derivatives 3.0 Unported | SPDX:CC-BY-NC-ND-3.0 |
| CC-BY-NC-ND-4.0 | Creative Commons Attribution Non Commercial No Derivatives 4.0 International | SPDX:CC-BY-NC-ND-4.0 |
| CC-BY-NC-SA-1.0 | Creative Commons Attribution Non Commercial Share Alike 1.0 Generic | SPDX:CC-BY-NC-SA-1.0 |
| CC-BY-NC-SA-2.0 | Creative Commons Attribution Non Commercial Share Alike 2.0 Generic | SPDX:CC-BY-NC-SA-2.0 |
| CC-BY-NC-SA-2.5 | Creative Commons Attribution Non Commercial Share Alike 2.5 Generic | SPDX:CC-BY-NC-SA-2.5 |
| CC-BY-NC-SA-3.0 | Creative Commons Attribution Non Commercial Share Alike 3.0 Unported | SPDX:CC-BY-NC-SA-3.0 |
| CC-BY-NC-SA-4.0 | Creative Commons Attribution Non Commercial Share Alike 4.0 International | SPDX:CC-BY-NC-SA-4.0 |
| CC-BY-ND-1.0 | Creative Commons Attribution No Derivatives 1.0 Generic | SPDX:CC-BY-ND-1.0 |
| CC-BY-ND-2.0 | Creative Commons Attribution No Derivatives 2.0 Generic | SPDX:CC-BY-ND-2.0 |
| CC-BY-ND-2.5 | Creative Commons Attribution No Derivatives 2.5 Generic | SPDX:CC-BY-ND-2.5 |
| CC-BY-ND-3.0 | Creative Commons Attribution No Derivatives 3.0 Unported | SPDX:CC-BY-ND-3.0 |
| CC-BY-ND-4.0 | Creative Commons Attribution No Derivatives 4.0 International | SPDX:CC-BY-ND-4.0 |
| CC-BY-SA-1.0 | Creative Commons Attribution Share Alike 1.0 Generic | SPDX:CC-BY-SA-1.0 |
| CC-BY-SA-2.0 | Creative Commons Attribution Share Alike 2.0 Generic | SPDX:CC-BY-SA-2.0 |
| CC-BY-SA-2.5 | Creative Commons Attribution Share Alike 2.5 Generic | SPDX:CC-BY-SA-2.5 |
| CC-BY-SA-3.0 | Creative Commons Attribution Share Alike 3.0 Unported | SPDX:CC-BY-SA-3.0 |
| CC-BY-SA-4.0 | Creative Commons Attribution Share Alike 4.0 International | SPDX:CC-BY-SA-4.0 |
| CC0-1.0 | Creative Commons Zero v1.0 Universal | SPDX:CC0-1.0 |
| CDDL-1.0 | Common Development and Distribution License 1.0 | SPDX:CDDL-1.0 |
| CDDL-1.1 | Common Development and Distribution License 1.1 | SPDX:CDDL-1.1 |
| CECILL-1.0 | CeCILL Free Software License Agreement v1.0 | SPDX:CECILL-1.0 |
| CECILL-1.1 | CeCILL Free Software License Agreement v1.1 | SPDX:CECILL-1.1 |
| CECILL-2.0 | CeCILL Free Software License Agreement v2.0 | SPDX:CECILL-2.0 |
| CECILL-2.1 | CeCILL Free Software License Agreement v2.1 | SPDX:CECILL-2.1 |
| CECILL-B | CeCILL-B Free Software License Agreement | SPDX:CECILL-B |
| CECILL-C | CeCILL-C Free Software License Agreement | SPDX:CECILL-C |
| CNRI-Jython | CNRI Jython License | SPDX:CNRI-Jython |
| CNRI-Python | CNRI Python License | SPDX:CNRI-Python |
| CNRI-Python-GPL-Compatible | CNRI Python Open Source GPL Compatible License Agreement | SPDX:CNRI-Python-GPL-Compatible |
| CPAL-1.0 | Common Public Attribution License 1.0 | SPDX:CPAL-1.0 |
| CPL-1.0 | Common Public License 1.0 | SPDX:CPL-1.0 |
| CPOL-1.02 | Code Project Open License 1.02 | SPDX:CPOL-1.02 |
| CUA-OPL-1.0 | CUA Office Public License v1.0 | SPDX:CUA-OPL-1.0 |
| Caldera | Caldera License | SPDX:Caldera |
| ClArtistic | Clarified Artistic License | SPDX:ClArtistic |
| Condor-1.1 | Condor Public License v1.1 | SPDX:Condor-1.1 |
| Crossword | Crossword License | SPDX:Crossword |
| CrystalStacker | CrystalStacker License | SPDX:CrystalStacker |
| Cube | Cube License | SPDX:Cube |
| D-FSL-1.0 | Deutsche Freie Software Lizenz | SPDX:D-FSL-1.0 |
| DOC | DOC License | SPDX:DOC |
| DSDP | DSDP License | SPDX:DSDP |
| Dotseqn | Dotseqn License | SPDX:Dotseqn |
| ECL-1.0 | Educational Community License v1.0 | SPDX:ECL-1.0 |
| ECL-2.0 | Educational Community License v2.0 | SPDX:ECL-2.0 |
| EFL-1.0 | Eiffel Forum License v1.0 | SPDX:EFL-1.0 |
| EFL-2.0 | Eiffel Forum License v2.0 | SPDX:EFL-2.0 |
| EPL-1.0 | Eclipse Public License 1.0 | SPDX:EPL-1.0 |
| EUDatagrid | EU DataGrid Software License | SPDX:EUDatagrid |
| EUPL-1.0 | European Union Public License 1.0 | SPDX:EUPL-1.0 |
| EUPL-1.1 | European Union Public License 1.1 | SPDX:EUPL-1.1 |
| Entessa | Entessa Public License v1.0 | SPDX:Entessa |
| ErlPL-1.1 | Erlang Public License v1.1 | SPDX:ErlPL-1.1 |
| Eurosym | Eurosym License | SPDX:Eurosym |
| FSFAP | FSF All Permissive License | SPDX:FSFAP |
| FSFUL | FSF Unlimited License | SPDX:FSFUL |
| FSFULLR | FSF Unlimited License (with License Retention) | SPDX:FSFULLR |
| FTL | Freetype Project License | SPDX:FTL |
| Fair | Fair License | SPDX:Fair |
| Frameworx-1.0 | Frameworx Open License 1.0 | SPDX:Frameworx-1.0 |
| FreeImage | FreeImage Public License v1.0 | SPDX:FreeImage |
| Freeware | Software made available to use at no monetary cost, without necessarily granting the rights to modify, redistribute, or access the source code that an open-source license would. | SPDX:Freeware |
| GFDL-1.1 | GNU Free Documentation License v1.1 | SPDX:GFDL-1.1 |
| GFDL-1.2 | GNU Free Documentation License v1.2 | SPDX:GFDL-1.2 |
| GFDL-1.3 | GNU Free Documentation License v1.3 | SPDX:GFDL-1.3 |
| GL2PS | GL2PS License | SPDX:GL2PS |
| GPL-1.0 | GNU General Public License v1.0 only | SPDX:GPL-1.0 |
| GPL-2.0 | GNU General Public License v2.0 only | SPDX:GPL-2.0 |
| GPL-3.0 | GNU General Public License v3.0 only | SPDX:GPL-3.0 |
| Giftware | Giftware License | SPDX:Giftware |
| Glide | 3dfx Glide License | SPDX:Glide |
| Glulxe | Glulxe License | SPDX:Glulxe |
| HPND | Historical Permission Notice and Disclaimer | SPDX:HPND |
| HaskellReport | Haskell Language Report License | SPDX:HaskellReport |
| IBM-pibs | IBM PowerPC Initialization and Boot Software | SPDX:IBM-pibs |
| ICU | ICU License | SPDX:ICU |
| IJG | Independent JPEG Group License | SPDX:IJG |
| IPA | IPA Font License | SPDX:IPA |
| IPL-1.0 | IBM Public License v1.0 | SPDX:IPL-1.0 |
| ISC | ISC License | SPDX:ISC |
| ImageMagick | ImageMagick License | SPDX:ImageMagick |
| Imlib2 | Imlib2 License | SPDX:Imlib2 |
| Info-ZIP | Info-ZIP License | SPDX:Info-ZIP |
| Intel | Intel Open Source License | SPDX:Intel |
| Intel-ACPI | Intel ACPI Software License Agreement | SPDX:Intel-ACPI |
| Interbase-1.0 | Interbase Public License v1.0 | SPDX:Interbase-1.0 |
| JSON | JSON License | SPDX:JSON |
| JasPer-2.0 | JasPer License | SPDX:JasPer-2.0 |
| LAL-1.2 | Licence Art Libre 1.2 | SPDX:LAL-1.2 |
| LAL-1.3 | Licence Art Libre 1.3 | SPDX:LAL-1.3 |
| LGPL-2.0 | GNU Library General Public License v2 only | SPDX:LGPL-2.0 |
| LGPL-2.1 | GNU Lesser General Public License v2.1 only | SPDX:LGPL-2.1 |
| LGPL-3.0 | GNU Lesser General Public License v3.0 only | SPDX:LGPL-3.0 |
| LGPLLR | Lesser General Public License For Linguistic Resources | SPDX:LGPLLR |
| LPL-1.0 | Lucent Public License Version 1.0 | SPDX:LPL-1.0 |
| LPL-1.02 | Lucent Public License v1.02 | SPDX:LPL-1.02 |
| LPPL-1.0 | LaTeX Project Public License v1.0 | SPDX:LPPL-1.0 |
| LPPL-1.1 | LaTeX Project Public License v1.1 | SPDX:LPPL-1.1 |
| LPPL-1.2 | LaTeX Project Public License v1.2 | SPDX:LPPL-1.2 |
| LPPL-1.3a | LaTeX Project Public License v1.3a | SPDX:LPPL-1.3a |
| LPPL-1.3c | LaTeX Project Public License v1.3c | SPDX:LPPL-1.3c |
| Latex2e | Latex2e License | SPDX:Latex2e |
| Leptonica | Leptonica License | SPDX:Leptonica |
| LiLiQ-P-1.1 | Licence Libre du Québec – Permissive version 1.1 | SPDX:LiLiQ-P-1.1 |
| LiLiQ-R-1.1 | Licence Libre du Québec – Réciprocité version 1.1 | SPDX:LiLiQ-R-1.1 |
| LiLiQ-Rplus-1.1 | Licence Libre du Québec – Réciprocité forte version 1.1 | SPDX:LiLiQ-Rplus-1.1 |
| Libpng | libpng License | SPDX:Libpng |
| MIT | MIT License | SPDX:MIT |
| MIT-CMU | CMU License | SPDX:MIT-CMU |
| MIT-advertising | Enlightenment License (e16) | SPDX:MIT-advertising |
| MIT-enna | enna License | SPDX:MIT-enna |
| MIT-feh | feh License | SPDX:MIT-feh |
| MITNFA | MIT +no-false-attribs license | SPDX:MITNFA |
| MPL-1.0 | Mozilla Public License 1.0 | SPDX:MPL-1.0 |
| MPL-1.1 | Mozilla Public License 1.1 | SPDX:MPL-1.1 |
| MPL-2.0 | Mozilla Public License 2.0 | SPDX:MPL-2.0 |
| MPL-2.0-no-copyleft-exception | Mozilla Public License 2.0 (no copyleft exception) | SPDX:MPL-2.0-no-copyleft-exception |
| MS-PL | Microsoft Public License | SPDX:MS-PL |
| MS-RL | Microsoft Reciprocal License | SPDX:MS-RL |
| MTLL | Matrix Template Library License | SPDX:MTLL |
| MakeIndex | MakeIndex License | SPDX:MakeIndex |
| MirOS | The MirOS Licence | SPDX:MirOS |
| Motosoto | Motosoto License | SPDX:Motosoto |
| Multics | Multics License | SPDX:Multics |
| Mup | Mup License | SPDX:Mup |
| NASA-1.3 | NASA Open Source Agreement 1.3 | SPDX:NASA-1.3 |
| NBPL-1.0 | Net Boolean Public License v1 | SPDX:NBPL-1.0 |
| NCSA | University of Illinois/NCSA Open Source License | SPDX:NCSA |
| NGPL | Nethack General Public License | SPDX:NGPL |
| NLOD-1.0 | Norwegian Licence for Open Government Data (NLOD) 1.0 | SPDX:NLOD-1.0 |
| NLPL | No Limit Public License | SPDX:NLPL |
| NOSL | Netizen Open Source License | SPDX:NOSL |
| NPL-1.0 | Netscape Public License v1.0 | SPDX:NPL-1.0 |
| NPL-1.1 | Netscape Public License v1.1 | SPDX:NPL-1.1 |
| NPOSL-3.0 | Non-Profit Open Software License 3.0 | SPDX:NPOSL-3.0 |
| NRL | NRL License | SPDX:NRL |
| NTP | NTP License | SPDX:NTP |
| Naumen | Naumen Public License | SPDX:Naumen |
| NetCDF | NetCDF license | SPDX:NetCDF |
| Newsletr | Newsletr License | SPDX:Newsletr |
| Nokia | Nokia Open Source License | SPDX:Nokia |
| Not licensed | No license has been specified or applied to the resource, so no usage rights beyond default copyright protections can be assumed. | Not available |
| Noweb | Noweb License | SPDX:Noweb |
| Nunit | Nunit License | SPDX:Nunit |
| OCCT-PL | Open CASCADE Technology Public License | SPDX:OCCT-PL |
| OCLC-2.0 | OCLC Research Public License 2.0 | SPDX:OCLC-2.0 |
| ODbL-1.0 | Open Data Commons Open Database License v1.0 | SPDX:ODbL-1.0 |
| OFL-1.0 | SIL Open Font License 1.0 | SPDX:OFL-1.0 |
| OFL-1.1 | SIL Open Font License 1.1 | SPDX:OFL-1.1 |
| OGTSL | Open Group Test Suite License | SPDX:OGTSL |
| OLDAP-1.1 | Open LDAP Public License v1.1 | SPDX:OLDAP-1.1 |
| OLDAP-1.2 | Open LDAP Public License v1.2 | SPDX:OLDAP-1.2 |
| OLDAP-1.3 | Open LDAP Public License v1.3 | SPDX:OLDAP-1.3 |
| OLDAP-1.4 | Open LDAP Public License v1.4 | SPDX:OLDAP-1.4 |
| OLDAP-2.0 | Open LDAP Public License v2.0 (or possibly 2.0A and 2.0B) | SPDX:OLDAP-2.0 |
| OLDAP-2.0.1 | Open LDAP Public License v2.0.1 | SPDX:OLDAP-2.0.1 |
| OLDAP-2.1 | Open LDAP Public License v2.1 | SPDX:OLDAP-2.1 |
| OLDAP-2.2 | Open LDAP Public License v2.2 | SPDX:OLDAP-2.2 |
| OLDAP-2.2.1 | Open LDAP Public License v2.2.1 | SPDX:OLDAP-2.2.1 |
| OLDAP-2.2.2 | Open LDAP Public License 2.2.2 | SPDX:OLDAP-2.2.2 |
| OLDAP-2.3 | Open LDAP Public License v2.3 | SPDX:OLDAP-2.3 |
| OLDAP-2.4 | Open LDAP Public License v2.4 | SPDX:OLDAP-2.4 |
| OLDAP-2.5 | Open LDAP Public License v2.5 | SPDX:OLDAP-2.5 |
| OLDAP-2.6 | Open LDAP Public License v2.6 | SPDX:OLDAP-2.6 |
| OLDAP-2.7 | Open LDAP Public License v2.7 | SPDX:OLDAP-2.7 |
| OLDAP-2.8 | Open LDAP Public License v2.8 | SPDX:OLDAP-2.8 |
| OML | Open Market License | SPDX:OML |
| OPL-1.0 | Open Public License v1.0 | SPDX:OPL-1.0 |
| OSET-PL-2.1 | OSET Public License version 2.1 | SPDX:OSET-PL-2.1 |
| OSL-1.0 | Open Software License 1.0 | SPDX:OSL-1.0 |
| OSL-1.1 | Open Software License 1.1 | SPDX:OSL-1.1 |
| OSL-2.0 | Open Software License 2.0 | SPDX:OSL-2.0 |
| OSL-2.1 | Open Software License 2.1 | SPDX:OSL-2.1 |
| OSL-3.0 | Open Software License 3.0 | SPDX:OSL-3.0 |
| OpenSSL | OpenSSL License | SPDX:OpenSSL |
| Other | A license not covered by any of the other listed values. | SPDX:Other |
| PDDL-1.0 | Open Data Commons Public Domain Dedication & License 1.0 | SPDX:PDDL-1.0 |
| PHP-3.0 | PHP License v3.0 | SPDX:PHP-3.0 |
| PHP-3.01 | PHP License v3.01 | SPDX:PHP-3.01 |
| Plexus | Plexus Classworlds License | SPDX:Plexus |
| PostgreSQL | PostgreSQL License | SPDX:PostgreSQL |
| Proprietary | A license under which the software's source code is not made publicly available and usage, modification, and redistribution are restricted by the copyright holder. | SPDX:Proprietary |
| Python-2.0 | Python License 2.0 | SPDX:Python-2.0 |
| QPL-1.0 | Q Public License 1.0 | SPDX:QPL-1.0 |
| Qhull | Qhull License | SPDX:Qhull |
| RHeCos-1.1 | Red Hat eCos Public License v1.1 | SPDX:RHeCos-1.1 |
| RPL-1.1 | Reciprocal Public License 1.1 | SPDX:RPL-1.1 |
| RPL-1.5 | Reciprocal Public License 1.5 | SPDX:RPL-1.5 |
| RPSL-1.0 | RealNetworks Public Source License v1.0 | SPDX:RPSL-1.0 |
| RSA-MD | RSA Message-Digest License | SPDX:RSA-MD |
| RSCPL | Ricoh Source Code Public License | SPDX:RSCPL |
| Rdisc | Rdisc License | SPDX:Rdisc |
| Ruby | Ruby License | SPDX:Ruby |
| SAX-PD | Sax Public Domain Notice | SPDX:SAX-PD |
| SCEA | SCEA Shared Source License | SPDX:SCEA |
| SGI-B-1.0 | SGI Free Software License B v1.0 | SPDX:SGI-B-1.0 |
| SGI-B-1.1 | SGI Free Software License B v1.1 | SPDX:SGI-B-1.1 |
| SGI-B-2.0 | SGI Free Software License B v2.0 | SPDX:SGI-B-2.0 |
| SISSL | Sun Industry Standards Source License v1.1 | SPDX:SISSL |
| SISSL-1.2 | Sun Industry Standards Source License v1.2 | SPDX:SISSL-1.2 |
| SMLNJ | Standard ML of New Jersey License | SPDX:SMLNJ |
| SMPPL | Secure Messaging Protocol Public License | SPDX:SMPPL |
| SNIA | SNIA Public License 1.1 | SPDX:SNIA |
| SPL-1.0 | Sun Public License v1.0 | SPDX:SPL-1.0 |
| SWL | Scheme Widget Library (SWL) Software License Agreement | SPDX:SWL |
| Saxpath | Saxpath License | SPDX:Saxpath |
| Sendmail | Sendmail License | SPDX:Sendmail |
| SimPL-2.0 | Simple Public License 2.0 | SPDX:SimPL-2.0 |
| Sleepycat | Sleepycat License | SPDX:Sleepycat |
| Spencer-86 | Spencer License 86 | SPDX:Spencer-86 |
| Spencer-94 | Spencer License 94 | SPDX:Spencer-94 |
| Spencer-99 | Spencer License 99 | SPDX:Spencer-99 |
| SugarCRM-1.1.3 | SugarCRM Public License v1.1.3 | SPDX:SugarCRM-1.1.3 |
| TCL | TCL/TK License | SPDX:TCL |
| TMate | TMate Open Source License | SPDX:TMate |
| TORQUE-1.1 | TORQUE v2.5+ Software License v1.1 | SPDX:TORQUE-1.1 |
| TOSL | Trusster Open Source License | SPDX:TOSL |
| UPL-1.0 | Universal Permissive License v1.0 | SPDX:UPL-1.0 |
| Unicode-TOU | Unicode Terms of Use | SPDX:Unicode-TOU |
| Unlicense | The Unlicense | SPDX:Unlicense |
| VOSTROM | VOSTROM Public License for Open Source | SPDX:VOSTROM |
| VSL-1.0 | Vovida Software License v1.0 | SPDX:VSL-1.0 |
| Vim | Vim License | SPDX:Vim |
| W3C | W3C Software Notice and License (2002-12-31) | SPDX:W3C |
| W3C-19980720 | W3C Software Notice and License (1998-07-20) | SPDX:W3C-19980720 |
| WTFPL | Do What The F*ck You Want To Public License | SPDX:WTFPL |
| Watcom-1.0 | Sybase Open Watcom Public License 1.0 | SPDX:Watcom-1.0 |
| Wsuipa | Wsuipa License | SPDX:Wsuipa |
| X11 | X11 License | SPDX:X11 |
| XFree86-1.1 | XFree86 License 1.1 | SPDX:XFree86-1.1 |
| XSkat | XSkat License | SPDX:XSkat |
| Xerox | Xerox License | SPDX:Xerox |
| Xnet | X.Net License | SPDX:Xnet |
| YPL-1.0 | Yahoo! Public License v1.0 | SPDX:YPL-1.0 |
| YPL-1.1 | Yahoo! Public License v1.1 | SPDX:YPL-1.1 |
| ZPL-1.1 | Zope Public License 1.1 | SPDX:ZPL-1.1 |
| ZPL-2.0 | Zope Public License 2.0 | SPDX:ZPL-2.0 |
| ZPL-2.1 | Zope Public License 2.1 | SPDX:ZPL-2.1 |
| Zed | Zed License | SPDX:Zed |
| Zend-2.0 | Zend License v2.0 | SPDX:Zend-2.0 |
| Zimbra-1.3 | Zimbra Public License v1.3 | SPDX:Zimbra-1.3 |
| Zimbra-1.4 | Zimbra Public License v1.4 | SPDX:Zimbra-1.4 |
| Zlib | zlib License | SPDX:Zlib |
| bzip2-1.0.5 | bzip2 and libbzip2 License v1.0.5 | SPDX:bzip2-1.0.5 |
| bzip2-1.0.6 | bzip2 and libbzip2 License v1.0.6 | SPDX:bzip2-1.0.6 |
| curl | curl License | SPDX:curl |
| diffmark | diffmark license | SPDX:diffmark |
| dvipdfm | dvipdfm License | SPDX:dvipdfm |
| eGenix | eGenix.com Public License 1.1.0 | SPDX:eGenix |
| gSOAP-1.3b | gSOAP Public License v1.3b | SPDX:gSOAP-1.3b |
| gnuplot | gnuplot License | SPDX:gnuplot |
| iMatix | iMatix Standard Function Library Agreement | SPDX:iMatix |
| libtiff | libtiff License | SPDX:libtiff |
| mpich2 | mpich2 License | SPDX:mpich2 |
| psfrag | psfrag License | SPDX:psfrag |
| psutils | psutils License | SPDX:psutils |
| xinetd | xinetd License | SPDX:xinetd |
| xpp | XPP License | SPDX:xpp |
| zlib-acknowledgement | zlib/libpng License with Acknowledgement | SPDX:zlib-acknowledgement |